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ABSTRACT
Anabolic-androgenic steroids (AASs; testosterone (T) and its many 
synthetic derivatives) have body-building properties. Therefore, they 
are widely prescribed for the treatment of muscle wasting conditions 
such as sarcopenia and cachexia. Although, the chronic effects of 
these compounds in skeletal muscle have been the subject of many 
previous studies and some of their chronic effects are well 
documented, little is known about their acute/non-genomic effects. 
Furthermore, in most tissues T is not the active hormone; instead it 
is converted to dihydrotestosterone (DHT). Despite this, the acute 
effects of DHT have never been investigated. Most of the previous 
studies were performed using animals or humans and some of the 
findings were highly variable. Therefore, to minimise this variability, 
small muscle fibre bundles isolated from the extensor digitorum 
longus and soleus of adult female CD1 mice were used to 
investigate the acute/non-genomic effects of DHT and T on amino 
acid uptake. Pharmacological interventions were then used to 
determine the cellular signalling pathway(s) and receptor(s) 
mediating these actions. My results, which form the bulk of this 
thesis, show that treatment of the muscle fibre bundles with DHT 
(but not T) led to increase in the uptake into proteins of the essential 
amino acid, isoleucine. These effects were mediated through the 
epidermal growth factor receptor (EGFR) and involved the activation 
of the extracellular-regulated kinases (ERK) 1/2 and the p90 
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ribosomal S6 kinases (RSK) 1/2. DHT treatment also increased the 
phosphorylation of the 20kDa regulatory myosin light chains and the 
expression of the L-type amino acid transporter (LAT) 2. From these 
results I suggest that DHT, and not T, is the more potent anabolic-
androgenic steroid hormone in mammalian skeletal muscle fibres 
and that its derivatives may be better drugs for the management of 
sarcopenia and cachexia than those of T.
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1CHAPTER 1
INTRODUCTION
1.1 Skeletal muscle structure and function
In this study, I investigated the cellular signal transduction events 
underlying the acute (=rapid/non-genomic) actions of testosterone
(T) and its metabolite dihydrotestosterone (DHT) in isolated intact 
mammalian skeletal muscle fibre bundles. Therefore, in this section 
of my thesis I will provide background information on the structure, 
organisation and function of mammalian skeletal muscles.
There are three types of muscles in the mammalian body namely; 
cardiac, skeletal and smooth muscle. Examined under polarising 
light, cardiac and skeletal muscles show highly regular repeats of 
dark and light bands or striations. Therefore, they are also referred 
to as striated muscles. On the other hand, smooth muscles show no 
striations when examined under a light microscope, hence the name 
smooth muscle (Randall et al. 1997).
Cardiac muscle is found in the heart, smooth muscle is located in the 
walls of all hollow visceral organs, whereas, skeletal muscle is 
closely associated with the skeletal system. As all the experiments 
reported here were performed using skeletal muscles, I will 
concentrate on the structure and function of this muscle type.
Figure 1.1
of a skeletal muscle. Note that 
cylindrical, multinucleated cells known as muscle fibres or myofibres 
that run from end to end. The 
and other cellular components such as mitochondria. The myofibril in 
turn consist of three types of protein filaments namely; actin, myosin 
and titin filaments. Moreover, the muscle is tethered at either end by 
straps o
aponeurosis. 
: A schematic diagram showing the structural organisation 
f tough connective tissues known as tendons or 
Figure adapted from R
myofibres are composed of myofibrils 
each muscle consists of long, 
andall et al. 1997.
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3Skeletal muscle forms the bulk of body weight (~40 to 50% of body 
mass) (Rooyackers & Nair, 1997). Its main function is to provide the 
force required for postural maintenance and to move joints. 
Macroscopically, skeletal muscles can be divided into red and white 
muscle. Red muscle is rich in myoglobin (which gives it its red 
appearance) and oxidative enzymes. Its fibres express a slow form 
of the contractile muscle protein, myosin, which splits ATP slowly. 
Therefore, it is also referred to as slow-twitch muscle (McComas, 
2005). It is used mainly for postural support and to power slow 
repetitive movements such as marathon running. In contrast, white 
muscle is devoid of myoglobin and is rich in glycolytic enzymes. It 
consists mainly of muscle fibres that express isoforms of myosin that 
split ATP rapidly. Therefore, it is also known as fast-twitch muscle 
(McComas, 2005). In the body, white muscle powers activities that 
require large amounts of energy for short periods of time such as 
sprint running (Pette & Staron, 2000). 
Figure 1.1 shows the functional organisation of a typical skeletal 
muscle. As the diagram shows, each skeletal muscle is tethered at 
either end to bones by straps of tough connective tissues known as 
tendons or to other muscles/tissues via a sheath of connective tissue 
known as an aponeurosis. Depending on their location, the tendons 
are referred to as either the tendon of origin or insertion. Thus, the 
tendon proximal to the body is known as the tendon of origin; 
4whereas, the one distal to it is referred to as the tendon of insertion 
(Garrett, 1990). 
As the diagram also shows, each muscle consists of long, 
cylindrical, multinucleated cells known as muscle fibres or myofibres. 
Except in immature or regenerating muscles where the nuclei are 
located in the centre of the fibre, in adult muscles the nuclei are 
arranged around the periphery of the fibre. The myofibres are 
arranged in groups of between 10 and 100 fibres, depending on their 
function, known as fascicles or fibre bundles. Each fascicle is 
surrounded by a thin connective tissue known as a perimysium and 
the muscle fibres in fascicle run parallel to each other from one 
tendon to the other. In adult mice, each muscle fibre is 30-60m in 
diameter and 6-7mm long (Hegarty & Hooper, 1971).
Each muscle fibre consists of protein filaments grouped together in 
bundles known as myofibrils. In all muscles, the myofibrils are 
surrounded by cytoplasm (or sarcoplasm) and other cellular 
organelles such as mitochondria, myoglobin, and glycogen. 
Furthermore, the volume density of each of these components 
depends on the fibre type (Peachey, 1968). Each myofibril is 
approximately 1m in diameter and in most muscles runs the whole 
length of the fibre (see figure 1.1). Moreover, 600-3000 of them can 
be packed into a single myofibre, which is equivalent to 60 to 70 % 
of its total volume (Luff & Goldspink, 1970). 
5As mention above, each myofibril consists of filaments or 
myofilaments that lie parallel to the long axis of the myofibril. In turn, 
the myofilaments consist of ordered repeats of thin and thick 
filaments. It is this ordered assembly of thin and thick filaments that 
gives skeletal and cardiac muscles their striated appearance when 
examined under a light microscope (Randall et al. 1997).
1.2 Thin filament
The thin filament consists of the contractile protein actin (Straub, 
1942). The actin molecule exists in two forms, globular (G) and 
filamentous (F) actin (Pardee & Spudich, 1982; Pollard & Borisy, 
2003). Actin is one of the most abundant proteins in eukaryotic cells 
and has a molecular weight of approximately 43kDa (Garells & 
Gibson, 1976). Additionally, its amino acid sequence is highly 
conserved and as a result actin is commonly used as a loading 
control in gel electrophoresis and Western blot analysis (Kabsch & 
Vandekerchovke, 1992). Therefore, in most of my studies, I used 
actin to check and correct for loading errors.
In higher vertebrates, the actin family consists of six isoforms 
namely; α-skeletal, α-cardiac, α-smooth muscle, γ-smooth muscle, γ-
cytoplasmic non-muscle and β-cytoplasmic non-muscle actin 
(Garells & Gibson, 1976; Mounier & Sparrow, 1997). Furthermore, 
the expression of each of these isoforms in vertebrates has been 
shown to depend on the tissue, its function and developmental stage 
(Cox & Buckingham, 1992; Bertola et al. 2008). Thus, adult skeletal 
6muscles express mainly α-actin and β-actin is only expressed during 
early myogenesis (Cox et al. 1990).
Each thin filament consists of two strands of F-actin that are 
intertwined to form a double helix with a diameter of ~7nm (Gordon 
et al. 2000). Running along the grooves between the two strands is 
another protein known as tropomyosin. Tropomyosin is a rod shaped 
molecule that is composed of two intertwined polypeptides each 
approximately seven actin monomers long (Gordon et al. 2000). 
Each tropomyosin molecule is held in place by another protein 
known as troponin (Gordon et al. 2000). The troponin molecule 
consists of three subunits namely; troponin T (TnT), which tethers 
the tropomyosin to the actin molecule, troponin C (TnC) which is the 
Ca2+ binding subunit and finally troponin I (TnI) or the inhibitory 
subunit of troponin (Gordon et al. 2000). TnI partially covers the 
myosin binding sites on the actin molecule (Figure 1.2) and under 
resting conditions prevents myosin from binding to actin.
Figure 1.2
the various proteins that form a thin filament. In (a) a transverse 
cross
section is displayed. Note that TnI (green globules) partially
obscures the myosin binding sites on actin (grey/white spheres), TnT 
(yellow sphere/rod) tethers tropomyosin (black and brown strands) 
onto actin and TnC (red globules) binds calcium ions (black spheres 
in (a)). Figure from Gordon, et al. 2000.
1.3
The thick filament consists mainly of the contractile protein myosin. 
However, it also contains several myosin binding proteins including 
C-protein, H
(Clark 
regions: a head or motor domain; a neck and a carboxylic terminal 
tail (Schiaffino & Reggiani, 1996). Members of the myosin 
: A schematic diagram showing the relationship between 
-section of the filament is shown; whereas, in (b) a longitudinal 
Thick 
et al.
filament
-protein, myomesin and the giant muscle protein titin 
2003). Each myosin molecule consists of three distinct 
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8superfamily are defined by their conserved head domain sequences 
and based on these sequences can be grouped into 20 classes each 
with a different structure and function (Krendel & Mooseker, 2005). 
The myosin found in skeletal muscle belongs to class II or 
conventional myosin (Sellers, 2000). Therefore, in this section of my 
thesis I will concentrate on the structure of this class of myosins.
Conventional (also referred to as sarcomeric) myosin is composed of 
two heavy chains with molecular masses of ~200kDa and two pairs 
of light chains with molecular masses, ranging from 16-27kDa 
depending on the muscle type (see Fig 1.3). Myosin molecules form 
a parallel, two-chain coiled-coil structure over most of their length 
except in the NH2-terminal region where they form two large, 
globular structures commonly referred to as myosin heads or 
subfragment 1(S1). One pair of light chains binds to each S1. The 
coiled-coil region of the myosin molecule, also known as the myosin 
rod, interacts with the rods of other myosin molecules via oppositely 
charged amino acids to form the myosin (thick) filaments. The 
molecules are also shifted along the filament by regular intervals of 
~14.3nm. Because of this stagger the myosin heads project 
outwards from the thick filament and are helically arranged with 
repeats of ~14.3nm (Gordon et al. 2000).
Figure 1.3
conventional/class II myosin. Note that it consists of two molecules 
each composed of a head (A), neck (B) and tail
Furthermore, the tails from the two molecules intertwine to form a α
helical coiled
trypsin yields two sub
light meromyosin (LMM). The HMM can be further split into two sub
fragments; S1 and S2. S1 consists of the myosin heads; whereas, 
S2 consists of the neck an
(MLC). Diagram adapted from Schiaffino 
In mammalian skeletal muscles both the myosin heavy chains 
(MyHCs
expressed in the various fibre types. Up to date six MyHC isoforms 
namely; MyHC
and MHC
(Schiaff
in slow
: A schematic diagram 
) and MLCs exist in several isoforms that are differentially 
-neo have been identified in mammalian skeletal muscles 
ino & Reggiani, 1996). MyHC
-twitch/type 1 fibres; whereas, MyHC
-coil. Limited prot
-β/slow, MyHC
-fragments; heavy meromyosin (HMM) and 
eolytic digestion of the molecule with 
d its associated myosin light chains 
-2A, MyHC
-β/slow is found predominantly 
showing the structure of 
& Reggiani (1996).
-2X, MyHC-2B, MyHC
-2A, MyHC
(C) regions. 
-2X and 
9
-
-
-emb 
MyHC
emb and MHC
fibres, respe
various fibre types, MyHCs are commonly used in the 
identification/classification of skeletal muscle fibre types.
Figure 1.4
location of the thin and t
associate with the thick filament. Diagram adapted from Schiaffino 
Reggiani (1996).
1.4
Adult mammalian skeletal muscles perform a wide variety of 
functions ranging from those requiring prolonged/
contractions for example the maintenance of posture to those 
requiring bursts of rapid movements such as sprint running. As a 
result they are composed of a mixture of fibre types that differ in their 
-2B are found in fast
: A schematic diagram of the sarcomere showing the 
Muscle 
-neo are found mainly in embryonic and neonatal 
ctively. Because of their unique distribution in the 
fibre types
-twitch/type 2 fibres. In contrast, MyHC
hick filaments as well as the proteins 
slow repetitive 
10
-
&
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metabolic capabilities, contractile properties, ultra-structural 
characteristics and fatigue resistance.
On the basis of these characteristics, adult mammalian skeletal 
muscle fibres have been classified as either fast-twitch (types 2A, 2B 
and 2X) or slow-twitch (type 1) (see summary in Table 1.1; 
Schiaffino & Reggiani, 1996). Both type 2B and 2X fibres express 
isoforms of the contractile protein, myosin (MyHCII/D and MyHCII, 
respectively) that hydrolyse ATP rapidly. In order to generate ATP 
quickly, they utilise anaerobic metabolism and hence they fatigue 
fairly rapidly (Pette, 1985). Therefore, they are adapted for 
movements such as sprint running that require short bursts of rapid 
contractions (Table 1.1; Pette, 1985). In contrast, type 1 fibres 
express a slow contracting isoform of myosin (MyHCI) that 
hydrolyses ATP slowly (Pette, 1985). These fibres are recruited 
when slow repetitive or prolonged postural movements are 
necessary (Pette & Staron, 2000). To power their slow contractions, 
type I fibres utilise predominantly aerobic metabolism and therefore, 
they are relatively fatigue resistant. Located in between these two 
groups are type 2A fibres. These fibres express a fast isoform of 
myosin (MyHCIIA) which utilises both oxidative and glycolytic 
metabolism (Delp & Duan 1996). Therefore, these fibres are 
relatively fatigue resistant and are recruited during movements that 
require high speeds sustained for long periods of time such as 
middle distance running (see Table 1.1; Sjostrom et al. 1987).
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Table 1.1: A summary of some of the characteristics of the various muscle fibre types. 
Fibre type name Histochemistry characteristics Immunohistochemical
characteristics
Metabolic 
characteristics
Use
mATPase acid pre-
incubation (pH 4.0)*
mATPase alkali pre-
incubation (pH 10.0)*
SDH stain** Myosin isoform*** Oxidative capacity
Type I 
(Slow Oxidative)
Stains dark Stains light Stains dark MyHC I High Postural 
maintenance, 
marathon running 
Type 2A
(Fast Oxidative 
Glycolytic)
Stains light Stains dark Stains light MyHC IIA Intermediate Middle distance 
running 
Type 2B Stains light Stains dark Stains light MyHC II/D Low Sprint running
Type2X
(Fast Glycolytic)
Stains light Stains dark Stains light MyHC IIX Low Sprint running 
13
*Acid pre-incubation (pH 4.6) inhibits the myosin ATPase activity in fast (Type 2A, 2X, and 2B) fibre types, but not in the slow 
(Type I) type. Alkali pre-incubation (pH 10.2) inhibits myosin ATPase in slow fibre types only. In this stain, phosphate reacts with 
Ca2+ to form calcium phosphate which precipitates. The Ca2+ is then replaced with cobalt which reacts with hydrogen sulphide to 
form colbalt sulfide (CoS2) (dark brownish) which precipitates to give the fibres the dark colour. As fast-contracting muscle fibres 
hydrolyse ATP faster than slow-contracting ones, when given equivalent times, fast-contracting fibres appear dark 
histochemically, and slow-contracting fibre appear light. When this method is used in conjunction with pre-incubation steps to 
accentuate or reverse this pattern, the myosin ATPase assay can be used to distinguish between fast- and slow-contracting 
muscle fibres.
**Succinic dehydrogenase (SDH) is found in all aerobic tissues and normally catalyses the hydrogenation of succinate to 
fumarate in the citric acid cycle. Therefore, it is very specific for mitochondrial density/activity. In this stain, the rate of the reaction 
is monitored using a redox dye such as sodium tetrazolium. As the conversion of succinate to fumarate occurs, the dye is reduced 
into an insoluble deep blue compound. 
***Probed using monoclonal antibodies against the various myosin heavy chains. 
14
Although most mammalian skeletal muscles consist of a mixture of 
the fibre types mentioned above, each fibre type shows a regional 
distribution (Wang & Kernell, 2001). Additionally, some skeletal 
muscles such as the extensor digitorum longus (EDL) and soleus 
are composed of mainly a single fibre type (Ranatunga & Thomas, 
1990). Because of their fibre type composition, these muscles are 
commonly used as experimental models of fast- and slow-twitch 
fibres, respectively (Mutungi & Ranatunga, 1996; Mutungi &
Ranatunga, 2000; Hamdi & Mutungi, 2010). For this reason, all the 
fibre bundles used in this study were isolated from the EDL and 
soleus of adult female mice. 
1.5 Skeletal muscle plasticity
Each of these fibre types is the product of a multi-gene programme 
that is tightly regulated in a fibre-type specific manner (Butler-
Browne and Whalen, 1984; Weydert et al. 1987) and in adult 
muscles can be rapidly switched from one type to another depending 
on the activity of the motor neurones innervating them; and the 
physiological and biochemical demands imposed upon them 
(Talmadge, 2000). This fibre type switching is commonly referred to 
as muscle plasticity (Schiaffino et al. 2007). During this process, 
fibre types are remodelled in a sequential manner (Ausoni et al. 
1990; Conjard et al. 1998). For example, endurance exercise (Green 
et al. 1984) and chronic electrical stimulation (Talmadge, 2000) 
leads to muscle fibres  switching in the following order;  2X/2B  2A 
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 I fibres; whereas, inactivity leads to the fibres switching in the 
opposite direction i.e. I  2A  2X/2B (Pette & Starron, 2000). 
Although this is what is thought to occur under most experimental 
conditions, it is now generally accepted that under certain conditions 
such as hind limb unloading or prolonged bed rest, the fibres can 
skip the expression of one or several of the myosin isoforms 
(Andersen et al. 1996). For example, when the soleus muscle 
switches from slow to fast fibres in response to inactivity or 
spaceflight unloading, a high number of fibres have been found to 
co-expressing type I and 2X myosin without expressing the type 2A 
myosin, so called ‘jump fibres’ (Talmadge, 2000). In addition to fibres 
that express a single myosin isoform, a considerable numbers of 
fibres have been shown to contain two or occasionally more myosin 
isoforms for example type I+2A, 2A+2X or 2X+2B (commonly 
termed‘ hybrid fibres’) (Talmadge, 2000). The co-existence of 
different myosin isoforms in a single fibre is characteristics of 
muscles undergoing rapid changes and in these muscles the 
population of hybrid fibres has been shown to increase. For 
example, the number of hybrid fibres has been shown to increase in 
human muscle following strength training (Staron & Hikida, 1992), 
endurance training (Klitgaard et al.1990) and in chronically electro-
stimulated vastus lateralis muscle of spinal-cord injured individual 
(Andersen et al. 1996).
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Although, many factors including the patterns of innervation (Pette &
Vrbova, 1985), altered weight bearing (Loughna et al. 1990), 
physical activity (Booth & Thomason, 1991) and various hormones 
(Izumo et al. 1986) have been shown to affect the fibre type 
composition and hence the gene programmes of adult mammalian 
skeletal muscles, the cellular signalling pathways and the 
transcription factors that regulate these changes are still not fully 
understood (Spangenburg & Booth, 2003). 
Another major determinant of muscle fibre type composition is 
ageing. One consequence of the ageing process is the progressive 
loss of skeletal muscle mass (Grimby & Saltin, 1983; Bruce et al.
1989; Brooks & Faulkner, 1994; Frontera et al. 2000). Previously, 
most of the decline in force with age was attributed to the loss in 
skeletal muscle mass (Grimby & Saltin, 1983; Bruce et al. 1989; 
Frontera et al. 2000). However, recent evidence suggests that 
changes in the contractile properties of the muscle fibres per se and 
a reduction in the number and cross-sectional area of muscle fibres, 
especially type 2B/2X fibres (Larsson & Moss, 1983; Larsson et al.
1991, Lexell, 1995; Brown & Hasser, 1996; Kadhiresan et al. 1996) 
play a far greater role in the ageing process than previously thought 
(Li & Larsson, 1996; Larsson et al. 1997; Degens et al. 1998; Hook 
et al. 1999; D’Antona et al. 2006). Thus, ageing leads to a decrease 
in both specific muscle force (specific Po) (Larsson et al. 1997) and 
maximum velocity of unloaded shortening (Vo) in type 1 and type 2A 
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fibres but not in type 2B/2X fibres (Li & Larsson, 1996; Larsson et al.
1997; Degens et al. 1998). 
1.6 Synthesis, structure and metabolism of T and DHT
As mentioned above, in this study I investigated the acute/rapid 
actions of T and its metabolite dihydrotestosterone (DHT). 
Therefore, in the next few pages I will describe the synthesis, 
metabolism and chronic effects of T. T, the principal sex hormone in
males, is a 19 carbon (C19) molecule that is synthesised from 
cholesterol in the Leydig cells of the male testes. It has 3 aromatic-
and 1 five-carbon rings (see Figure 1.5; labelled A, B, C and D) with 
a hydroxyl (OH-) group at the C17 position. The synthesis of T occurs 
in the mitochondria and the endoplasmic reticulum of the Leydig 
cells. T, like all other steroid hormones, is synthesised from 
cholesterol and uses the same pathway but different enzymes. Thus, 
in Leydig cells the 11- and 21-hydroxylases found in the adrenal 
cortex are missing and instead these cells contain 17α-hydroxylase 
which hydroxylates pregnenolone at the C17 to produce 17α-
hydroxypregnenolone (see figure 1.5). 17α-hydroxypregnenolone is 
then hydroxylated into androstenedione. The androstenedione is 
then subjected to side chain cleavage and conversion by 17β-
hydroxysteroid dehydrogenase into T.
Figure 1.5
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sex hormones binding globulin (SHBG), and only 2% is free [normal 
range free T: 1.5 to 20ngdl-1] (Pardridge, 1986, Evans, 2004) and 
hence physiologically active. In certain target tissues such as the 
liver, brain, prostate and pubic skin, T is irreversibly converted to 
DHT by the enzyme 5α-reductase (5αRD) (see figure 1.5)
(Bruchovsky & Wilson, 1968). In healthy young adult men, the 
plasma concentration of DHT [normal range 4 to 57.5ngdl-1] is 
similar to that of free T. DHT is also considered to be the more 
potent hormone because it has a higher receptor binding affinity and 
a lower dissociation constant than T (Saartok et al. 1984). However, 
as skeletal muscle is thought to lack 5αRD (Thigpen, et al. 1993), it 
is uncertain whether the anabolic effects of anabolic androgenic 
steroids arise from T itself or from its more potent metabolite DHT.
In the body, T has a short active-life of 1hour (Singh et al. 2001). 
However, it can be chemically modified to increase its anabolic 
potency, slow its rate of metabolism and decrease its aromatisation 
into oestrogen (Wilson, 1990). For example, T can be alkylated at 
C17 into methyltestosterone making it resistant to hepatic 
degradation or it can be made more lipophilic by esterification at C17 
to produce testosterone cypionate thus prolonging its half-life in 
circulation (Evans, 2004). These synthetic derivatives of T are 
commonly referred to as anabolic androgenic steroids (AAS) (Kuhn, 
2002). Although in the market, AAS come with range of effective 
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doses and active life, none of them have convincingly demonstrated 
any effects that are different from those of native T (Evans, 2004).
1.6.1 Clinical use of T
Because of their anabolic properties, T and its many derivatives 
(commonly known as anabolic-androgenic steroids, AAS) has been 
prescribed for the treatment of cachexia (muscle wasting associated 
with chronic debilitating diseases such as AIDS, chronic obstructive 
pulmonary disease, cancer) and sarcopenia (muscle wasting due to 
old age) since the 1940s (Kuhn, 2002). However, in recent years the 
number of patients on T has increased dramatically. For example, in 
the USA alone one million patients were on T in 1991. However, by 
2004 this number had risen to 3 million (Evans, 2004). Worldwide, 
the incidence of chronic debilitating diseases such as chronic 
obstructive pulmonary disease (COPD) and cancer is increasing at 
an alarming rate, and the proportion of the population over 65 years 
old continues to increase rapidly (Bonita, 1998; Justl & Hartigan, 
1999; Lievre et al. 2007). This will further increase the number of 
patients on T unless ways of arresting/reducing the incidence of both 
cachexia and sarcopenia are found. In addition to their use in clinical 
medicine, T and its derivatives is commonly abused by athletes and 
body builders. It is estimated that 1 to 3 million athletes in the USA 
alone have used T (Silver 2001). Thus, each year, the sales of T in 
the sports industry have increased by between 20 and 30%, and are 
now estimated to be worth over 100 million US dollars (Tok
2004). 
Although 
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Although studies demonstrate an increase in mRNA synthesis 
following the chronic administration of T propionate to castrated 
animals (Xu et al. 2004); oxandrolone in healthy young men 
(Sheffield-Moore, et al. 1999) and T enanthate in elderly men (Urban 
et al.1995), no  evidence showing that these compounds increase 
protein synthesis and decrease its breakdown exists. It is also 
uncertain whether they lead to an improvement in performance.
1.7 Mechanism of action for DHT and T
1.7.1 Genomic mechanism
Both DHT and T are lipid soluble and can freely cross the cell 
membrane. Once inside the cell, they bind to the classic androgen 
receptors (AR).  The AR gene is located on the long arm of 
chromosome X at position 11-12 (Gelmann, 2002). It consists of 8 
exons coding for the N-terminus DNA binding domain (DBD), 
nuclear localisation sequences (NLS), and C-terminal 
ligand/hormone binding domain (LBD) (for general structure see 
Figure 1.7) (Gelmann, 2002). The AR is a 110kDa receptor protein 
consisting of 919 amino acids forming a structure with 12 α-helices 
and 2 β-sheets (Rochette-Egly, 2003). It belongs to the large family 
of nuclear transcription factors and normally resides in the cytoplasm 
where it is bound to chaperone molecules such as heat shock 
protein 90 (HSP90) that protect it from enzymatic damage (Pratt & 
Toft, 2003). Studies have shown that AR can be found in all tissues 
except in adrenal medulla and spleen (Takeda 
McPhaul, 1996).
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1.7.2 Non-genomic mechanism
In addition to their genomic actions, it is now generally accepted that 
steroid hormones can also exert actions that are too rapid to be 
explained by the classic/genomic pathway (Falkenstein et al. 2000; 
Heinlein & Chang, 2002; Simoncini & Genazzani, 2003). 
These actions occur within seconds to minutes after administration 
of the hormone, and are generally insensitive to inhibitors of the 
androgen receptor (Estrada et al. 2003); suggesting that they are 
regulated by cellular signalling pathways involving surface 
membrane receptors and second messengers (Heinlein & Chang, 
2002). This mechanism of steroid action is commonly referred to as 
the non-genomic or non-classical mechanism. Because of the speed 
at which it occurs, it is also referred to as the rapid/acute action of 
AAS (see Fig. 1.9).
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skeletal muscles. However, both studies were performed on cultured 
muscle cells and used supra-physiological concentrations of T
(Estrada et al. 2000; Estrada et al. 2003). Therefore, it is uncertain 
whether physiological levels of T or its metabolite DHT have any 
rapid/non-genomic actions in isolated intact mammalian skeletal 
muscle fibres. Furthermore, little is known about the identity of the 
receptor/s mediating these actions.
Although little is known about the receptor(s) mediating the non-
genomic effects of steroid hormone (Falkenstein et al. 2000; Losel et 
al. 2003; Simoncini & Genazzani, 2003), there are reports 
suggesting that these effects may not be uniform and therefore, they 
may involve a variety of receptors. For example, some studies have 
implicated the classical AR (for general structure see figure 1.7) 
(Cinar et al. 2007); whereas others suggest that they involve a G 
protein receptor localised at the membrane (Estrada et al.2003). 
Therefore, in the following sections I will review some of the 
receptors that could mediate the acute/rapid actions of these 
hormones.
1.7.3 G-protein coupled receptors (GPCRs)
GPCRs are cytoplasmic membrane receptors with seven trans-
membrane (heptahelical) domains that are closely associated to 
signal transducing heterotrimeric guanine nucleotide binding proteins 
(G proteins) (Dorsam & Gutkin, 2007). They comprise the largest 
group of cell surface receptors with more than 1000 members some 
of which can be 
cells (for general structure see figure 1.10; Gutkin
Baptiste 
external stimuli including growth factor, 
1998; Hryb 
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and the size of the extracelluar loops, GPCR can be split into 4 
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al. 2007, Lagerstrom 
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subunits of the G protein. The G proteins are composed of a 36-
52KDa α-subunit, a 35-36KDa β-subunit and an 8-10KDa γ-subunit 
(Dorsam & Gutkind, 2007). The α-subunit particularly αs, functions 
as a regulatory molecule for the integral membrane enzyme adenylyl 
cyclase (AC). AC hydrolyses ATP into cyclic adenosine 
monophosphate (cAMP) which induces cAMP dependant PKA signal 
transmission (Griner & Kazanietz, 2007). The β and γ-subunits form 
the βγ-dimer which is only separable under strong denaturing 
conditions (Bjarnadottir et al. 2007). The βγ-dimer activates the 
effector enzyme phospholipase C (PLC) which activates its 
downstream signalling cascade.  
1.7.4 Receptor tyrosine kinases
Another group of receptors that can mediate the acute/non-genomic 
actions of AAS is the receptor tyrosine kinases. Many cellular 
activities including cell growth and proliferation are regulated by 
extracellular signals (Pawson, 2002). Most of these signals are 
transduced across the cell membrane through receptor tyrosine 
kinases (RTKs) such as insulin-like growth factor-1 receptor (IGF-
1R) (Rennie et al. 2004), platelet derived growth factor receptor 
(PDGFR) (Albrecht & Tidball, 1997) and epidermal growth factor 
receptor (EGFR) (Zwick et al. 1999). In general, all RTKs are 
monomers in the cell membrane except insulin receptor (IR) and 
IGF-1R (Schlessinger, 2000). All RTKs consist of an extracellular N 
terminal ligand binding domain that is commonly glycosylated, a 
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transmembrane spanning domain and a cytoplasmic/cytosolic c-
terminal domain (Hunter, 1998). The cytoplasmic domain contains a 
conserved protein tyrosine kinase core and additional regulatory 
sequences that can be phosphorylated by protein kinases that can 
transfer a phosphate from ATP to the hydroxyl groups of the tyrosine 
residues on these receptors (Hunter, 1998). This enables the 
receptors to recruit signalling molecules to the RTKs and activation 
of their downstream effectors (Hunter, 1998). 
1.7.4.1 Insulin growth factor-1receptor
The chronic administration of nandrolone in female rats (Lewis et al. 
2002); oxandrolone in healthy young men (Sheffield-Moore, et al.
1999; Bamman et al. 2001) and testosterone enanthate in healthy 
elderly men (Ferrando et al. 2002) is accompanied by an increase in 
the mRNA for IGF-1. Therefore, it has been suggested that some of 
the effects of T are exerted through the IGF-1R. 
The IGF-1R consists of 2α and 2β subunits and has tyrosine kinase 
activity (see figure 1.11) (Alessi et al. 1996). A fully functional IGF-
1R is a dimer that is activated by at least three ligands, IGF-1, IGF-2 
and insulin (Alessi et al. 1996). IGF-2R, also known as cation 
independent mannose-6-phosphate receptor, is a monomeric 
receptor that consists of 15 extracellular domains, a transmembrane 
domain and Intracellular domain (MacDonald et al. 1988). However, 
the IGF-2R seems have no role in growth factor signalling 
(MacDonald et al. 1988). When activated, IGF-1R transmit a signal 
to its two major substrates 
cytoplasmic adaptor proteins with a phosphotyrosine
domain, PTB leading to the 
pathway for protein synthesis, cell
& Kahn, 
(Baserga, 1995) an important pathway for cell grow
proliferation.  
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1.7.4.2 Platelet derived growth factor receptor
Another receptor that can mediate the non-genomic actions of DHT 
and T is the PDGFR. The PDGFR was originally identified in 
fibroblasts, smooth muscle cells, skeletal muscle and glial cells 
(Raines & Ross, 1993; Albrecht & Tidball, 1997; Fiaschi et al. 2003). 
Each receptor consists of an extracellular region with five 
immunoglobulin like domains namely D1-D5, a single 
transmembrane domain, a juxtamembrane domain and an 
intracellular cytoplasmic tyrosine kinase domain (Williams, 1989). 
The kinase domain exists in two isoforms; α and β (Kelly et al. 
1991). The α-isoform has a molecular weight of ~170kDa; whereas, 
that of the β isoform is 180 KDa (see figure 1.12). Thus, the receptor 
can contain two α-kinase domains, two β-kinase domains or a 
mixture of both. The α-kinase dimer binds PDGF-AA, PDGF-BB and 
PDGF-AB, the β-kinase binds PDGF-BB only; whereas, the 
heterodimer binds PDGF-AB and PDGF-BB (Williams, 1989). 
Autophosphorylation of tyrosine residues in the kinase domain serve 
as docking sites for various signalling molecules including src, PI3K 
and PLC which further activate downstream signalling pathways 
(Kypta et al. 1990)
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domain consisting of 23 amino acids. It has been suggested that this 
transmembrane domain regulates receptor dimerization 
(Schlessinger, 2002). The transmembrane domain is followed by the 
intracellular domain which has a juxtamembrane region, a tyrosine 
kinase region and a carboxyl terminal end region. Ligand binding to 
the receptor activates autophosphorylation of the intracellular region 
leading to recruitment of Ras/Raf and subsequently activation of the 
MAPK pathway (Jorissen et al. 2003). 
1.8 Amino acid transporters
Although membrane receptors have an important role in the 
transduction of extracellular signals, the transport of solutes such as 
ions and nutrients (for example amino acids across cell membrane) 
is also important in all cells. Almost all transmembrane transport 
processes are conducted by integral membrane proteins, sometimes 
functioning in association with cytoplasmic receptors (Saier, 2000; 
Conde et al. 2010). Amino acids are the building blocks of proteins 
and come in all shapes and sizes, For example, they can be neutral 
with aliphatic side chains such as glycine, leucine and isoleucine or 
polar such as arginine and glutamic acid. However, they all require 
transporters to move from one side of the membrane to the other. 
Furthermore, since the intracellular amino acid concentrations in 
mammalian cells are generally higher than (or at least equal to) 
those in the extracellular fluid, amino acids need to be actively 
transported into the cell (Hyde et al. 2003). 
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Amino acids enter and leave cell through specialised proteins known 
as amino acid transporters (Christensen, 1990) which have been 
placed into distinct ‘systems’ depending on their substrate specificity, 
transport mechanism and regulatory properties as shown in table 
1.2 and 1.3 (Hyde et al. 2003). 
1.8.1 Sodium dependent neutral amino acid transporters
The sodium-coupled neutral amino acid transporters also known as 
sodium dependent neutral amino acid transporters (SNAT), are 
members of the solute like carrier 38 (SLC 38) family which consist 
of system A and system N amino acid transporters (see table 1.2) 
(Mackenzie & Erickson, 2004). Amino acid transporters in this group 
prefer small zwitterionic amino acids such as glycine (Mackenzie & 
Erickson, 2004) and are poor at transporting branched chain amino 
acids (Hyde et al. 2003). Of the two systems, those belonging to 
system N subtypes have a narrow range of substrates including 
glutamine, histidine and asparagine. On the other hand, transporters 
belonging to system A have a broader range of substrates including 
alanine, asparagine, cysteine, glutamine, methionine and serine 
(Hyde et al. 2003). Amino acid transporters in both systems are 
tolerant to lithium (Reimer et al. 2000) but are highly sensitive to pH 
(Baird et al. 2006). System A and N transporters depend on sodium 
gradient to pump amino acids into the cell through secondary active 
transport (Lingrel et al. 1994). Therefore, they tend to be coupled to 
the sodium/ potassium ATPase (Na+/K+ATPase) pump. Subtypes of 
37
system A include SNAT1, SNAT2 and SNAT4; whereas, subtypes of 
system N include SNAT3 and SNAT 5 (Mackenzie & Erickson,
2004).
Transporters belonging to system A are all electrogenic and pH 
sensitive (Mackenzie & Erickson, 2004; Bevington et al. 2002) and
can easily be distinguished from those belonging to system N 
because they are inhibited by the model substrate α-
(methylamino)isobutyric acid (MeAIB) (Christensen, 1985). They are 
composed of eleven hydrophobic transmembrane alpha helices 
connected to each other by hydrophilic intra- and extracellular loops. 
Also, they have sites that can be glycosylated and phosphorylated 
by protein kinase C (PKC) (see Fig. 1.14; Yao et al. 2000). They 
have been identified in lung, skeletal muscle, spleen and intestine 
(Sugawara et al. 2000; Hatanaka et al. 2001) and their expression is 
up-regulated by many factors including hormones, growth factors 
and mitogens (Taylor, 2009).They are also subject to adaptive 
regulation mediated by intracellular and possibly extracellular amino 
acid levels (Franchi-Gazzola et al. 2004).
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Neutral -amino -acid transporters: sodium -dependent
System Protein Gene Amino acid substrates 
(one- letter code)
Tissue distribution
A
SNAT1 SLC38A1 Me-AIB, G, A, S, C, Q, N,H, 
M, T, P, Y, V
Widespread including brain, heart, 
placenta
SNAT2 SLC38A2 Me-AIB, G, P, A, S, C, Q N, 
H, M,
Muscle, kidney, intestine
SNAT4 SLC38A4 G, P, A, S, C, N,M, H, K, R Placenta
ASC
ASCT1 SLC1A4 A, S, C Liver
ASCT2 SLC1A5 A, S, C, T, Q, Widespread
B ASCT2 SLC1A5 A, S, C, T, Q, F, W,Y Epithelial cell
N
SNAT3 SLC38A3 Q, N, H Liver
SNAT5 SLC38A5 Q, N, H, S, G Brain
Table 1.2: List of some of the amino acid transporter systems found in the cells of eukaryotes. Table adapted from 
Christensen, (1983); McGivan & Pastoranglada, (1994); Hyde et al. (2003)
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Anionic -amino -acid transporters: sodium -dependent
X− AG
EAAT1 SLC1A3 E, D Widespread
EAAT2 SLC1A2 E, D Brain
EAAT3 SLC1A1 E, D, C Brain
EAAT4 SLC1A6 E, D Cerebellum
EAAT5 SLC1A7 E, D Retina
Cationic -amino -acid transporters: sodium -dependent
Bo,+ ATB(o,+) SLC6A14 K, R, A, S, C, T, N, Q, H, M, I, 
L, V, F,Y,W
Intestine
y+L* y+ LAT1 SLC7A7 K, R, Q, H, M, L Placenta
y+LAT2 SLC7A6 K, R, Q, H, M, L,A,C Erythrocytes
X− AG denotes systems that are substantially specific to Aspartate and Glutamate; (+) plus, (-) minus or (o) and neutral sign indicate the 
need for appropriately charged amino acid substrates; (y+L*) heteromeric transporters formed upon association with glycoprotein CD98 
(also known as 4F2hc) encoded by gene SLC3A2.
Table 1.2 continued
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1.8.2 Sodium independent amino acid transporters
Another subset of neutral amino acid transporters are the L-type 
amino acid transporters. Transporters belonging to system L 
mediate the transport of large neutral amino acids with bulky 
branched and aromatic side chains (Palacin et al. 1998). They do 
not require a sodium gradient to transport amino acids (see table
1.3). Instead they function as amino acid exchangers (Hyde et al. 
2003). 
Members of this group are heterodimeric proteins that consist of a 
light chain subunit namely L-type amino acid transporter (LAT) 1 and 
2; and a heavy chain subunit commonly referred to as 4F2hc (see 
Fig. 1.15. The heavy chain subunit is also known as CD98 and is 
approximately 80-kDa in size. It was first identified in activated 
lymphocytes and is highly glycosylated. On the other hand, the light 
chains are non-glycosylated and are approximately 40-kDa (Hemler 
& Strominger, 1982). The main function of 4F2hc is to support the 
translocation and insertion of the transporter complex into the cell 
membrane. Thus, without the heavy chain, the transporter resides 
mainly in the cytoplasm.
System L amino acid transporters are obligatory exchanger proteins
with a 1:1 stoichiometry that exchange small neutral amino acids 
such as glutamine for large branched chain amino acids like leucine 
and isoleucine (so called tertiary amino acid transport) (Hyde et al.
2003). Therefore, for these transporters to function normally they 
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require an intracellular pool of these small neutral amino acids
(Verrey, 2003). Therefore, they tend to be coupled to (for example) 
system A transporters which provide the amino acids they exchange.
One of the distinguishing features of L-type amino acid transporters 
is the observation that they are inhibited by the non-metabolisable 
amino acid analogues 2-aminoendobicycle (2,2,1)–heptane-2-
carboxylic acid (BCH) and 3-aminoendobicyclo-(2,2,1)- heptane-2-
carboxylic acid (BCH) (Palacin et al. 1998; Franchi-Gazzola et al.
2004). LAT1 has substrate affinity in the micromolar range and 
prefers to transport large neutral amino acids such as leucine, 
valine, phenylalanine, tryptophan methionine and histidine; and is 
found mainly in the brain, spleen, placenta and testis (Kanai et al.
1998). On the hand, LAT2 transports a broader range of substrates 
including all L-isomers of neutral amino acid and has been identified 
in may tissues including the small intestines, brain and skeletal 
muscle (Segawa et al. 1999). 
Other members of system L include LAT3 and LAT4 L (Babu et al. 
2003; Bodoy et al. 2005). These are relatively new members of the 
system that can be distinguished from LAT1 and LAT2 based on 
their structural features. For example LAT3 and LAT4 are not 
heteromeric transporter and hence do not require 4F2hc to elicit 
transport activity (Bodoy et al. 2005). 
Figure
units
(numbered 1
1.15: A schematic diagram showing the general structure of an L
a light (numbered cylinders) and a heavy chain (filled cylinder, hc
–12). Diagram adapted from Mastroberardino et al. 1998.
). The light chain consists of 12 
-type amino acid transporter. LATs consist of two sub
transmembrane domains 
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Neutral -amino -acid transporters: sodium -independent
System Protein Gene Amino acid substrates (one- letter code) Tissue distribution
Asc Asc1 SLC7A10 G, A, S, C, T Brain
Asc2 - G, A, S, T Erythrocytes, kidney
L LAT1 SLC7A5 BCH, H, M, L, I, V, Y , W, Q Placenta, adipocyte, smooth  
muscle
LAT2 SLC7A8 BCH, A, S, C, T, N, Q, H, M, L, I, V, F, Y,W Kidney, skeletal muscle, placenta
T TAT1 SLC16A10 F, Y, W Erythrocytes
Anionic -amino -acid transporters: sodium -independent
X−c xCT SLC7A11 ET Brain
– XAT2 – D, E Kidney
Table 1.3: List of some of the amino acid transporter systems found in the cells of eukaryotes. Table adapted from Christensen, (1985); 
Hyde et al. (2003); Verrey (2003)
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Cationic -amino -acid transporters: sodium -independent
bo,+** b(o,+)AT SLC7A9 K, R, A, S, C, T, N,Q, H, M, I, L, V, F, Y, W, Ci Small intestine, blastocycts
y+
Cat-1 SLC7A1 R, K, H Endothelial cells
Cat-2 SLC7A2 R, K, H Liver
Cat-3 SLC7A3 R, K Thymus, uterus, brain
Cat-4 SLC7A4 Unknown Glioblastoma cells
X−c where Cystine shares transport with Glutamate; System T is mainly found in human red blood cells; (+) plus, (-) minus or (o) and 
neutral sign indicate the need for appropriately charged amino acid substrates; (bo,+**) heteromeric transporter formed upon association 
with rBAT glycoprotein encoded by gene SLC3A1; y+ consist of two subfamilies SLC7A1-4 (consist of 14 transmembrane domain) and 
SLC7A5-11 (not listed in this table) form heteromeric transporter with 4F2hc or rBAT (Verrey, 2003).
Table 1.3 continued
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1.9 Protein synthesis
As stated in section 1.5, skeletal muscle is highly plastic and its 
fibres can rapidly switch from one type to another depending on the 
biochemical and physiological demands imposed upon them. This 
process, commonly known as skeletal muscle plasticity, involves the 
synthesis of new proteins and/or the remodelling existing ones,
thereby, making the control of protein synthesis important in this 
process (Rooyackers & Nair, 1997). Protein synthesis is
energetically a highly expensive process (Mamane et al. 2006). 
Therefore, it is tightly regulated. Protein synthesis is a two-step 
process and involves transcription and translation.  Transcription is 
the initial step and involves the copying of the genetic information 
encoded by genes into messenger RNA (mRNA); whereas,
translation involves decoding of the genetic information in the mRNA 
into proteins. Therefore in section 1.9.1 below, I will describe the 
transcription process and in the next section (1.9.2) I will briefly 
outline the translation process.
1.9.1 Transcription process
All the genetic information in a cell is encoded by genes located 
within the deoxyribonucleic acid (DNA). However, in this form the 
information is inaccessible and cannot be directly utilised by the 
protein synthesising machinery. Instead, the information has to be 
first transcribed into mRNA through a complex process known as 
transcription. Each DNA consists of two strands held together in a 
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double helix by weak hydrogen bonds. To prevent it from damage,
the DNA strands are bound to acetylated histones (forming the 
nucleosomal complex) in a coiled transcriptional repressed 
orientation (Kornberg, 1974). Therefore, for transcription to occur, 
the histones are acetylated by histone acetylases (HATs). HATs add 
the acetyl residues removing the positive charge on the lysine 
residue of the histone protein. This allows the strands to unwind and
increases the space between the nucleosome and the DNA wrapped 
around it allowing access for the recruitment of transcription factors
to begin. The unwound DNA now is ready for transcription initiation. 
At the 5’end, ~100 nucleotides upstream from the transcriptional 
start site, is the gene promoter and enhancer regions (see Figure 
1.16).  The promoter region contains AT rich sequences, known as 
the TATA box, which binds the TATA box binding protein (TBP). 
TBP, TBP associated factors (TAFs) together with RNA polymerase 
II complex forms the general transcription complex which then binds 
to the core promoter region.
Figure 1.16
general transcription complex positions RNA polymerase II on the 
promoter region at the beginning of a gene. The general 
transcription complex consist 
(green), co
activators (red) that bind the enhancer. The basal factors cannot by 
themselves increase or decrease the rate of transcription. However 
recruitment of co
reduce (as co
from Johnson, (2001)
Starting from the promoter region, during the transcription process, 
the transcription machinery
gene. As it encounters each DNA nucleotide, corresponding 
complementary RNA nucleotide
-
: Assembly of the general transcription complex. The 
activators collectively known as TAFs (brown) and 
-regulators can either enhance (as co
-repressors) (purple) transcription. Diagram adapted 
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of the basal factor
moves along the DNA strand into the 
s are added to a chain of growing 
s which include TBP 
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RNA until it reaches the stop codon at the opposite end of the gene. 
At the stop site, it disengages from the DNA releasing the newly 
assembled RNA transcript. The transcribed RNA then undergoes
post transcriptional processing, introns are excised and exons are 
spliced producing a mature messenger RNA (mRNA), which is the 
transcriptional unit conveying the encoded instruction that tells the 
cell to assemble amino acid to make a particular protein. 
Although core promoters can accurately direct transcription initiation,
in vitro intact eukaryotic transcription requires sequence specific 
regulatory transcription factors (also known as trans elements) 
(Pabo & Sauer, 1992). These interact with the DNA sequence via 
characteristic structural motifs that enter the DNA grooves. There 
are four types of general structural motifs including; helix-turn-helix 
(HTH), homeodomain, zinc finger and leucine zipper (Pabo & Sauer, 
1992).
1.9.2 Translation process
After transcription, the mRNA must then be translated into proteins. 
This is a complex process and requires the ribosome, the mRNA 
and the aminoacylated tRNAs to come together in the correct 
configuration. For this to happen many proteins that bind each of 
these components are involved. Translation can be divided into 
three main steps, initiation, elongation and termination. During the 
initiation phase eukaryotic initiation factor (eIF)2 binds a complex 
consisting of the initiating methionyl-tRNA (MET-tRNA) and a 
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molecule of GTP and places this complex on the smaller (40S) 
ribosomal subunit. Simultaneously, eukaryotic initiation factors 4E 
(eIF4E) binds directly to mRNA through its 5’ methylated guanosine 
cap structure (Clemens & Bommer, 1999). eIF4E is the rate limiting 
protein and is normally bound to translational repressor eukaryotic 
initiation factor binding protein (4EBP)1; and is only released when 
4EBP1 is phosphorylated (Gingras et al. 1999). eIF4E has the ability 
to bind to the scaffolding protein eIF4G. This protein has binding site 
for many other initiation factors including the ribosome-associated 
protein eIF3 which enhances the binding the eIF2 complex to the 
40S ribosomal subunit.
In order for initiation to start the correct site at the beginning of the 
mRNA open reading frame must be found. The 40S subunit.Met-
tRNA, scans the mRNA and finds the initiating/start codon, usually 
AUG. Once the start codon is identified the GTP associated with 
eIF2 is hydrolysed to GDP and inorganic phosphate. The inorganic 
phosphate together with all the other initiation factors is released 
from the ribosome. The GDP bound eIF2 is also released and the 
GDP is exchanged for GTP in readiness for the start of another 
initiation process. The larger (60S) ribosomal subunit binds to the 
complex to form the complete 80S initiation complex.
During elongation, another aminoacyl-tRNA is added to the 
ribosome at the A-site by eukaryotic elongation factor (eEF) 1 and 
another amino acid is added to the growing polypeptide chain. 
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Following the formation of the peptide bond, the ribosome 
translocates from the A- to the P- site bringing the next codon into 
position and the whole process is repeated again until one of the 
three stop codons is reached (Sheikh & Fornace, 1999). The 
translocation from the A-site to the P-site is catalysed by 
unphosphorylated elongation factor (eEF2) and requires the
hydrolysis of GTP to GDP (Clemens & Bommer, 1999).
This mode of protein synthesis is known as cap-dependent protein 
synthesis and is thought to be the main mechanism of protein 
synthesis in eukaryotic cells (Merrick, 2004). However, another 
mode of translation initiation occurs in eukaryotic cells subjected to 
stress known as cap-independent or internal ribosome entry site 
(IRES) mediated translation (see figure 1.17). This mechanism is 
faster and has been observed within 2 hours after transcription 
(Johannes et al.1999). In this process, the uncapped 5’mRNA-end 
interacts with the 40S ribosome subunit directly (Vagner et al. 2001). 
Figure 1.1
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machinery to begin transcription or recruit co-regulators. The co-
regulators then can either enhance (as co-activators) or reduce (as 
co-repressor) transcription (see figure 1.16) (Heemers & Tindall 
2007).
Although It has been reported that acute T treatment can lead to the 
activation of co-activators such as cyclic AMP response element 
(CREB) in prostate (Unni et al. 2004) and sertoli cells (Cheng et al. 
2007), no activation of transcription factors was observed following 
the acute treatment of cultured myotubes with T (Estrada et al. 
2003). However, whether T treatment in adult skeletal muscles 
involves the activation of transcription factors is uncertain. 
Gene regulation can also occur at the translational level. Compared 
to transcriptional regulation, translational regulation of existing 
mRNAs allows for more rapid changes in the cellular concentrations 
of the encoded proteins. Thus, it can be used for the general 
maintenance of cells (Sonenberg & Hinnebusch, 2009). However, as 
there is no data available it is uncertain whether the acute effects of 
anabolic-androgenic steroids involve the translational regulation of 
proteins.
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1.11 General aims of the study
The primary aims of this study were to;
1. Develop an ex vivo technique suitable for investigating the 
acute/non-genomic effects of testosterone (T) and 
dihydrotestosterone (DHT) in adult mammalian skeletal 
muscle fibres
2. Use the small, isolated skeletal muscle fibre bundle technique 
developed to investigate;
a) The acute effects of DHT and T on amino acid uptake by fast-
and slow-twitch mouse skeletal muscle fibre bundles.
b) The cellular signalling pathway(s) mediating the acute effects 
of T and DHT on amino acid uptake in mammalian skeletal 
muscle fibres.
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CHAPTER 2
GENERAL MATERIALS AND METHODS
2.1 General materials
All the materials and methods specific to a particular experiment are 
described in the appropriate/relevant chapter. Therefore, in this 
chapter I will only describe the materials and methods that are 
common to several chapters.
2.1.1 Animals
All the experiments in this study were performed using small muscle 
fibre bundles isolated from the extensor digitorum longus (EDL) and 
the soleus muscles of adult CD1 mice. The mice belonged to an 
outbred stock obtained from Charles River (Charles River UK Ltd. 
Margate, Kent) and were maintained in the Disease Modelling Unit 
(DMU), University of East Anglia. They were kept in individual cages 
and received 12 hours light and 12 hours dark. They were fed 
standard rodent chow and fresh water ad libitum.
The CD1 mice originated from outbred stock from the Anticancereux 
laboratory in Switzerland. They were then imported to the 
Rockefeller Institute, United States in 1926. Later in 1948, the 
Hauschka Ha/ICR stock was initiated at the Institute for Cancer 
Research in Philadelphia from the Swiss mice. Then in 1959, they 
were designated as HaM/ICR or CD1 by Charles River Laboratory 
Incorporated (Rice & O’Brien, 1980). CD1 mice were used in this 
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study because they are relatively inexpensive (Aldinger et al. 2009), 
readily available in large numbers (Aldinger et al. 2009) and have 
short lifespans (Enthoven et al. 2008). Furthermore their genetic 
composition is relatively stable and retains the same amount of 
variation as that found in natural murine or human populations (Rice 
& O’Brien, 1980; Aldinger et al. 2009). They are also widely used in 
toxicological and cancer testing and as laboratory animals (Maugh, 
1978; Chia et al. 2005; Aldinger et al. 2009). Thus, the CD1 outbred 
stock represents a general mouse population with minimal potential 
for genetic complications; thereby, making it a suitable mouse stock 
for this study (Rice & O’Brien, 1980; Enthoven et al. 2008; Aldinger 
et al. 2009).
In this study, a total of 95 CD1 mice, consisting of 7 males ~38g in 
weight and 88 females ~30g in weight, were used. The mice had a 
mean age (mean  SEM) of 53.73 6.00 days (see table 2.1 for 
overall mice characteristics) and before they were released from the 
DMU, the mice were physically inspected for general health. 
Moreover, as shown in Fig. 2.1, their characteristics including 
weight, gender and mean age matched those of a normal healthy 
CD1 population (Rowe & Goldspink, 1969; Percy and Jonas, 1971). 
Thus, the inspection regime ensured that all the mice used in the 
study were healthy. 
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Table 2.1: The overall profile of the CD1 mice used in this study 
Animals used for Male Female Mean  SEM days/
(age range in days)
Investigating the effect of DHT/T on MAPK  pathway in isolated 
intact skeletal muscle fibre bundles (Chapter 3)
3 17 48.61  2.83 days (42 to 56)
Investigating the effect of DHT/T on Akt/mTOR  pathway in isolated 
intact skeletal muscle fibre bundles (Chapter 4)
4 13 57.39  4.49 days (49 to 63)
Investigating the physiological effects of DHT/T on amino acid 
uptake in isolated intact skeletal muscle fibre bundles (Chapter 5)
- 8 59.67  1.33 days (57 to 62)
Investigating the pathway and the transporter mediating  the amino 
acid uptake in isolated intact skeletal muscle fibre bundles (Chapter 
5)
- 20 57.43  2.01 days (54 to 61)
Investigating the receptor mediating the non-genomic effects of DHT 
in isolated intact skeletal muscle fibre bundles (Chapter 6)
- 30 52.13  2.22 days (48 to 56)
Total numbers of CD1 mice used 7 (7.36%) 88 (92.64%) 53.73  6.00 days (43 to 63)
Figure 
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2.2 Isolation of the small muscle fibre bundles
The mice were killed by cervical disarticulation as recommended by 
the Animals (Scientific Procedures) Act 1986, UK (for details of the 
regulations see http: //www. legislation. gov. uk / ukpga / 1986 / 14 /
contents) and all the experiments performed conformed to the UEA 
animal welfare committee guidelines. The extensor digitorum longus
(EDL, a mainly fast-twitch muscle in adult mice) and the soleus
(SOL, a predominantly slow-twitch muscle in adult mice) muscles 
from both hind limbs were isolated using a scalpel blade and fine 
forceps. They were then pinned at in situ length in a silicone 
elastomer (Sylguard, Dow Corning Europe SA) coated petri dish 
filled with the standard Ringer’s solution. The standard Ringer’s 
solution contained (in mM); 109 NaCl, 5 KCl, 1 MgCl2, 4 CaCl2, 24 
NaHCO3, 1 NaHPO4, 10 sodium pyruvate plus  200mgl-1 bovine calf 
serum; and its pH was maintained at approximately 7.4 by 
continuously bubbling it with 95% O2 and 5% CO2 (British Oxygen 
Company, Ltd Guilford). For details of the chemicals used to prepare 
the Ringer’s solution and their source(s) see Table 2.2.
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Table 2.2: A summary of the basic information such as scientific name, molecular weight and source of the chemicals used in the 
preparation of the standard Ringer’s solution. 
Scientific Name Formula/Molecular 
weight/Formula Weight
Catalogue No. Source
Sodium chloride NaCl/ FW:58.44 BDH4534-5KGP BDH/VWR International Ltd, 
Lutterworth, Leicestershire
Potassium chloride KCl/ FW:74.55 BDH4532-500GP BDH/VWR International Ltd, 
Lutterworth, Leicestershire
Magnesium chloride MgCl2/ FW: 203.31 M/060053 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Calcium chloride (1M solution) CaCl2/ MW: 110.98 21115-250ML Sigma-Aldrich, Gillingham, Dorset
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Sodium  hydrogen carbonate NaHCO3/ FW: 84.01 S/4240/53 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Sodium dihydrogen  
orthophosphate 
NaHPO4/ FW: 156.01 S/3760/53 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Sodium pyruvate CH3COCOONa/ 
MW: 110.04 
P5280 Sigma-Aldrich, Gillingham, Dorset
Bovine serum albumin Protease free 
MW: 67000.00 
05479-10G Sigma-Aldrich, Gillingham, Dorset
To prepare the small fibre bundles, the muscles were transferred 
into a specially designed muscle chamber 
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Table 2.3: The basic information such as name, description, model and source of the instruments used in the preparation of the 
small muscle fibre bundles. 
Instrument Description Model/
Catalogue No.
Source
Long arm stereo dissection 
Microscope
Magnifications: X10, X20, X35, 
X70
BM 2 Meiji Techno Co. Ltd. Saitama, 
Japan.
Scalpel blade No. 15 Small curved cutting edge for short 
and precise incision.
0305 Swann-Morton Ltd. Sheffield, UK.
Scalpel blade handle No.3 Standard blade handle No.3 Swann-Morton Ltd. Sheffield, UK.
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2.3 Myosin isoforms in the skeletal muscle fibre bundles 
used in this study
Although there are many studies on fibre type composition in rat-
extensor digitorum longus (Pullen et al. 1977; Dekleva & Sirca, 
1978; Eddinger et al. 1985), guinea pigs-oesophageal muscularis 
externa (Gutmann et al. 1970;Whitmore, 1982) and rabbit-tibialis 
anterior (Salmons, 1992) muscle, no studies have investigated the
fibre type composition of the  mouse EDL and soleus muscle. 
Therefore, in this study I randomly performed Western blot analysis 
to determine the fibre type composition of the bundles I used. As the 
results displayed in Fig. 2.2 show, the fibre bundles isolated from the 
EDL expressed entirely fast myosin; whereas those from the soleus 
expressed the slow isoform of myosin.
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2.4 Treatment of the muscle fibre bundles with DHT and T
All the experiments reported here were performed at room 
temperature (~20 C) on small muscle fibre bundles isolated from 
the EDL and SOL of adult female CD1 mice. During an experiment, 
the fibre bundles were mounted horizontally between two stainless 
steel hooks in one of the various muscle chambers used in the study 
(Figure 2.2).  The fibre bundles were divided into two groups; half 
were treated with the standard Ringer’s solution plus 6.3l per 100ml 
(1.07mM) of the vehicle (absolute ethanol) used to dissolve the DHT 
and T for 1hour. These fibre bundles acted as the control samples. 
The other half was treated for the same period of time (1hour) with 
Ringer’s solution containing either 630pgml-1 (2.16nM) DHT or 
(1.82nM) T. These fibre bundles acted as the experimental/treated
samples. For the details of the chemicals used in these experiments 
see Table 2.4.
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Table 2.4: The basic information such as scientific name, molecular weight and source of the chemicals used in treatment of the 
fibre bundles with DHT and T.
Scientific Name/Commercial name Formula/Molecular weight/ 
Density
Catalogue No. Source
Absolute ethanol C2H5OH/ FW: 46.04 
Density:0.789gml-1
NC9602322 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
17β-Hydroxy-4-androsten-3-one 17-
propionate/ Testosterone propionate
C22H32O3/ MW: 344.49 T1875 Sigma-Aldrich, Gillingham, 
Dorset
17β-hydroxy-5α-androstan-3-one/ 
Androstanolone
C19H30O2/ MW: 290.45 A8380 Sigma-Aldrich, Gillingham, 
Dorset
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2.6 Protein extraction and quantitation
At the end of the experiments described above, the muscle fibre 
bundles were snap frozen in liquid nitrogen and pulverised using a 
mortar and pestle. The samples were then mixed with 100 to 200l 
of the non-ionic lysis buffer NP40. The buffer contained (in mM); 150 
NaCl, 50 Tris (pH 7.5), 1.5 MgCl2, 10% Glycerol and 1% NP-40. 
100l of complete phosphatase inhibitor cocktail and one tablet of 
complete protease inhibitor cocktail were then added to 10ml of
buffer just before use. For details of the chemicals used to prepare 
the NP40 buffer are shown in Table 2.5,
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Table 2.5: Summary of the chemicals used in the preparation of the NP40 lysis buffer. 
Scientific Name/Commercial 
name
Formula/Molecular weight/Formula 
Weight/ Description 
Catalogue No. Source
Sodium chloride NaCl/ FW:58.44 BDH4534-5KGP BDH/VWR International Ltd, 
Lutterworth, Leicestershire
Tris(hydroxymethyl) aminomethane C4H11NO3/ MW: 121.14 B2005 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Magnesium chloride MgCl2/ FW: 203.31 M/060053 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Glycerol C3H8O3/ MW: 92.09 G5516 Sigma-Aldrich, Gillingham, Dorset
4-Nonylphenyl-polyethylene glycol 
/NP40
C18H30O3/ MW: 294.429 74385-1L Sigma-Aldrich, Gillingham, Dorset
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(Ethylenedinitrilo)tetraacetic acid 
/EDTA
C10H16N2O8/ MW: 292.24 EDS-100G Sigma-Aldrich, Gillingham, Dorset
Phosphatase inhibitor cocktail set II A cocktail of phosphatase inhibitors for the 
inhibition of acid, alkaline and tyrosine 
phosphatases during protein extraction
524625 Calbiochem, Nottingham, UK
Protease inhibitor cocktail tablets For complete inhibition of proteases during 
protein extraction
04693116001 Roche, Basel, Switzerland
Hydrochloric acid HCl/ FW: 36.46 H/1000/PB17 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
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The frozen samples were then transferred into 0.5ml eppendorf 
tubes. They were then vortexed and left on ice for 10minutes before 
they were centrifuged for 10minutes at 15000g. The supernatant, 
containing mainly cytosolic proteins, was collected and the pellet 
was kept for the isolation of membrane proteins. 
To isolate membrane proteins, the pellet was washed 3 times using 
phosphate buffer saline (PBS). It was then snap frozen in liquid 
nitrogen, pulverised and membrane proteins extracted as described 
above. Briefly, the samples were mixed with 30-50 l NP40buffer. 
The lysate was then vortexed and centrifuged at 15000g. The 
supernatant was collected and the pellet was discarded this time.
The concentration of proteins in each lysate was determined using 
the Quick Bradford Assay (Bradford 1976) and the details of the 
chemicals used are shown in Table 2.6. During an assay, various 
volumes (0,1,5,10 and 20l) of a 1 mgml-1 solution of bovine serum 
albumin (BSA) were mixed with double distilled water and the protein 
assay dye in a 1ml disposable cuvette. These samples were used to 
generate the standard curve. The concentration of proteins in each 
lysate was then assayed by mixing 5l of the sample with double 
distilled water and the protein assay dye. The mixture was then 
thoroughly mixed and the optical density of each mixture was 
determined using a spectrophotometer.
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Table 2.6: The volume of 1g/l BSA standard; double distilled water; sample and 1X Quick Bradford dye used in the Quick 
Bradford protein assay.
BSA standard (l) Double distilled water (ml) 1X Protein Assay dye (ml)
0* 0.8 0.2
1 0.8 0.2
5 0.795 0.2
10 0.79 0.2
20 0.78 0.2
Sample(s)
5 0.795 0.2
*Blank used for zeroing the spectrophotometer    
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The spectrophotometer (Helios-γ, Fisher Scientific, UK) was set at a 
wavelength of 595nm (for details of the spectrophotometer and the 
dye see table 2.7). The blank sample was then used to zero the 
spectrophotometer reading. The absorbance or optical densities 
(OD) of the samples were then measured. The ODs of the BSA 
mixtures were then used to generate a standard curve. The amounts 
of protein (in g/l) in the lysates was then determined from the 
standard curve.
The assay is based on the direct binding of proteins to Coomassie 
brilliant blue G-250 dye (CBBG). The dye exists in three forms;
cationic (red), neutral (green) and anionic (blue) (Compton & Jones 
1985). Under acidic conditions the protonated dye is predominantly 
red. However; when it binds to arginine, tryptophan, tyrosine, 
histidine, and phenylalanine residues in proteins, its absorbance 
shifts from 495nm to 595nm (Reisner et al. 1975). In the Quick 
Bradford assay that I described above, it is this unprotonated blue 
protein-dye complex that is detected using the spectrophotometer. 
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Table 2.7: Details of the dye reagent and the spectrophotometer used in the Quick Bradford assay. 
Reagent and Instrument Description Model/
Catalogue No.
Source
Protein assay dye reagent 1L Coomasie Brilliant Blue dye G-
250 reagent for Quick Bradford
500-0201 BioRad Laboratories Ltd, Hemel 
Hempstead, UK.
Spectrophotometer UV-Visible wavelength range: 190-
1100nM
Thermo spectronic Helios-γ Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
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2.7 Preparing the proteins for gel electrophoresis
Antibodies recognise a modest portion of the antigen, known as an 
epitope which may still remain in its tertiary structure. To enable 
access of the antibody to the epitope the protein needs to be 
unfolded or denatured. To denature, 10 g of the sample was mixed 
with 5L of loading buffer containing denaturing and reducing 
agents. The loading buffer contained; 2g sodium dodecyl sulphate 
(SDS) which served as the denaturing detergent, 10l/ml β-
mercaptoethanol (added  just before use) which served as the 
reducing agent, 8ml trisbase pH 6.8, 6ml glycerol, 1.2mg 
bromophenol blue. The mixture was then boiled for 2 minutes 
followed by a quick spin at 13000g. The samples were then loaded 
in individual wells and resolved using a discontinuous gel (Shapiro et 
al. 1967, Weber & Osborn 1969). 
The SDS binds strongly to proteins at an approximate ratio of 1 
dodecyl sulphate molecule per 2 amino acid residues and 
neutralises the charges on the proteins (Reynolds & Tanford, 1970). 
It also disrupts the secondary, tertiary and quaternary structure of 
the protein to produce a linear polypeptide chain coated with 
negative charge with equal charge densities per unit length 
(Reynolds & Tanford, 1970). Normally proteins form random-coil 
configuration created by disulfide bonds. Therefore addition of β-
mercaptoethanol reduces the disulfide bonds within-and-between 
the proteins. Other chemicals such as, glycerol and bromophenol 
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blue have their own functions. For example, glycerol increases the
density of the sample, thereby preventing uneven gel loading and 
sample overflow; whereas, bromophenol blue serves as an indicator 
of how far the sample has travelled (Laemmli, 1970). For the details 
of the chemicals used in the preparation of the loading buffer see 
table 2.8. 
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Table 2.8: Summary of the chemicals used for preparation of the loading buffer. 
Scientific Name Formula/Molecular weight Catalogue No. Source
Tris(hydroxymethyl) aminomethane C4H11NO3/ MW: 121.14 B2005 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Glycerol C3H8O3/ MW: 92.09 G5516 Sigma-Aldrich, Gillingham, 
Dorset
Sodium dodecyl sulphate C12 H25 NaO4S/  
MW: 288.38 
B2008 Melford Laboratories Ltd. 
Chelsworth, Ipswich
3’,3’’,5’,5’’-tertrabromophenol 
sulphonephthalein (Bromophenol blue)
C19H10Br4O5S/ 
MW: 669.96 
B0126-25G Sigma-Aldrich, Gillingham, 
Dorset
β-Mercaptoethanol HSCH2CH2OH/ MW: 78.13 7154 Sigma-Aldrich, Gillingham, 
Dorset
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2.8 Gels
Most of the gels used in this study were 10% SDS/polyacrylamide 
and consisted of a 4% acidic (pH 6.8) stacking gel at the top and a 
10% alkali (pH8.8) separation gel at the bottom. The stacking gel 
consisted of 1ml polyacrylamide (40%), 6.4ml double distilled water, 
2.5ml 1.5M Tris buffer (pH 6.8), 100l of 10% SDS, 50l of 10% 
ammonium persulphate and 10l of TEMED (a cross-linker); 
whereas, the separation gel consisted of 5ml polyacrylamide (40%),
9.69ml double distilled water, 5.0ml of 1.5M Tris buffer (pH 8.8), 
200l of 10% SDS, 100l of 10% ammonium persulphate and 10l 
of TEMED. For details of the chemicals used in the preparation of 
both the separation and stacking gel see table 2.9. 
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Table 2.9: Summary of the chemicals used for preparing separation and stacking gel. 
Scientific Name Formula/Molecular weight/Formula 
Weight/Description 
Catalogue No. Source
40% Acrylamide/Bis solution Contains 99.9% acrylamide and bis-
acrylamide at 9:1 ratio
161-0141 BioRad Laboratories Ltd, Hemel 
Hempstead, UK.
Tris(hydroxymethyl) aminomethane C4H11NO3/ 
MW: 121.14 
B2005 Melford Laboratories Ltd. Chelsworth, 
Ipswich
Glycine NH2CH2COOH/ 
MW: 75.0 
G0709 Melford Laboratories Ltd. Chelsworth, 
Ipswich
Sodium dodecyl sulphate C12 H25 NaO4S/ 
MW: 288.38 
B2008 Melford Laboratories Ltd. Chelsworth, 
Ipswich
Ammonium persulphate (NH4)2S2O8/ MW: 228.20 A3678-25G Sigma-Aldrich, Gillingham, Dorset
1,2-Bis(dimethylamino)ethane/
TEMED
(CH3)2NCH2CH2N(CH3)2/ 
MW: 116.20 
T9281-25G Sigma-Aldrich, Gillingham, Dorset
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In some experiments, 6% gels were used because they provided 
better resolution especially for proteins larger than 100kDa. For the
volume of each chemical and buffers required to prepare the 
separation and stacking gels see Table 2.10.
Table 2.10: The chemicals and buffers required for preparing the 
various gels
Chemicals/buffers
Separation Stacking
6%** 12%* 10% 4%
Acrylamide (40%) 3.0ml 6.0ml 5.0ml 1.0ml
Distilled water 11.69ml 8.69ml 9.69ml 6.4ml
Tris HCl pH8.8 3.0ml 5.0ml 5.0ml -
Tris HCl pH6.8 - - - 2.5ml
10% SDS 200.0l 200.0l 200.0l 100.0l
10% AMPS 100.0l 100.0l 100.0l 50.0l
TEMED 10.0l 10.0l 10.0l 10.0l
Total volume 20.0ml 20.0ml 20.0ml 10.0ml
*12% separation gel was used to obtain better separation for protein 
less than 50KDa. ** As for protein with a molecular weight of more 
than 100KDa, a 6% gel was used.
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2.9 Gel electrophoresis
To separate the proteins, the gels were placed in a mini 
electrophoresis tank (BioRad, Hempstead, UK) filled up to the level 
recommended by the manufacturer with running buffer. The running 
buffer contained (1L)-1; 25mM trisbase, 1.9M glycine, 1% SDS and 
its pH was set at 8.3 using concentrated HCL. Each well was then 
loaded with the sample plus loading buffer. To ensure that the 
molecular weight of the separated proteins could be easily 
determined, one of the wells was loaded with 8-10l of a dual 
precision protein standard (Bio-Rad, Hempstead, UK). The samples 
were then resolved by applying a constant voltage of ~80V for 2-3 
hours. For details of the apparatus used and the chemicals used for 
preparing the running buffer see table 2.11. 
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Table 2.11: Details of the apparatus used for gel electrophoresis and the chemicals used for preparing the running buffer. 
Items and chemicals Formula/Molecular weight/Formula 
Weight/ Description 
Catalogue No. Source
Mini-Protean Tetra-Cell Consist of 4-gel vertical electrophoresis 
system for 1 and 0.75 mm gel thickness. 
(includes casting stands, casting frames, 
10-well combs, thick and thin glass 
plates)
165-8000 BioRad Laboratories Ltd, 
Hemel Hempstead, UK.
PowerPac HC High current power supply 
(250V/0.3mA/300W)
164-5052 BioRad Laboratories Ltd, 
Hemel Hempstead, UK.
Tris(hydroxymethyl) 
aminomethane 
C4H11NO3/ 
MW: 121.14 
B2005 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Glycine NH2CH2COOH/ 
MW: 75.0 
G0709 Melford Laboratories Ltd. 
Chelsworth, Ipswich
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Sodium dodecyl sulphate C12 H25 NaO4S/  
MW: 288.38 
B2008 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Sodium hydroxide NaOH/ MW: 40.00  80085-362 BDH/VWR International Ltd, 
Lutterworth, Leicestershire
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2.10 Transfer of the proteins from the gel onto membranes
For the resolved proteins to be analysed by Western blotting, they 
need to be immobilised onto a pliable membranes (Towbin et al. 
1979). Immobilisation of the proteins on a pliable membrane makes 
them accessible and easy to probe. Therefore, in this study, the 
proteins were transferred onto polyvinylidene difluoride (PVDF) 
membranes using either the wet or semi dry technique. 
2.10.1 Wet transfer
This technique is also known as the tank transfer technique and was 
used during the early part of my studies before the semi-dry 
technique was introduced into the laboratory. It was performed using 
a mini trans-blot cell assembly from Bio-Rad (Bio-Rad, Hempstead, 
UK). Briefly, the gel holder cassette was placed with the black side 
down on a flat surface. A thick fibre pad/sponge was placed on the 
black side of the cassette. Two sheets of pre-soaked thick filter 
paper were placed on the fibre pad. The equilibrated gel was then 
placed on the filter paper. The PVDF membrane soaked in methanol 
was placed on the gel and the sandwich was completed by adding 
two sheets of pre-soaked thick filter paper on the PVDF membrane. 
Small air bubbles trapped in the sandwich were removed by gently 
rolling a glass tube on the filter paper. Finally, a fibre pad was placed 
on the thick filter paper. The cassette was firmly closed and placed 
in the electrode module. A bio-ice cooling unit and the electrode
module were placed in the transfer tank. The transfer tank was filled 
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with cooled (4C) transfer buffer. For details of the membrane and 
chemicals used in the preparation of the transfer buffer see table 
2.12. A magnetic flea was then added to maintain ion distribution 
and even buffer temperature. The lid was secured and a constant 
current of 200mAmps for 1 hour was applied. This technique 
requires the temperature of the whole system to be maintained at 
4C and thus was performed in a cold room (4C).
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Table 2.12: Characteristics of the membrane and summary of the chemicals used for preparing the transfer buffer. 
Items/ Scientific Name Formula/Molecular weight/Formula 
Weight/Description 
Catalogue 
No.
Source
Polyvinyl difluoride /PVDF transfer 
membrane 
One roll of the transfer membrane measuring 
26.5cm width x 3.75m length with pore size: 
0.45m 
88518 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Absolute methanol CH3OH/ FW: 32.04 The methanol is for 
soaking the transfer membrane
67-56-1 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Tris(hydroxymethyl) aminomethane C4H11NO3/ 
MW: 121.14 
B2005 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Glycine NH2CH2COOH/ 
MW: 75.0 
G0709 Melford Laboratories Ltd. 
Chelsworth, Ipswich
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Sodium dodecyl sulphate C12 H25 NaO4S/  
MW: 288.38 
B2008 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Absolute ethanol C2H5OH/ FW: 46.04 NC9602322 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
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2.10.2 Semi dry transfer (semi dry)
This is the technique currently used in the laboratory. It is performed 
using a trans-blot SD assembly (Bio-Rad, Hempstead, UK), that 
consists of a flat platinum anode bed and does not require extra 
electrode assembly. This technique also uses a small quantity of 
transfer buffer.  Firstly, a pre-soaked sheet of extra thick filter paper 
was placed onto the platinum anode bed. The methanol soaked 
PVDF membrane was then placed onto the extra thick filter paper. 
This was followed by the gel and the sandwich was completed by 
adding a sheet of pre-soaked thick filter paper on top of the gel. 
Small air bubbles trapped in the sandwich were removed by gently 
rolling a glass tube on the filter paper. Finally, the cathode was 
placed on top of the stack. A constant current of 200mA for 45 
minutes was then applied. This technique was performed at room 
temperature. For details of the instruments used for protein transfer 
see table 2.13. Although transfer can be done in wet or semi-dry 
conditions there are advantages and disadvantages of each of these 
techniques (see table 2.14 for comparison of the two transfer 
systems). Both techniques use transfer buffer whose composition 
was as follows (1L)-1 0.2% ethanol, 390mM Glycine, 480mM 
Trisbase and 1%SDS.
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Table 2.13: Details of the instruments used to transfer proteins from the gels to the membranes
Instrument Description Catalogue No. Source
PowerPac HC High current power supply (250V/0.3mA/300W) 164-5052 BioRad Laboratories Ltd, Hemel 
Hempstead, UK.
Mini-Transblot Electrophoretic 
Transfer Cell 
Consist of gel transfer cell, for two 10 x 7.5 cm 
gels, 2 gel holder cassettes, foam pads, 
electrodes, tank, cooling unit, lid with cables 
170-3930 BioRad Laboratories Ltd, Hemel 
Hempstead, UK.
Trans-Blot SD Semi Dry Transfer 
Cell
Semi-dry electrophoretic transfer cell 170-3940 BioRad Laboratories Ltd, Hemel 
Hempstead, UK.
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Table 2.14: Comparison of the two transfer systems
Wet transfer Semi-dry transfer
Molecular weight range Broad molecular weight range (>100kDa) For medium size proteins (20-70KDa)
Transfer time Extended transfer is possible (up to 24 hours) without 
buffer depletion. Under high-intensity conditions rapid 
transfer (15min-1hour) can be performed 
Extended transfer is not possible due to 
buffer depletion
Temperature control Specific temperature regulation (4-10C), refrigerated 
buffer circulator and cooling unit permit native protein 
transfer 
Temperature regulation by external cooling 
is not possible
Buffer capacity Use 2 – 3 litres of transfer buffer Use approximately 250ml per experiment; 
reduced cost of reagents and experiment 
time
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2.11 Blocking of the membranes
The use of antibodies raised against specific proteins enables further 
analysis of the immobilised proteins (Renart et al. 1979, Burnette 
1981). To increase specificity of antigen detection, the membrane 
needs to be blocked for non-specific binding of the primary and/or 
secondary antibodies to the membrane. Two commonly used 
blocking solutions are 0.5-5% non-fat dairy milk (NFDM) or 1-5% 
BSA. Although NFDM is cheaper it contains the phosphoprotein,
casein, which causes high background. On the other hand, some 
antibodies give a stronger signal on membranes blocked with BSA 
as opposed to NFDM for unknown reasons.  
For the blocking process each of the membranes was placed in a 
square petri dish with a single compartment approximately 
100x100mm. The membrane was then blocked in 5% (w/v) dried 
milk powder dissolved in TBST for 1 hour. The TBST contained (1L)-
1; 250mM Trisbase, 1.4M NaCl, 30mM KCl, 0.5% Tween 20. The pH 
of the buffer was set at 7.4 using concentrated HCl. For details of the 
chemicals used to prepare the TBST buffer are given in table 2.15.
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Table 2.15: Summary of the chemicals used in the preparation of TBST buffer. 
Scientific Name Formula/Molecular 
weight/Formula Weight/ 
Density
Catalogue No. Source
Tris(hydroxymethyl) 
aminomethane 
C4H11NO3/ 
MW: 121.14 
B2005 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Sodium chloride NaCl/ FW:58.44 BDH4534-5KGP BDH/VWR International Ltd, 
Lutterworth, Leicestershire
Potassium chloride KCl/ FW:74.55 BDH4532-500GP BDH/VWR International Ltd, 
Lutterworth, Leicestershire
Polyoxyethelene-20-sorbitan 
monolaurate/Tween 20  
C58H114O26/ MW: 1228.00 BP337-100 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Concentrated Hydrochloric acid HCl/Density: 1.18 kgl-1 BDH3028-2.5LG BDH/VWR International Ltd, 
Lutterworth, Leicestershire
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2.12 Incubation with antibodies
Once blocked, the PVDF membranes are now ready for incubation 
with the primary antibodies. The primary antibody was diluted to the 
required concentration using TBST. The appropriate dilution was 
determined by testing a range of dilutions (usually 1:100 - 1: 2000).
The PVDF membranes were then incubated overnight at 4C in 5% 
milk in TBST (w/v) containing the mono/polyclonal antibodies raised 
against the various proteins of interest (the antibody dilutions used 
are given in the appropriate chapters). The specificity of some of the 
antibodies was tested by incubating the membranes with blocking 
peptides.
The following day, the membranes were given 4 x 15 minute washes 
in TBST. The membranes were then incubated with species-specific 
secondary antibodies conjugated to horse-radish peroxidise for 
1hour at room temperature. The details of the secondary antibodies 
and the dilutions used are provided in the relevant chapters. 
The membranes were then given 4x15minute washes using TBST. 
They were then washed for 10 minutes in PBS. All washes were 
done on an orbital shaker (Bibby Scientific Ltd. Staffordshire) set at 
90rpm. 
2.13 Development of the membranes
Protein bands were developed by the enhanced chemiluminescent 
reaction between HRP-conjugated secondary antibodies on the 
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membrane and the enhanced chemiluminescent (ECL) developing 
solution. After the last wash with PBS, each of the membranes was 
treated with ECL developing solutions (SuperSignal, Thermo 
Fisher, Loughborough, UK) as per the manufacturer’s instructions, 
and incubated in the dark for 10 minutes. After the incubation period, 
the membranes were dabbed on tissue paper to remove any excess 
ECL liquid. A thin transparent double-layer plastic sheet was 
prepared and the membrane was placed in between the sheets. Any 
air bubbles trapped between the sheet and the membrane were 
removed by pressing the bubbles toward the edges of the plastic 
sheet. The assembly was then placed in an x-ray cassette to protect 
the membranes from light.
The optimum exposure time was then determined and the 
membranes were then exposed to film in the darkroom. The 
exposed x-ray film was then processed in the darkroom using a 
medical x-ray film processor (Konica Minolta, SRX101A, Hampshire, 
UK) for permanent documentation. Oversaturated films were 
discarded, and those which clearly showed the probed band of 
interest were selected for digitisation. For details of the ECL 
developing system see table 2.16.
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Table 2.16: Summary of the apparatus and chemicals used in the exposure and development of the membranes.
ECL developing system Description Model/
Catalogue No.
Source
SuperSignal West Pico 
Chemiluminescent Substrate 
Consist of Luminol/Enhancer, 
500mL stable peroxide buffer, 
500mL
34078 BioRad Laboratories Ltd, Hemel 
Hempstead, UK.
X-Ray cassette Kodak X-Omatic Regular, 18 x 
24cm 
525-7068 GB Medical Ltd. Andover, 
Hampshire, UK.
X-Ray Film processor Konica Minolta SRX 101A SRX101A GB Medical Ltd. Andover, 
Hampshire, UK.
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2.14 Membrane stripping and re-probing for actin/total protein
Stripping is the term used for describing the removal of the primary 
and secondary antibodies from the membrane. It is used when more 
than one protein is investigated on the blot or the same protein is 
being probed with a different antibody. For example, a membrane is 
probed using a phosphor-specific antibody. Then it is re-probed with 
an antibody against the total protein. There are three stripping
techniques; soft stripping - which uses two subsequent washes in 
PBS each for 10minutes followed by two subsequent washes in 
TBST each for 20minutes; medium stripping - which uses a stripping 
buffer containing 0.1%SDS and harsh stripping - which employs a 
stripping buffer containing 10%SDS and β-mercaptoethanol. As 
stripping may remove some of the protein from the membrane and 
damage fragile proteins, it is always advisable to use soft stripping 
before proceeding to harsher ones.
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For my study, the medium stripping technique was adopted. The 
membranes were stripped using a medium stripping buffer, which 
contained (1L-1) 200mM Glycine, 0.1%(w/v) SDS, 1%(v/v) Tween 20. 
The pH of the buffer was set at 2.2 using concentrated HCl. For 
details of the chemicals used and their source(s) see table 2.17.
Briefly, the membrane was incubated in the stripping buffer for 20
minutes. This was followed by 2x10 minute washes in PBS. The 
PBS contained (1L)-1; 1.4M NaCl, 155mM Na2HPO4, 47mM 
NaH2PO4, 27mM KCl and its pH was set at 7.2 using concentrated 
HCl. For details of the chemicals used in the preparation of the PBS 
and their sources see table 2.18.
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Table 2.17: Summary of the characteristics and source of the chemicals used to prepare the stripping buffer. 
Scientific Name Formula/Molecular 
weight/Formula Weight
Catalogue No. Source
Glycine NH2CH2COOH/ 
MW: 75.0 
G0709 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Sodium dodecyl sulphate C12 H25 NaO4S/  
MW: 288.38 
B2008 Melford Laboratories Ltd. 
Chelsworth, Ipswich
Polyoxyethelene-20-sorbitan 
monolaurate/Tween 20  
C58H114O26/ MW: 1228.00 BP337-100 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Hydrochloric acid HCl/ FW: 36.46 H/1000/PB17 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
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Table 2.18: Summary of the chemicals used to prepare the PBS buffer and their sources. 
Scientific Name Formula/Molecular 
weight/Formula Weight
Catalogue No. Source
Sodium chloride NaCl/ FW:58.44 BDH4534-5KGP BDH/VWR International Ltd, 
Lutterworth, Leicestershire
Disodium hydrogen phosphate/ Sodium 
phosphate dibasic 
Na2HPO4/ FW: 141.96 42437-0025 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Sodium dihydrogen phosphate/ Sodium 
phosphate monobasic
NaH2PO4/ FW: 119.98 20780-0025 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
Potassium chloride KCl/ FW:74.55 BDH4532-500GP BDH/VWR International Ltd, 
Lutterworth, Leicestershire
Hydrochloric acid HCl/ FW: 36.46 H/1000/PB17 Fisher Scientific UK Ltd. 
Loughborough, Leicestershire
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After stripping, the membrane was blocked in 5% (w/v) dried milk 
powder dissolved in TBST for 1 hour. It was then incubated for 1 
hour at room temperature in 5% milk in TBST (w/v) containing 
mono/polyclonal antibodies raised against the protein of interest. 
The membranes were then washed as described above, and 
incubated for 1-hour in HRP- conjugated species specific secondary 
antibodies diluted in 5% milk dissolved in TBST (w/v). The 
membranes were then washed with TBST as described in sections
2.10 and 2.11. They were then prepared for development and 
visualisation as described in 2.12. 
2.15 Data handling 
2.15.1 Western (-Immunoblotting)
After development, the films were digitised, at a resolution of 600dpi, 
using a scanner (HP PSC 1400, Hewlett Packard, Berkshire, UK) 
and the images were saved in a computer as black and white tiff 
files.
The intensity of each protein band was then analysed using Scion 
image software from NIH. The intensity of the bands of interest were 
then normalised to those of the corresponding total protein or actin in 
the same sample and the data are presented as mean of the ratios  
S.D. 
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2.16 Statistical analysis
Statistical analyses was performed on the mean intensities of the 
probed bands from the western blot analysis. A paired t-test was 
used to compare the control and the DHT/T treated samples; 
whereas,a three-way ANOVA was used to compare the data from 
the two fibre types and to perform comparisons between the various 
treatment groups i.e. untreated (control, group 1), treated with 
DHT/T (group 2), treated with inhibitor only (group 3), and those 
treated with DHT plus the inhibitor (group 4). A Sidak-Holmes Post-
Hoc test was then used to confirm the statistical significance of the 
data. All of the statistical tests were carried out using Sigma Plot for 
Windows version 11.0 (Systat Software Inc., San Jose California)
and a p-value <0.05 was considered to be statistically significant.
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CHAPTER 3
EFFECTS OF DHT AND T ON THE MITOGEN-ACTIVATED 
PROTEIN KINASE (MAPK) PATHWAY
3.1 Introduction
As stated in section 1.7, anabolic androgenic steroids have both 
genomic/chronic and non-genomic/acute/rapid effects (Heinlein & 
Chang, 2002; Simoncini & Genazzani, 2003). Although the long 
term/genomic actions of AAS have been the subject of numerous 
previous studies and some of their physiological functions are well 
known, little is known about their acute/non-genomic actions 
especially in adult mammalian skeletal muscle fibres (Estrada et al.
2000; Estrada et al. 2003). Indeed, only one study has previously 
investigated the acute/non-genomic effects of testosterone (T) and 
nandrolone (a synthetic derivative of testosterone) in myotubes. 
Treatment of the myotubes with  both hormones led to a rapid and 
transient increase in inositol triphosphate (IP3) and intracellular Ca2+
as well as the phosphorylation of the extra-cellular signal regulated 
kinases (ERK)1/2 (Estrada et al. 2003).
ERK1/2 are members of the ubiquitous proline-directed protein-
serine/threonine kinases commonly referred to as mitogen-activated 
protein kinases (MAPKs). These kinases are arranged in a series to 
form a cascade commonly referred to as the MAPK pathway. MAPK 
signal transduction pathways are the most wide-spread of all 
eukaryotic cellular regulation mechanisms. They are activated by a 
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wide variety of extracellular signals including hormones, 
inflammatory cytokines and environmental stresses such as 
irradiation, osmotic shock and ischemia (Krishna & Narang, 2008). 
To date, six distinct MAPK pathways have been identified in 
mammalian cells namely;   extracellular signal-regulated kinases 
(ERK1/2), c-Jun NH2-terminal kinases or stress activated protein 
kinases (JNK or SAPK), p38, ERK3/4, ERK5 and ERK6/7 (Paul et al.
1997; Johnson & Lapadat, 2002). However, the three that have been 
extensively studied and whose functions are well known are ERK1/2, 
p38 and JNK (Pearson et al. 2001; Krishna & Narang, 2008). 
Therefore, in this study I investigated the effects of DHT and T on 
these three modules only.
Although each MAPK pathway is unique and responds to specific 
stimuli, all six pathways share some common features. For example, 
they all consist of a set of three evolutionary conserved kinases that 
are sequentially activated namely, a MAPKK kinase (MAP3K), 
MAPK kinase (MAPKK) and MAPK (see Fig 3.1; Krishna & Narang, 
2008). 
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The downstream targets of the MAPK or MAPK activated protein 
kinases (MKs) add extra specificity, diversity and amplification to 
each pathway (Cargnello & Roux, 2011). Kinases in this group 
include p90 ribosomal S6 kinases (RSK) 1-4, mitogen and stress-
activated kinases (MSK) 1/2 and the MAPK-activated protein 
kinases (MK) 2/3. However, amongst these kinases only the RSK 
family has been shown to be exclusively activated by ERK1/2 (Roux 
et al. 2007). So far, no MKs have been assigned to JNK (Cohen, 
1997; Cargnello & Roux, 2011) and p38 (Ronkina et al. 2008; 
Cargnello & Roux, 2011). Once activated, ERK1/2 have been shown 
to accumulate in both the cytoplasm as well as the nucleus where
they activate numerous proteins including cytoskeletal proteins 
(Crean et al. 2002), transcription factors (Xing et al. 1996) and MKs 
(Dalby et al. 1998; Frodin & Gammeltoft, 1999).
Figure 3.1
MAPK pathway namely ERK, JNK and 
biological responses
: A schematic diagram showing the arrangement and biological responses of the three well studied module of the 
. Diagram adapted from 
p38. Note that the three modules are activated by different extracellular stimuli and induce 
Krishna & Narang (2008).
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As mentioned above, only one study has previously investigated the 
effects of T and nandrolone in skeletal muscle. However, the study 
was performed using cultured myotubes and supramaximal levels of 
T and nandrolone (Estrada et al. 2003). Therefore, it is uncertain 
whether physiological levels of T or its active metabolite 
dihydrotestosterone (DHT) have any acute/non-genomic actions in 
adult mammalian skeletal muscle fibres. Also, the study by Estrada 
et al investigated the effects of T and nandrolone on ERK1/2 only. 
Therefore, it is unknown whether T and DHT affect the other 
modules of the MAPK pathway.
3.2 Aim of this Chapter
Therefore, the primary aim of the experiments reported in this 
chapter were to investigate the effects of treating small skeletal 
muscle fibre bundles, isolated  from the EDL (a fast-twitch muscle) 
and soleus (a slow twitch-muscle) of adult CD1 mice, with 
physiological concentrations of DHT and T on the activation of 
ERK1/2, JNK, p38 and their downstream substrates.
3.3 Materials and method
3.3.1 Treatment of the fibre bundles with DHT and T
The general materials and methods used in this study were 
described in detail in chapter 2 and will only be briefly mentioned in 
this chapter.  All the experiments were performed at room 
temperature (~20C) using small muscle fibre bundles isolated from 
either the EDL (a fast-twitch muscle) or soleus (a slow-twitch 
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muscle) of female adult CD1 mice prepared as described in section 
2.2. The fibre bundles were then mounted horizontally between two 
stainless steel hooks in purpose built muscle chambers (internal 
measurement approximately 20mm width x 67mm length x 26mm 
depth) filled with the standard Ringer’s solution. They were then 
divided into two equal groups. Half were treated with the standard 
Ringer’s solution plus the vehicle (1.07mM absolute ethanol) used to 
dissolve DHT and T for 1hour. Proteins extracted from these fibres 
acted as controls. The other half was treated for the same period of 
time (1hour) with the Ringer’s solution containing 630pgml-1 of DHT 
(2.16nM DHT) or T (1.82nM T). Proteins extracted from these fibre 
bundles acted as the experimental/treated samples.  During the 
experiments, the Ringer’s solution was continuously bubbled with 
medical gas (95%O2, 5%CO2). Additionally, every 10 minutes, the 
Ringer’s solution was completely replaced and the fibre bundles 
were electrically stimulated to elicit a series of twitch contractions. 
To investigate the cellular signalling pathway(s) mediating the effects 
of DHT and T, some of the fibre bundles were pre-incubated for 
30minutes in Ringer’s solution containing 20M of the MEK inhibitor, 
PD98059 (Alexis Biochemicals). They were then treated for 1hour 
with Ringer’s solution containing the inhibitor alone or the inhibitor 
plus 630pgml-1 DHT or T. 
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3.3.2 Immunoblotting  
At the end of the experiments described above, proteins were 
extracted and separated using gel electrophoresis as described in 
chapter 2 sections 2.6 and 2.9. They were then transferred on to 
PVDF membranes and blocked as described in sections 2.10 and 
2.11. The membranes were then incubated overnight with the 
antibodies listed in table 3.1.The following day, they were incubated 
with species-specific secondary antibodies conjugated to horse-
radish peroxidase for 1 hour at room temperature. Later, they were 
developed using ECL substrate and exposure of the membranes to 
film. On the third day, the membranes were stripped and re-probed 
for total ERK 1/2(Santa Cruz Biotechnology, USA) or actin (Abcam, 
Cambridge England). These blots acted as loading controls.
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3.3.3 Data handling and analysis
All the Western blots were run in triplicate and each experiment was 
repeated at least three times. The Western blots were digitised as 
described in section 2.14.1 and the intensity of each protein band 
was analysed using Scion image software from NIH. The intensity 
of the bands of interest were then normalised to those of the 
corresponding total protein or actin in the same sample and the data 
are presented as the Mean  S.D. Statistical analysis of the data 
performed using SigmaPlot  11.2 (Systat Software Inc., London, 
UK). The data obtained from the two fibre types under control and 
the various experimental conditions were then compared using a 
three way ANOVA and a p<0.05 was considered statistically 
significant. 
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Table 3.1: List of the antigens and the antibodies used in these experiments.
ANTIBODIES/PEPTIDES SOURCE
Antigens Description Dilution
ERK 1/2 phosphorylated at Threonine 202 and 
Serine 204  
Rabbit polyclonal antibody 1:1000 SantaCruz Biotechnology Inc. 
(USA).
Total ERK 1 [C-16] Rabbit polyclonal antibody 1:1000 SantaCruz Biotechnology Inc. 
(USA).
JNK phosphorylated at Threonine 183 and 
Threonine 185
Mouse monoclonal 
antibody
1:500 Cell signaling technology Inc. 
(Beverly, USA)
MSK 1&2 phosphorylated at Serine 360 Rabbit monoclonal 
antibody 
1:500 Abcam (Cambridge, England)
p38 phosphorylated at Threonine 180 and 
Tyrosine 182
Rabbit polyclonal antibody 1:500 Cell signaling technology Inc. 
(Beverly, USA)
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p90RSK phosphorylated at Serine 380 Rabbit monoclonal 
antibody 
1:500 Abcam (Cambridge, England)
Myosin Light Chain phosphorylated at Serine 20 Rabbit polyclonal antibody 1:1000 Abcam (Cambridge, England)
Total myosin light chain Rabbit polyclonal antibody 1:1000 Abcam (Cambridge, England)
Actin Mouse monoclonal 
antibody
1:1000 Abcam (Cambridge, England)
Goat anti-rabbit IgG-HRP 1:1000 SantaCruz Biotechnology Inc. 
(USA).
Goat anti mouse IgG-HRP 1:1000 SantaCruz Biotechnology Inc. 
(USA).
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3.4 Result
3.4.1 Effects of DHT and T on the activation of ERK1/2
The results in figure 3.2 (A,B) show the basic observation in this 
study. As the results show, the untreated fibre bundles expressed 
mostly phosphorylated pERK 2 (p42). Furthermore, its expression 
was always greater in the fast- than in the slow-twitch fibre bundles. 
Moreover, treatment of fibre bundles with Ringer’s solution 
containing physiological levels of DHT for 1hour increased the 
phosphorylation of ERK 1 (p44) in both fibre types (see Fig. 3.2A). 
On the other hand, treating them with in Ringer’s solution containing 
physiological levels of T for 1 hour, increased the phosphorylation of 
ERK1 (p44) in slow-twitch fibre type only (Fig. 3.2B).
In a previous study, T was shown to have no effects on the force 
production in isolated intact mammalian skeletal muscle fibre 
bundles (Hamdi & Mutungi, 2010) and because in this study it only 
increased the phosphorylation of ERK1/2 in the slow-twitch fibre 
bundles, its effects were not investigated any further.
.
Figure 
A
3.2 : DHT increases the phosphorylation of ERK 1/2 in both fibre types 
Bar 
DHT
Graph 1A
* *
Bar Graph 2A 
B
Testosterone
Bar Graph 1B Bar Graph 2B
*
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Representative Western blots showing the concentration of 
phosphorylated ERK1/2 (p44/p42 respectively) and total/ non-
phosphorylated ERK1/2 (p44/p42) in female fast-(filled bars) and 
slow-(clear bars) twitch skeletal muscle fibre bundles treated with the 
standard Ringer’s solution (A,B,FC,SC) or the standard Ringer’s 
solution plus 2.16nM DHT (A,FT,ST) or 1.82nM T (B,FT,ST). Note 
that treatment of the fibre bundles with DHT led to a significant 
increase (p=0.04; p<0.05) in the phosphorylation of ERK 1(p44) in 
both fibre types (A,FT,ST, Bar Graph 1A); whereas, treatment with T
increased the phosphorylation of ERK 1(p44) in slow-twitch fibre
bundles only (B,ST, Bar Graph 1B). Also note that the concentration 
of the  non-phosphorylated (total) p44/p42 in fast-twitch (A,B,FC,FT) 
fibre bundles was always higher than that in the slow-twitch fibre 
bundles (A,B,SC,ST) (p=0.043;p<0.05).
3.4.2 Effects of DHT and T on activation of JNK and p38
As mentioned in section 3.1, the MAPK pathway has three parallel 
modules ERK, JNK and p38. Therefore, in another experiment, I 
examined the effects of treating small muscle fibre bundles with 
physiological levels of DHT on the phosphorylation of JNK and p38. 
The results from these experiments are shown in Fig. 3.3. As the 
results show, the expression of phosphorylated JNK and p38 in 
untreated fibre bundles was always 2-3 times higher in the slow-
twitch than in the fast-twitch fibre bundles. Furthermore, treatment of 
the muscle fibre bundles with DHT had no effect on the 
phosphorylation of both JNK and p38 in either fibre type.
Figure 3.3
A
: DHT had no effect on the phosphorylation of JNK and p38 in both fibre types 
B
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Representative Western blots showing the effects of DHT on the 
phosphorylation of JNK (A, pJNK) and p38 (B, pp38). Note that both
antibodies identified a single band with a molecular weight of
~54KDa in the case of pJNK and ~43KDa in the case of pp38. 
Moreover, the untreated slow-twitch muscle fibre bundles expressed 
higher concentrations of the phosphorylated proteins than the fast-
twitch ones. FC=control fast-twitch; SC=control slow-twitch; FT=DHT 
treated fast-twitch; ST=DHT treated slow-twitch 
3.4.3 Comparison of female DHT-treated muscles with 
untreated male muscles
T and DHT are male sex steroids and their concentrations are higher 
in male than in female animals. Therefore, in another experiment I 
investigated whether the DHT- and T-induced changes in the 
phosphorylation of ERK1/2 were similar to those found naturally in 
male animals. The results from this experiment are shown in Fig. 
3.4 and as they show, treatment of the muscle fibre bundles with 
DHT and T were similar to those reported in section 3.4. Thus, DHT 
increased the phosphorylation of ERK1/2 in both fibre types; 
whereas, T increased its phosphorylation in the slow-twitch fibre 
bundles only. Moreover, treatment of the muscle fibre bundles with 
these hormones did not replicated the levels of phosphorylation of 
ERK1/2 found in the untreated male muscles. Instead, the 
phosphorylation of ERK1/2 in the untreated male muscles was very 
similar to that found in the corresponding untreated female muscle.
Figure 3.4
A
: Untreated female and male muscle fibre bundles express similar concentration of phosphorylated ERK1/2. 
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*
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles isolated from adult female (FC,SC,FT,ST) and male 
(MF,MS) with the standard Ringer’s solution (FC,SC,MF,MS) or the 
standard Ringer’s solution plus 2.16nM DHT (A, FT,ST) or 1.82nM T
(B,FT,ST). Note that treatment of the fibre bundles with DHT led to a 
significant increase (p=0.04; p<0.05) in the phosphorylation of ERK 
1(p44) in both fibre types (A,FT,ST, Bar Graph 1A); whereas,
treatment with T increased its phosphorylation in the slow-twitch 
fibres only (B,ST, Bar Graph 1B). Also note that the concentrations
of the phosphorylated proteins in the untreated with DHT or T female 
and male muscle fibre bundles are similar.
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3.4.4 The effects of DHT on the activation of the MAPK 
pathway are abolished by the MEK inhibitor PD98059
All MAPK pathways are regulated mainly at the level of MAPK 
(Garrington & Johnson, 1999; Johnson & Lapadat, 2002). At the 
level of MAPK, each protein kinase is activated by their respective 
upstream dual specificity enzyme, MEK, resulting in the 
phosphorylation of threonine and tyrosine residues in the area 
known as the activation loop of each substrate (Pearson et al. 2001;
Shaul & Seger 2007). Both ERK1/2 are phosphorylated by their 
upstream kinases, MEK1/2, at their dual phosphorylation motifs, Thr-
Glu-Tyr (TEY) (Payne et al. 1991). Therefore, in another experiment
I investigated the effects of pre-treating the fibre bundles with the 
MEK specific inhibitor, PD98059 for 20minutes, followed by a 1hour 
incubation in Ringer’s solution containing DHT and PD98059. The 
results from this experiment are displayed in Fig.3.5 and as they 
show, pre-treatement of the fibre bundles with PD98059 completely 
abolished the effects of DHT on the phosphorylation of ERK1/2. 
Figure 3.5
phosphorylation of ERK1/2 in both fibre types
: Pre-treatment of the muscle fibre bundles 
Graph 1
A
with the MEK inhibitor PD98059 
A
* *
abolishes the 
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Representative Western blots showing the effects of pre-treating 
fast-twitch (F, filled bars) and slow-twitch (S, clear bars) fibre 
bundles with 20M PD98059 (FMi,SMi) on the phosphorylation of 
ERK1/2. Note that treatment of the fibre bundles with DHT led to a 
significant increase (p=0.01; *p<0.05) in the phosphorylation of ERK 
1(p44) in both fibre types. Furthermore, pre-treatment of the fibre 
bundles with PD98059 completely abolished the DHT-induced 
increase in the phosphorylation of ERK1/2 in both fibre types.
3.4.5 Effects of DHT on signal transduction downstream of the 
ERK1/2
p90 ribosomal S6 kinases (RSK) 1/2 as well as mitogen- and stress-
activated protein kinases (MSK1 and MSK2) have been identified as 
downstream substrates of ERK1/2 (Blenis, 1993; Deak et al. 1998). 
Therefore, in another experiment, I determined whether the acute 
effects of DHT in adult mammalian skeletal muscle fibre bundles 
were transduced through RSK1/2 or MSK1/2.  To do this, another 
set of fibre bundles was treated with the standard Ringer’s solution 
or the standard Ringer’s solution plus DHT. The phosphorylation of 
RSK1/2 and MSK1/2 was then determined in the control and treated 
fibre bundles. As the results shown in Fig.3.6 show, the untreated 
fast- and slow-twitch fibre bundles expressed very low 
concentrations of phosphorylated RSK and its expression was 
similar in the two fibre types. Moreover, treating the fibre bundles 
with DHT increased its expression in both fibre types. In contrast, the 
untreated slow-twitch fibre bundles expressed higher levels of 
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phosphorylated MSK1/2 than the fast-twitch fibre bundles. 
Additionally, their treatment with DHT did not significantly affect its 
expression in either fibre type.
Figure 3.6: The acute effects of 
A
DHT 
*
in adult mammalian skeletal muscle 
B
fibres are mediated through RSK1/2
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with physiological concentrations of DHT on the 
phosphorylation of RSK1/2 (A) and MSK1/2 (B). Note that treatment 
of the fibre bundles with DHT significantly increases (p=0.02; 
*p<0.05) the phosphorylation of RSK 1/2 in both fibre types. In 
contrast, DHT had no effect on the phosphorylation of MSK1/2 in 
either fibre types.
To investigate whether the effects of DHT on the phosphorylation of 
RSK1/2 were mediated through MEK1/2/ERK1/2 pathway, in some 
experiments the fibre bundles were pre-treated with the MEK 
specific inhibitor PD98059. As the results in Fig.3.7 show, pre-
treating the fibre bundles with the inhibitor completely abolished the 
effects of DHT on the phosphorylation of RSK1/2. 
Figure 3.7
MEK in both 
Representative 
fast-twitch (F, filled bars) and slow
bundles with 20M PD98059 (FMi,SMi) on the phosphorylation of 
RSK1/2. Note that treatment of the fibre bundles with DHT led to a 
significant increase (p=0.01; *p<0.05) in the phosphorylation of 
RSK1/2 in both fibre types. Furthermore, p
bundles with PD98059 completely abolished the DHT
increase in phosphorylation of RSK1/2 in both fibre types.
: DHT increases the phosphorylation of RSK1/2 through 
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3.4.6 Effects of DHT and T on the phosphorylation of the 
20KDa RMLCs
It has previously been shown that treating small muscle fibres 
bundles with DHT, but not with T, increases force production in fast-
twitch fibre bundles and decreases it in slow-twitch fibre bundles
(see Hamdi & Mutungi, 2010). However, the mechanism(s) 
underlying these observations is still poorly understood. Therefore, 
in another experiment I examined whether DHT exerted these 
effects by regulating the phosphorylation of the 20kDa regulatory 
myosin light chains (RMLCs). 
Figure 3.8
A
: DHT increases the phosphorylation of the 20kDa 
DHT
*
RMLC
B
s in fast
Testosterone
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with physiological concentrations of DHT (A) and T (B) on 
the phosphorylation of the 20kDa RMLCs. Note that treatment of the 
fibre bundles with DHT significantly increases (0.018;*p<0.05) the 
phosphorylation of RMLC in the fast-twitch fibre bundles only. In 
contrast, T has no effects on the phosphorylation of RMLC in either 
fibre type.
As the results displayed in Fig.3.8 show, treating the muscle fibre 
bundles with DHT led to a 20-40% increase in the phosphorylation of 
the RMLCs in fast twitch fibre bundles only (Fig. 3.8A).  In contrast, 
T led to a decrease in the phosphorylation of RMLCs in both fibre 
types (Fig. 3.8B).
Previously, a number of studies have shown that the motility of non-
muscle cells results from an ERK1/2-dependent increase in the 
phosphorylation of the 20KDa RMLCs (Klemke et al. 1997; Iwabu et 
al. 2004). Therefore, to examine whether the DHT-induced increase 
in the phosphorylation of the 20kDa RMLCs was mediated through 
the same pathway, some of the fibre bundles were pre-treated with 
PD98059. They were then treated with DHT plus the inhibitor. As the 
results in Fig. 3.9 show, pre-treatment of the fibre bundles with the 
inhibitor completely abolished the effects of DHT on the 
phosphorylation of the 20kDa RMLCs.
Figure 3.9
intact mammalian skeletal muscle fibres
Representative Western blots and summary data showing the 
effects of treating fast (F) and slow (S) twitch skeletal muscle fibre 
bundles isolated from female mice with the standard Ringer’s 
solution
SMT) on the phosphorylation of regulatory myosin light chains 
(pMLC). Note that treating the muscle fibre bundles with DHT 
significantly (p=0.01;*p<0.05) increases the phosphorylation of the 
regulator
fibre bundles with PD89059 abolishes these effects.
: Inhibiting 
(FC, SC), DHT alone (FT, ST) or DHT plus PD
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3.5 Discussion
A key finding in this study was the observation that treating fast- and 
slow twitch muscle fibre bundles isolated from adult female mice with 
physiological concentrations of DHT for 1hr increases the 
phosphorylation of ERK1 (p44) in both fibre types. Although similar 
results have previously been reported (see the study by Estrada et 
al. 2003), this the first time that DHT has been shown to have acute 
effects in mammalian skeletal muscle fibres. It is also the first time 
that any anabolic-androgenic steroid has been shown to have acute 
effects in adult mammalian skeletal muscle fibres. The study by 
Estrada and colleagues used cultured myocytes and the cells were 
treated with either T or nandrolone. In the present study, treatment 
of the muscle fibre bundles with T increased the phosphorylation of 
ERK1 in the slow-twitch fibre bundles only. Why T treatment has 
different effects in cultured myocytes and adult mammalian skeletal 
muscle fibres is uncertain. However, this might arise from the 
differences in concentration of T used in the two studies. The study 
by Estrada et al. (2003) used supraphysiological concentrations of T; 
whereas, physiological concentrations were used in the present 
study.
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It noteworthy that although DHT treatment increased the 
phosphorylation of ERK1, it had no effect on the activation of the 
other MAPK modules, Thus,  DHT treatment had no significant effect 
on phosphorylation of JNK (Fig. 3.3A) and p38 (Fig. 3.3B) in both 
fibre types. This finding is similar to those of other studies (Shi et al. 
2007; Shi et al. 2008) and probably suggests that p38 and JNK 
might not be involved in skeletal muscle plasticity. 
Another key finding in this study was all the observation that all fibre 
bundles expressed similar concentrations of phosphorylated/active 
ERK2 (p42) irrespective of whether they were treated or not and 
their fibre type composition. Moreover, the untreated fibre bundles 
expressed little or no phosphorylated ERK1 (p44) and only the DHT-
treated muscle fibre bundles expressed this isoform in large 
quantities. This observation suggests that the two isoforms may 
have different roles in mammalian skeletal muscle fibres. My 
hypothesis is that ERK2 is essential for the survival of both the fast-
and slow-twitch muscle fibres; whereas, ERK1 is involved in the 
regulation of muscle plasticity and is what is regulated by external 
stimuli. This hypothesis is supported by the findings of Saba-El-Leil 
and co-workers who showed that mice lacking ERK2 died inutero
(Saba-El-Leil et al. 2003). On the other hand, mice deficient in ERK1 
were viable and of normal size (Pages et al. 1999). Taken together 
these findings suggest that ERK2 maybe essential for the 
development and maintenance of all cells in the body; whereas, 
ERK1 is what is transduced and regulated by environmental factors 
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including mitogens and growth factors. Indeed, in ERK1 knockout 
mice, thymocyte maturation and differentiation was severely reduced 
suggesting that ERK1 may be essential for cell differentiation (Pages 
et al. 1999).
As mentioned above, treatment of the muscle fibre bundles with 
physiological concentrations of DHT increased the 
phosphorylation/activation of ERK1 in both fibre types; whereas, 
treatment with T increased its phosphorylation in the slow-twitch 
fibre bundles only (see Fig. 3.2). There are two interpretations of 
these findings; (1) DHT is the more potent anabolic-androgenic 
steroid in adult mammalian skeletal muscles. Indeed, DHT has been 
shown to have higher receptor binding kinetics than T (Bruchovsky & 
Wilson, 1968). (2) DHT is the only anabolic-androgenic steroid that 
has acute effects in adult mammalian skeletal muscle fibres. 
Therefore, for T to exert its effects it has to be converted in to DHT 
first. This process requires time and therefore, can account for the 
increase in the phosphorylated ERK1 in slow-twitch fibres. However, 
whether slow-twitch fibres have higher concentrations of 5α-
reductase (the enzyme that converts T into DHT) that fast-twitch 
fibres is uncertain and further studies are needed.
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Another important result from this study is the observation that 
treatment of the muscle fibre bundles with DHT increases the 
phosphorylation of RSK1/2 in both fibre types and that of the 20kDa 
myosin light chains in the fast-twitch fibre bundles only. On the other 
hand, DHT had no effect on the phosphorylation of MSK1/2. RSK 
1/2 is one of the downstream effector molecules of ERK1/2; the 
other being MSK1/2 (Blenis, 1993). RSK has two kinase domains, a 
linker region, C- and N-terminal tails and the Arg-X-X-Ser consensus 
N terminal tail sequence. It is activated upon sequential 
phosphorylation by ERK (Zhao et al. 1996; Frodin & Gemmeltoft, 
1999) and its activation is believed to promote cell growth and 
survival (Roux et al. 2007) and therefore, its activation may be 
important in skeletal muscle fibre hypertrophy. Indeed, one of the 
certain outcomes of long-term administration of anabolic-androgenic 
to both humans and rodents is an increase in skeletal muscle mass.
As mentioned above, in addition to its effects on RSK1/2, DHT 
treatment also increases the phosphorylation of the 20kDa 
regulatory myosin light chains (RMLCs). In non-muscle cells, the 
phosphorylation these light chains is essential for cell motility to 
occur (Iwabu et al. 2004). Additionally, mutation of the 
phosphorylation sites on these myosin light chains impairs muscle 
function in Drosophila melanogaster; suggesting that 
phosphorylation of these chains might be important in force 
production (Tohtong et al. 1995). Indeed, recent studies from this
laboratory (Hamdi & Mutungi, 2010) and other previous studies (see 
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review by Sweeny et al. 1993) suggest that phosphorylation of these 
light chains may be important in the regulation of force production in 
adult mammalian skeletal muscle fibres.
Another important finding from this study was the observation that all 
the above effects of DHT could be abolished by pre-treating the 
muscle fibres with the MEK inhibitor PD98059; suggesting that they 
were all mediated via the MAPK pathway.
In summary, the results I present here show that one of the 
physiological functions of the acute effects of DHT in adult 
mammalian skeletal muscle fibres is to regulate the phosphorylation 
of the 20kDa RMLCs. These effects are mediated through the MAPK 
pathway and involve an increase in the phosphorylation ERK1 and 
RSK1/2 (see Fig. 3.10). From these results I suggest that one of the 
physiological actions of DHT is to modulate force production in adult 
mammalian skeletal muscles by regulating the phosphorylation of 
the 20kDa RMLCs by myosin light chain kinase.
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CHAPTER 4
EFFECTS OF DHT AND T ON THE PHOSPHORYLATION OF AKT 
4.1 Introduction
As stated in 1.6.1, the prolonged administration of testosterone (T)
or any of its many synthetic analogues increases skeletal muscle 
mass and decreases fat mass in both humans (Brodsky et al.1996; 
Bhasin et al. 2001; Ferrando et al. 2002) and rodents (Exner et al. 
1973). Although this has been a constant finding in most previous 
studies (Brodsky et al.1996; Bhasin et al. 2001 Ferrando et al.
2002), little is known about the cellular signalling pathway(s) 
involved.
After the post-natal period, skeletal muscle mass increases mainly 
as a result of an increase in the size rather than the number of 
skeletal muscle fibres (Sandri, 2008). Furthermore, in most tissues
including skeletal muscle, cell size is generally believed to be
regulated by the protein kinase B (also known as Akt)/mammalian 
target of rapamycin (mTOR) pathway (Glass, 2003).
Protein kinase B (PKB) (or Akt) is a serine threonine kinase that 
occurs in three different isoforms, namely Akt-1 (PKB-α), Akt-2 
(PKB-β) and Akt-3 (PKB-γ), that are encoded by different genes 
(Coffer et al. 1998). However, their protein sequences are closely 
related and show an 80% homology. All three isoforms have a 
pleckstrin homology, PH, domain that binds phospholipids and at 
least one phosphorylation site (Coffer et al. 1998).  Akt-1 is 
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phosphorylated at Threonine 308 and Serine 473; Akt-2 is 
phosphorylated at Threonine 309 and Serine 474, while Akt-3 is 
phosphorylated at Threonine 302 and Serine 472 (Kandel & Hay, 
1999). Akt-1 is found in many tissues including skeletal muscle 
(Coffer et al. 1998; Cleasby et al. 2007), Akt-2 is highly abundant in 
embryonic brown fat (Altomare et al. 1998) and Akt-3 is expressed 
mainly in breast and prostate tissue (Nakatani et al 1999). Since 
they have a high homology all three isoforms are capable of 
phosphorylating the same substrates (Kandel & Hay, 1999). 
As stated in chapter 1 (section 1.7.4.1), the binding of growth factors 
to the tyrosine kinase receptor IGF-1R recruits insulin receptor 
substrate (IRS). PI3 Kinase is activated by binding of its p85 
regulatory subunit to IRS, which in turn increases the activity of its 
p110 catalytic domain. Upon activation, PI3 Kinase phosphorylates 
phosphoinositides at the 3-position of the inositol ring generating 
phosphatidyl (3) phosphate (PIP); phosphatidyl (3,4) diphosphate
(PIP2) and phosphatidyl (3,4,5) triphosphate (PIP3). PIP3 binds the 
PH domain of Akt and this brings it into close proximity with the PIP3-
dependant protein kinase 1 (PDK1) at the plasma membrane. PDK1 
then phosphorylates Akt at Threonine 308 and PDK2 at Serine 473 
for full activation (Belham et al. 1999). The PI3 Kinase signal is then 
attenuated by the phosphatase, phosphate and tensin homolog on 
chromosome 10 (PTEN) which dephosphorylate PI3 Kinase. Once
phosphorylated, Akt then translocates from the cytosol into the 
nucleus where it phosphorylates its downstream signalling 
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molecules such as mTOR leading to the regulation of protein 
synthesis and hence cell size (Richardson et al. 2004).
Therefore, an increase in skeletal muscle mass, as occurs following 
the chronic administration of T, must be accompanied by an 
increase in skeletal muscle fibre size and/or protein synthesis or a 
decrease in protein degradation; and for this to occur I hypothesised 
that T must lead to the activation of the Akt/mTOR pathway. So far,
no studies have ever investigated the acute/non-genomic effects of 
DHT and T on the activation of Akt.
4.2. Aim of this chapter
Therefore, the primary aim of this study was to investigate the 
acute/non-genomic effects of treating small skeletal muscle fibre 
bundles with physiological levels of DHT and T on the 
phosphorylation of Akt. 
4.3 Materials and methods
4.3.1 Treatment of the fibre bundles with DHT and T
The general materials and methods used in study are similar to 
those described in detail in Chapter 2. Therefore, they will only be 
briefly mentioned here. All the experiments reported here were 
performed at room temperature (~20C) using small muscle fibre 
bundles isolated from either the EDL (a fast-twitch muscle) or soleus 
(a slow-twitch muscle) of female adult CD1 mice prepared as 
described in section 2.2. The fibre bundles were mounted 
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horizontally between two stainless steel hooks in purpose built
muscle chambers (internal measurement 20mm width x 67mm 
length x 26mm depth) filled with the standard Ringer’s solution. They 
were then divided into two equal groups. Half were treated for 1hour 
with the standard Ringer’s solution plus 1.07mM of the vehicle 
(absolute ethanol) used to dissolve DHT and T. Proteins extracted 
from these fibres acted as controls. The other half was treated for 
the same period of time (1hour) with the Ringer’s solution containing 
630pgml-1 of DHT (2.16nM DHT) or T (1.82nM T). Proteins extracted 
from these fibre bundles acted as the experimental/treated samples. 
During the experiments, the Ringer’s solution was continuously 
bubbled with medical gas (95%O2, 5%CO2). Additionally, every 10
minutes, the Ringer’s solution was completely replaced and the fibre 
bundles were electrically stimulated to elicit a series of twitch 
contractions. 
To determine whether the effects of Akt were time dependent, some 
of the fibre bundles were treated with DHT for 3hours (3hrs). In one 
experiment, the fibre bundles were stimulated every 10 minutes with 
a short burst of twitch contractions (intermittent); whereas, in another 
they were subjected to twitch contractions every 2 minutes 
(continuous).
To determine whether the Akt pathway was intact and functional, 
another set of fibre bundles was treated for 1hr with Ringer’s solution 
containing 300ηM insulin (Sigma-Aldrich, UK). 
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4.3.2 Immunoblotting
At the end of the experiments described above, proteins were 
extracted and separated as described in chapter 2 sections 2.6 and 
2.9. They were then transferred on to PVDF membranes and 
blocked as described in sections 2.10 and 2.11. The membranes 
were then incubated overnight with the antibodies listed in table 4.1
and the following day they were incubated with species-specific 
secondary antibodies conjugated to horse-radish peroxidase for 
1hour at room temperature. They were then developed using ECL 
substrate and exposure of the membranes to film. On the third day, 
the membranes were stripped and re-probed for either total Akt
(Santa Cruz Biotechnology, USA) or actin (Abcam, Cambridge 
England). These blots acted as loading controls.
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Table 4.1: A list of the antibodies used to probe the various proteins described in this chapter
ANTIBODIES/PEPTIDES SOURCE
Antigens Description Dilution
Akt phosphorylated at Threonine 308 Rabbit polyclonal antibody 1:1000 Cell signaling technology Inc. 
(Beverly, USA)
Akt phosphorylated at Serine 473 Rabbit polyclonal antibody 1:1000 Cell signaling technology Inc. 
(Beverly, USA)
Total Akt 1/2/3 Rabbit polyclonal antibody 1:1000 SantaCruz Biotechnology Inc. (USA).
Goat anti-rabbit IgG-HRP 1:1000 SantaCruz Biotechnology Inc. (USA).
Goat anti mouse IgG-HRP 1:1000 SantaCruz Biotechnology Inc. (USA).
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4.3.3 Data handling and analysis
All the Western blots were run in triplicate and each experiment was 
repeated at least three times. The Western blots were digitised as 
described in section 2.15.1 and the intensity of each protein band 
was analysed using Scion image software from NIH. The intensity 
of the bands of interest were then normalised to those of the 
corresponding total protein or actin in the same sample and are 
presented as mean  S.D. Statistical analysis of the data performed 
using SigmaPlot  11.2 (Systat Software Inc., London, UK). The 
data obtained from the two fibre types under control and the various 
experimental conditions were then compared using a three way 
ANOVA and a p<0.05 was considered statistically significant.
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4.4 Result
4.4.1 Effects of DHT and T on the phosphorylation of Akt
The basic observations in this study are displayed in Fig. 4.1. As the 
results show, incubating the fast- and slow-twitch muscle fibre 
bundles in Ringer’s solution containing physiological levels of DHT 
or T for 1hour completely abolished the phosphorylation of Akt at 
Thr308 (Fig.4.1). Similar observations were made when the effects 
of DHT and T on the pAkt-Ser473 were examined (Fig. 4.2). Thus, 
phosphorylated Akt was observed only in the untreated fibre bundles 
and was higher in the slow-twitch fibre bundles than in the fast-twitch 
ones.
Although the Western blots shown were obtained using an antibody 
from Cell Signalling Technology, similar results were obtained when 
the experiments were repeated using antibodies from Santa Cruz 
Biotechnology and Epitomics.
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with DHT (A, FT, ST) and T (B, FT, ST) on the 
phosphorylation of Akt at Threonine 308 (pAKT-Thr308) probed 
using rabbit polyclonal antibody. Note that the antibody identified 
only one protein band at ~60KDa. Furthermore, treatment of the 
fibre bundles with DHT and T abolished the phosphorylation of Akt in 
both fibre types. The bar graphs show the intensity of the
phosphorylated Akt bands normalised to that of total Akt in the same 
samples.
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with DHT (A, FT, ST) and T (B, FT, ST) on the 
phosphorylation of Akt at serine 473 (pAKT-Ser473) probed using a 
rabbit polyclonal antibody. Note that the antibody identified only a 
single protein band at ~60KDa. Furthermore, treatment of the fibre 
bundles with DHT and T abolished the phosphorylation of Akt in both 
fibre types. The bar graphs show the intensity of the bands 
normalised to that of total Akt in the same samples.
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4.4.2 Comparison of Akt phosphorylation in DHT and T treated 
female muscle fibre bundles with untreated male muscle fibre 
bundles.
As mentioned in Chapter 3, T and DHT are male sex steroids and
their concentrations are higher in males than in females. Therefore, 
in another experiment, I examined whether the phosphorylation of 
Akt induced by DHT and T and that found naturally in male mice 
were similar.
As the results displayed in Fig.4.3 show, the concentration of 
phosphorylated Akt was always higher in the untreated male muscle 
fibre bundles than in the female ones. Moreover, treating the female 
mice muscle fibre bundles with DHT had the opposite effects on the 
phosphorylation of Akt to those I expected i.e. it reduced rather than 
increased its phosphorylation (similar observations were made when 
the phosphorylation of Akt at Ser473 was examined, result not 
shown).                                        
Figure 4.3: Male and female muscles express different
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with the standard Ringer’s solution (FC, SC, MF, MS), DHT 
(A, FT, ST) and T (B, FT, ST) on the phosphorylation of Akt at 
threonine 308 (pAKT-Thr308) probed using a rabbit polyclonal 
antibody. Note that the muscles fibre bundles isolated from male 
mice (MF, MS) always expressed higher concentrations of pAkt308 
than the corresponding female fibre bundles. Furthermore, treatment 
of the fibre bundles with DHT and T abolished the phosphorylation of 
Akt in both fibre types. The bar graphs show the intensity of the
phosphor Akt bands normalised to those of total Akt in the same 
samples.
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4.4.3 Effects of Insulin on the phosphorylation of Akt in mouse 
skeletal muscle fibre bundles
As DHT and T treatment abolished the phosphorylation of Akt at both 
threonine 308 and serine 473, I decided to investigate whether this pathway 
was intact and fully functional. To do this, I treated another set of fibre 
bundles with 300nM insulin. Insulin-like growth factor (IGF)1 is a potent 
stimulus of the PI3K/Akt pathway (Alessi et al. 1996) and can be mimicked 
by insulin (Alessi et al. 1996). As the results displayed in Fig.4.4 show, 
treatment of the muscle fibre bundles with insulin increased the 
phosphorylation of Akt in both fibre types. Furthermore, the insulin-treated 
female muscles and the untreated male muscles this time expressed similar 
concentrations of phosphorylated Akt.
Figure 
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with the standard Ringer’s solution (FC, SC, MF, MS) or the 
Ringer’s solution plus 300ηM insulin on the phosphorylation of Akt at 
threonine 308 (Thr-308) and serine 473 (pAKT-Ser473). Note that 
treatment of the fibre bundles with insulin increases the 
phosphorylation of Akt at Thr308 and Ser473 in both fibre types. 
Furthermore, the male muscles fibre bundles (MF, MS) and the 
insulin treated (FIn, SIn) muscle fibre bundle, express similar 
concentrations of Akt phosphorylated at both sites. The bar graphs 
show the intensity of the pAkt bands normalised to those of total Akt 
in the same samples.
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4.4.4 Effects of treating skeletal muscle fibre bundles with DHT 
for 3hrs on the phosphorylation of Akt
As shown above, muscle fibres isolated from untreated male mice 
always expressed higher concentrations of pAkt than the 
corresponding untreated fibres from female mice. To me this 
suggested that the effects of DHT on the phosphorylation of Akt may 
be time dependent. Therefore, in another experiment I tested this 
hypothesis. As the results displayed in figures 4.5 and 4.6 show, 
perfusing the fibre with DHT for three hours increased the 
phosphorylation of Akt at both Thr308 and Ser473 
irrespective of whether the fibres were electrically                                   
stimulated continuously (ST-Con) or intermittently (FT-Inter).
Figure
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with the standard Ringer’s solution (B, FC, SC) or the 
standard Ringer’s solution plus 630ρgml-1 DHT for 3hrs on the 
phosphorylation of Akt at threonine 308 (Thr-308). Note that 
treatment of the fibre bundles with DHT for 3hours increases the 
phosphorylation of Akt at Thr308 in both fibre types irrespective of 
whether the fibre bundles were subjected to intermittent (B, FT-inter 
3hrs, ST-inter 3hrs) or continuous (B, FT-Con 3hrs, ST-Con 3hrs) 
twitch stimulation. Also note that (A, FC, SC) and (A, FC3hrs,
SC3hrs) are untreated control in standard Ringer’s solution for 1hour 
and 3hours respectively.
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Representative Western blots showing the effects of treating fast-
twitch (F, filled bars) and slow-twitch (S, clear bars) muscle fibre 
bundles with the standard Ringer’s solution (B, FC, SC) or the 
standard Ringer’s solution plus 630ρgml-1 DHT for 3hrs on the 
phosphorylation of Akt at Serine 473 (Ser-473). Note that treatment 
of the fibre bundles with DHT for 3hours increases the 
phosphorylation of Akt at Ser473 in both fibre types irrespective of 
whether the fibre bundles were subjected to intermittent (B, FT-inter 
3hrs, ST-inter 3hrs) or continuous (B, FT-Con 3hrs, ST-Con 3hrs) 
twitch stimulation. Also note that (A, FC, SC) and (A, FC3hrs,
SC3hrs) are untreated control in standard Ringer’s solution for 1hour 
and 3hours respectively.
4.5 Discussion
As stated in section 4.1 above, the prolonged administration of 
anabolic-androgenic steroids always increases skeletal muscle mass 
(Exner et al. 1973; Bhasin et al. 2001; Ferrando et al. 2002). 
Therefore, when I started performing these experiments I expected 
DHT and T to increase the phosphorylation of Akt at both Thr308 
and Ser473. However, as results presented in Figs. 4.1 and 4.2
show, treatment of the muscle fibre bundles with Ringer’s solution 
containing physiological levels of DHT and T, for 1hour, completely 
abolished the phosphorylation in both fibre types (Fig. 4.1). Contrary 
to my expectations, these findings suggest that one of the 
immediate/early effects of DHT and T treatment in mammalian 
skeletal muscle fibres is to switch off the Akt/mTOR pathway and to 
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switch on the MAPK pathway. Although this is the first time the acute 
effects of DHT and T on the activation of this pathway in adult 
mammalian skeletal muscle fibres have been investigated, treating 
castrated mice with T also switches off the genes involved in Akt 
pathway (Haren et al. 2011), As suggested in the previous chapter, 
one of the effects of the MAPK pathway in these fibres is to initiate 
the conversion of slow-twitch fibres into fast-twitch fibres. Therefore, 
switching off the Akt pathway allows the changes initiated by 
activation of the MAPK to occur first. However, why and how DHT 
and T switch off this pathway is unknown and further studies are 
needed.
Initially, when I made the above observations I thought that there 
may be a problem with the antibodies or the fibres. However, as the 
results displayed in Fig. 4.4 show, treatment of the fibre bundles with 
insulin led to a marked increase in the phosphorylation of Akt. 
Similar observations were also made when the fibre bundles were 
treated with DHT for 3hrs (see Figs. 4.5 and 4.6); suggesting that the
pathway was intact and the fibre bundles were working properly. 
Therefore, from these findings it seems as if the effects of DHT on 
the Akt pathway are time dependent. However, further studies are 
needed to confirm this.
Another key finding in this study was the observation that the 
untreated male muscle always expressed higher concentrations of 
active Akt than the corresponding female muscle fibre bundles.  
Here, I postulate that the higher concentrations of active Akt in the 
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male muscles than in the female ones may be the reasons why
males have bigger muscles than females. However, this is the first 
time that effects of gender on the phosphorylation of Akt have been 
investigated and more research is needed to ascertain this.
In summary, the results I presented here show that the acute/non-
genomic effects of DHT on the phosphorylated of Akt are time 
dependent. Thus, DHT initially switches of the Akt pathway, when 
the MAPK pathway is active, and switches it on later. However 
further studies to confirm this and to investigate the mechanism(s) 
underlying this effect are necessary. 
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CHAPTER 5
THE NON-GENOMIC EFFECTS OF DHT ON THE TRANSPORT 
OF AMINO ACIDS IN ISOLATED INTACT FAST- AND SLOW 
TWITCH MAMMALIAN SKELETAL MUSCLE FIBRE BUNDLES
5.1 Introduction
In the body testosterone (T) is rapidly and irreversibly reduced into
dihydrotestosterone (DHT) by 5α-reductase (Bruchovsky & Wilson, 
1968). Although the free unbound concentrations of the two 
hormones are similar, it is generally believed that DHT is the more 
potent hormone because it has higher receptor binding kinetics than
T (Bruchovsky & Wilson, 1968). However as the expression of 5α-
reductase (5αRD) in adult mammalian skeletal muscle is 
controversial it has been suggested that DHT may not have 
physiological functions in this tissue (Thigpen et al. 1993).
Nevertheless, in a recent study, we showed that DHT, but not T, can 
modulate force production in isolated intact mouse skeletal muscle 
fibres (Hamdi & Mutungi, 2010). Furthermore, as the data reported in 
Chapter 3 of this thesis show these effects were mediated through 
the MAPK pathway and involving the activation of ERK1. From these 
studies, it is clear that DHT has acute/non-genomic actions in adult 
mammalian skeletal muscle fibres (Hamdi & Mutungi, 2010). 
However, whether it has any other acute/non-genomic physiological 
functions in skeletal muscle is unknown.
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In adult animals/humans, T and its derivatives commonly referred to 
as anabolic-androgenic steroids (AASs) are major determinants of 
body composition (Wilson, 1988; Bhasin et al. 2001). For example,
treating adult female laboratory animals (Exner et al.1973), 
hypogonadal men (Brodsky et al. 1996), elderly individuals with 
serum low T level (Ferrando et al. 2002) and men suffering from 
AIDS (Bhasin et al. 2000) with AASs for several weeks has been 
shown to increase lean body mass. Although the mechanisms 
underlying the changes in lean body mass induced by AAS 
treatment are still poorly understood, it is generally thought that 
these compounds increase protein synthesis (Kochakian 1949; 
Ferrando et al. 2002) while at the same time decreasing its 
breakdown (Ferrando et al. 2002).
Skeletal muscle is the largest pool of essential amino acids in the 
body and these amino acids form up to 35% of its total muscle 
proteins (Harper et al. 1984). Therefore, for skeletal muscle to 
increase in mass, as occurs following the chronic administration of 
AASs, it must have an adequate supply of essential amino acids. 
However, the few studies that have investigated the effects of AAS 
administration on amino acid uptake by skeletal muscles were 
unable to demonstrate any changes in amino acid uptake following 
the administration of T to human subjects (Bhasin et al. 1997; 
Ferrando et al.1998). Thereby leaving the source of the new amino 
acids unresolved.
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Amino acids enter and leave cells through specialized transport 
systems known as amino acid transporters (Christensen, 1990). 
Although all cells express a variety of these transporters, the 
combinations found in each cell type seem to depend on its 
physiological functions and the location of the transporters;
suggesting that the expression and activity of these transporters may 
be carefully regulated (McGivan & Pastoranglada, 1994; Wagner et 
al. 2001). While some of the physiological factors regulating the 
activity and expression of amino acid transporters belonging to 
system A, in mammalian cells, have been the subject of a number of 
previous studies (Bevington et al. 2002; Franchi-Gazzola et al. 2004;
Kashiwagi et al.2009), little is known about the physiological factors 
regulating the expression and activity of L-type amino acid 
transporters, especially in adult mammalian skeletal muscles.
5.2 Aims of this chapter
Therefore, the primary aims of this study were to investigate the 
acute/non-genomic effects of DHT and T on;
(1) Amino acid uptake,
(2) The expression of the amino acid transporters SNAT2 and LAT2,
(3) The cellular signalling pathway(s) mediating these actions,
in fast- and slow-twitch muscle fibre bundles isolated from adult 
female mice.
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5.3.1 Determination of the effects of DHT and T on the uptake 
of isoleucine (Ile) and α-(Methylamino)isobutyric acid (MeAIB)
To determine the uptake of the amino acids, 8 fast-twitch and 8 
slow-twitch muscle fibre bundles, were divided into two groups. Half 
were treated with the standard Ringer’s solution containing 
6.3l/100ml (1.07mM) ethanol (the vehicle used to dissolve both 
DHT and T) plus either 2mM C14 isoleucine (L-(U-14 C) Ile;
radioactivity level 3.46Ciml-1) (Doi et al. 2007) or 68.3M C14 α-
methylaminoisobutyric acid (α-(1-14C) MeAIB; radioactivity level 
0.8Ciml-1) (Kashiwagi et al. 2009) (both purchased from 
PerkinElmer, Buckinghamshire, UK) for 1hour. 
These preparations acted as controls. The other half were treated 
with the Ringer’s solution containing 630ρgml-1 DHT or testosterone 
propionate (T) (both from Sigma, Gillingham, Dorset, UK) plus the 
radio-labelled amino acids for the same duration (1hour). These fibre 
bundles acted as the experimental/treatment group. Radio-labelled 
Ile was used in these studies because, unlike leucine, it does not 
stimulate protein synthesis in adult mammalian skeletal muscle 
(Anthony et al. 2000). At the end of this experiment the fibre bundles 
were processed for liquid scintillation counting as described in 
section 5.3.4
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5.3.2 Determination of the amino acid transporter mediating 
the effects of DHT on amino acid transport in mammalian 
skeletal muscle fibre bundles
To investigate the amino acid transporters mediating the effects of 
DHT on amino acid uptake observed in the preceding experiments, 
the following experiment was performed. The muscle fibre bundles 
were divided into four groups each containing 10 fast- and 10 slow-
twitch fibre bundles. Each group was then treated for at least 20 
minutes as follows; Group 1 (control) was treated with the standard 
Ringer’s solution plus 1.07mM ethanol, Group 2 was treated with the 
Ringer’s solution plus DHT alone, Group 3 was treated with the 
Ringer’s solution containing either BCH or MeAIB alone plus 
1.07mM ethanol; whereas, Group 4 was treated with the Ringer’s 
solution containing DHT plus either 10mM BCH or 100M MeAIB. At 
the end of this period, the solutions were then replaced with the 
same solutions but this time 2mM L-(U-14 C) Ile was added. The 
bundles were then incubated in these solutions for 1hour after which 
the uptake of Ile by the fibre bundles was determined as described in 
section 5.3.4
To determine the effects of DHT on the expression of LAT2 and 
SNAT2, another set of fibre bundles was treated with the standard 
Ringer’s solution plus the vehicle (1.07mM ethanol) or the standard 
Ringer’s solution plus DHT. Cytosolic and crude membrane proteins 
were then extracted and immunoblotted for the expression of SNAT2 
and LAT2 as described below.
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5.3.3 Determination of the cellular-signal transduction
pathway(s) mediating the effects of DHT on amino acid uptake
To investigate the cellular-signal transduction events mediating the 
effects of DHT on amino acid uptake described above, 10 fast- and 
10 slow- twitch muscle fibres bundles were treated with the standard 
Ringer’s solution plus the vehicle or the standard Ringer’s solution 
plus DHT for 1hour. In some of the experiments, the fibre bundles 
were pre-incubated with the standard Ringer’s solution plus 
PD98059 (a MEK specific inhibitor), deguelin (a PI3K/Akt inhibitor), 
rapamycin (an mTOR specific inhibitor), actinomycin D (a 
transcription inhibitor) or cyclohexamide (a translational inhibitor) for 
20minutes. They were then treated with the Ringer’s solution 
containing the inhibitor whose effects were being investigated plus 
DHT for 1hour (see table 5.1 for list of inhibitor). At the end of the 
experiments, the muscle fibre bundles were immunoblotted as 
described in section 5.3.6.
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Table 5.1: A table showing details of the inhibitors used in the experiments described in this chapter
PROTEIN/PROCESS INHIBITORS
Scientific name                                   Common name       Concentration   Source
LAT2 2-Aminobicyclo[2,2,1]heptane-2-carboxylic acid BCH 100M Sigma-Aldrich 
SNAT2 2,N-Dimethylalanine,2 (Methylamino)-2-methylpropionic acid MeAIB 10μM Sigma-Aldrich
Transcription Actinomycin IV Actinomycin D 1gml-1 Sigma-Aldrich 
Translation 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-
hydroxyethyl]glutarimide
Cyclohexamide 10gml-1 Sigma-Aldrich 
MAP kinase kinase 
(MEK)
2-Amino-3-methoxyflavone PD98059 20μM Alexis 
Biochemicals
AKT (7aS,13aS)-13,13a-Dihydro-9,10-dimethoxy-3,3-dimethyl-3H-
bis[1]benzopyrano[3,4-b:6′,5′-e]pyran-7(7aH)-one
Deguelin 100nM Sigma-Aldrich 
mTOR 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine Rapamycin 100ngml -1 Sigma-Aldrich
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5.3.4 Liquid scintillation counting
At the end of the experiments described above, the Ringer’s solution 
was aspirated and the fibre bundles were washed twice in ice cold 
phosphate buffer saline (PBS). The excess buffer was blotted out 
and the bundles were then snap frozen in liquid nitrogen, pulverised 
and cytosolic proteins were extracted using the non-ionic cell lysis 
buffer NP40 as described in section 2.4. The amount of proteins in 
each lysate was then determined using the quick Bradford assay 
(Bradford, 1976). The rest of the lysate was mixed with an equal 
amount of Optima Gold XR liquid scintillant (PerkinElmer, 
Buckinghamshire, UK), in a capped plastic vial measuring 15mm in 
diameter x 55mm in height.  The level of radioactivity in the mixture 
was then determined using a liquid scintillation counter (Tri-Carb 
2250 CA, Canberra-Packard) 1hour and 24hours after the end of 
each experiment. Also, each experiment was repeated at least twice.
Carbon-14 is a long half-life, low energy (0.156MeV) β emitter that 
can be used to label amino acids including isoleucine. Using a radio 
scintillation counter, the radioactivity in the protein lysates can then 
be counted. Liquid scintillation counting is a common technique for 
measuring radiation emitted from β nuclide of the C-14 in biological 
samples suspended in a liquid scintillant cocktail (LSC) (Reid et al. 
2000; Reid et al. 2001). As stated earlier, the lysate was mixed with 
LSC because the cocktail contains ethoxylated alkyphenol which 
serves as a surfactant enabling the aqueous lysate, in contact with 
the aromatic solvent, to form a stable micro emulsion (Stolzenberg et 
172
al.1982). Sixty to 99% of the LSC is an aromatic solvent such as 
diisopropylnaphthalene (DIN) and serves as a source of high density 
π (pi) electron for efficient energy transfer (Birks, 1964). Phosphor or 
scintillants such as 2,5,-diphenyloxazole (PPO) and 1,4-bis(2-
methylstyryl) benzene (bis-MSB), that constitute 0.3-1% of the LSC 
cocktail converts the captured energy into emitted light (Dianu et al.
2007). In theory, during the liquid scintillation counting, β emission 
from the muscle lysate transfers energy to the solvent molecules 
which in turn transfer their energy to the scintillant. The excited 
scintillant molecules dissipate the energy by emitting light. In this 
way, each β emission results in a pulse of light detected by the liquid 
scintillation counter (Birks, 1964). 
Quenching is the loss of count due to the characteristics of the 
sample or LSC cocktail (Horrocks, 1974). In my study, Optima Gold 
XR was used because it has a good quench resistance 
characteristic (Reid et al. 2001; Verrezen et al. 2008). Sometimes 
energy transfer such as heat and room light or sunlight can excite 
aromatic solvent molecules in the LSC, which causes unwanted 
background reading which in turn interfere with actual signal (Bruno 
& Christian, 1961). Therefore in my study the lysate was kept for 24 
hours in the dark to minimise non-specific emission.
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Two liquid scintillation counting machines a Tri-Carb 2250 CA 
(Packard Instrument Co, Meridien, USA) and a Canberra-Packard or 
Wallac 1409 DS (Perkin Elmer, Waltham, USA) were used in this 
study. Most of the experiments were performed using the Tri-Carb 
2250 except when this was being used by others when the Wallac 
1409 was used. Therefore, the performance of both machines was 
assessed by measuring radioactivity from four different samples FC 
(Fast control); FTesto (Fast testosterone); FCyp only (Fast 
Cyproterone only) and FCyp+DHT (Fast Cyproterone plus DHT).
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5.3.5 Calibration
In this study I used two radiolabeled amino acids; isoleucine and 
MeAIB that have never been used in the laboratory before. 
Therefore, my first test was to ensure that the concentrations I am
using were within the linear range of the liquid scintillation machines. 
To do this I used 0, 2, 4, 6, 8, 16, 32, 40 and 50l of -L-(U14-C) 
isoleucine and α-(1-14C)-MeAIB in 50mls of the standard Ringer’s 
solution. The radioactivity of the samples was then measured using 
liquid scintillation counting and plotted as shown in Fig.5.3.
AFigure 
.
5.3: Calibration of the liquid scintillation counter 
B
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Calibration curves showing the radioactivity (Bq) of pre-determined 
concentrations of L-(U14-C) isoleucine (A) and MeAIB α-(1-14 C) 
measured using the liquid scintillation counter. Note that the 
radioactivity of the samples is almost linear. For example the R2 for 
isoleucine was 0.965; whereas that of MeAIB was 0.947 for
α-(1-14 C)-MeAIB (B), Note that the volume range for isoleucine are 
0.39l and 19.47l and those of MeAIB are 6.80l and 25.02l 
respectively. Therefore, the liquid scintillation counting system is 
calibrated and the concentration of amino acids used in the study 
(2.07 – 8l per 3ml) are within the detectable range of the machine
As in the results plotted in Fig. 5.3 show, the radioactivity of the 
samples was within the linear range of the machine. For example, R2
for L-(U14-C) isoleucine was 0.965; whereas, that for MeAIB was 
0.947. 
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Table 5.2: List of the proteins and the antibodies used in this chapter.
ANTIBODIES/PEPTIDES SOURCE
Antigens Description Dilution
SNAT2 Mouse monoclonal antibody 1:500 SantaCruz Biotechnology Inc. 
(USA).
LAT2 Rabbit polyclonal antibody 1:500 SantaCruz Biotechnology Inc. 
(USA).
CREB phosphorylated at Serine 133 Rabbit monoclonal antibody 1:500 Abcam (Cambridge, England)
Total cmyc Mouse monoclonal antibody 1:500 SantaCruz Biotechnology Inc. 
(USA).
ATF2 phosphorylated at Threonine 71 Rabbit polyclonal antibody 1:500 Cell signaling technology Inc. 
(Beverly, USA)
eEF2 phosphorylated at Threonine 56 
and Threonine 58
Rabbit monoclonal antibody 1:500 Abcam (Cambridge, England)
Actin Mouse monoclonal antibody 1:1000 Abcam (Cambridge, England)
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Goat anti-rabbit IgG-HRP 1:1000 SantaCruz Biotechnology Inc. 
(USA).
Goat anti mouse IgG-HRP 1:1000 SantaCruz Biotechnology Inc. 
(USA).
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5.3.6 Immunoblotting
At the end of the experiments described above, the fibre bundles 
were snap frozen in liquid nitrogen, pulverized and cytosolic as well 
as crude membrane proteins were extracted using NP40 lysis buffer. 
To extract cytosolic proteins, the lysates were centrifuged for 10min 
at 15000rpm. The supernatant was then collected and stored at -
80C until required. To extract crude membrane proteins, the pellets 
from the cytosolic extractions were washed twice in ice-cold PBS 
and blotted with filter paper to remove the excess buffer. They were 
then snap frozen in liquid nitrogen, pulverized and proteins were 
extracted as described above. Equal amounts (10g) of the proteins 
were then immunoblotted as described in (Mutungi, 2008). Briefly, 
the proteins were resolved in either 10% or 5% SDS-polyacrylamide 
gels, depending on the molecular weight of the proteins being 
probed. They were then transferred onto PVDF membranes. The 
membranes were blocked for non-specific antibody labelling with 5% 
milk for 30 minutes. They were then incubated overnight at 4C with 
primary antibodies against; L-type amino acid transporter 2 (LAT2), 
sodium neutral amino acid transporter 2 (SNAT2), phosphorylated 
CREB, cmyc, phosphorylated ATF2 and phosphorylated eEF2 (for 
details see Table 5.2). The following day they were washed and 
incubated for 1hour with species specific secondary antibodies 
conjugated with horse-radish peroxidase. Finally, they were 
visualised using SuperSignal WestPico (Perbio Science UK Ltd, 
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Cramlington, Northumberland) chemiluminescence substrate and 
exposure to film.
The following day, the membranes were stripped as described in 
Hamdi & Mutungi (2010). They were then re-probed with either a 
pan-actin antibody or an antibody against the total 
(unphosphorylated) protein whose phosphorylation was being 
investigated. These blots were used as loading controls. 
5.3.7 Analysis and Data handling
The radioactivity of each lysate was counted and expressed as the 
disintegration per minute. It was then normalized to the protein 
content of the lysate and expressed as Becquerel per microgram of 
protein (Bq/g). The radioactivity was then normalized to that 
recorded under control conditions and all the data are presented as 
the mean percentage change in uptake S.D.
All the Western blots were run in triplicate and each experiment was 
repeated at least three times. To determine the statistical 
significance of the changes, the intensity of the bands, from each 
experiment, was analyzed using Scion Image from NIH and was 
normalized to that of the loading control (either actin or the total 
protein).
182
Statistical analysis of the data was performed using SigmaPlot 
11.2 (Systat Software Inc., London, UK). The data obtained from the 
two fibre types under control and from the various experimental 
conditions were then compared using a 3-way ANOVA and p<0.05 
was considered statistically significant. 
5.4 Results
5.4.1 Effects of DHT and T on Isoleucine Uptake in adult 
mammalian skeletal muscle fibre bundles
The basic observations from this study are shown Fig. 5.4. As the 
results show, incubating the fast- and slow-twitch muscle fibre 
bundles in Ringer’s solution containing physiological levels of DHT 
for 1 hour significantly (p<0.05) increased the uptake of isoleucine 
(Ile)in the fast-twitch fibre bundles only. In contrast, treating the fibre 
bundles with similar concentrations of T did not significantly (p>0.05) 
increase the uptake of (Ile) in either fibre type. For example, treating 
the muscle fibre bundles with DHT led to an 88.83  14.12% and to 
a 15.89  4.55% increase in the uptake of Ile in the fast- and slow-
twitch fibre bundles, respectively. On the other hand, treatment of 
the fibre bundles with T led to a 9.19  9.67% increase in the uptake 
of Ile in the fast-twitch fibre bundles but to a 8.04  5.67 % decrease
in the uptake of Ile in the slow-twitch fibres.
Figure 5.4
A
: DHT but not T increases isoleucine uptake in fast-twitch skeletal muscle fibre bundles
B
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Bar graphs showing the effects of treating fast- (filled bars) and slow-
(clear bars) twitch fibre bundles with physiological levels of DHT (A) 
and T (B) on the uptake of L-(U-14 C) Ile. Note that treating the fibre 
bundles with DHT, but not T, significantly (p=0.001) increases the 
uptake of L-(U-14 C) Ile in the fast-twitch fibre bundles. In contrast, 
DHT had little or no effect on the uptake of L-(U-14 C) Ile in the slow-
twitch bundles. In contrast, T leads to a slight decrease in the uptake 
of L-(U-14 C) Ile in these fibre bundles.* p<0.05 when compared to 
control.
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5.4.2 Effects of DHT and T on α-(Methylamino)isobutyric acid
uptake in adult mammalian skeletal muscle fibre bundles
The results in figure 5.5 show, the effects of treating the muscle fibre 
bundles with DHT (A) and T (B) on the uptake of MeAIB. As the 
results show, treating the fibre bundles with DHT significantly 
(p<0.05) increased the uptake of MeAIB in the fast-twich fibre 
bundles only. In contrast, treating the fibre bundles with T did not 
significantly (p>0.05 increase the uptake of MeAIB in either fibre 
type. Thus, treating the fibre bundles with DHT led to a 36.89  
7.86% increase in the uptake of  α-(1-14 C)-MeAIB in the fast-twitch 
fibre bundles and to a 17.09  4.05% increase in its uptake in the 
slow-twitch fibre bundles (Fig. 5.5A). In contrast, treating the fibre 
bundles with T led to a 8.98  4.79 % increase in α-(1-14 C)-MeAIB 
uptake in fast twitch fibre bundles and to a 9.48  5.65 % decrease 
in α-(1-14 C)-MeAIB uptake in slow-twitch fibre bundles (Fig. 5.5B).
Figure 5.5
A
: DHT but not T increases α-(Methylamino)isobutyric acid uptake in fast
B
-twitch skeletal muscle fibre bundles
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Bar graphs showing the effects of treating fast- (filled bars) and slow-
(clear bars) twitch fibre bundles with physiological levels of DHT (A) 
and T (B) on the uptake of α-(1-14 C)-MeAIB. Note that treating the 
fibre bundles with DHT, but not T, significantly (p=0.001) increases 
the uptake of α-(1-14 C)-MeAIB in the fast-twitch fibre bundles. In 
contrast, DHT had little or no effect on the uptake of α-(1-14 C)-
MeAIB in the slow-twitch bundles. In contrast, T led to a slight 
decrease in the uptake of α-(1-14 C)-MeAIB in these fibre bundles.
* p<0.05 when compared to control.
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5.4.3 The transporter mediating amino acid uptake in adult 
mammalian skeletal muscle fibre bundles
In another experiment, I decided to investigate the amino 
transporter(s) mediating the effects of DHT reported in the previous 
sections. To do this, I pre-treated another set of fiber bundles with 
the L-type amino acid transporter inhibitor BCH and the system A 
inhibitor MeAIB for 20minutes. The Ringer’s solution was then 
changed to one containing radiolabelled isoleucine, DHT and the 
inhibitor whose effects was being investigated for 1hour. The uptake 
of the radiolabelled isoleucine was then determined. In some 
experiments, proteins were extracted and probed for the expression 
of LAT2 and SNAT2 proteins.
Figure 5.
A
6: BCH and MeAIB inhibit the effects of DHT on amino acid uptake by the muscle fibre bundles.
B
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Figure 5.
SNAT2 activity
A
7: The effects of DHT on amino acid uptake in skeletal muscle fibre bundles are mediated through LAT2 but require 
*
B
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In figure 5.6; bar graphs showing the effects of treating fast-twitch 
(filled bars) and slow-twitch (clear bars) muscle fibre bundles with 
DHT plus BCH (A) or DHT plus MeAIB (B) on the uptake of L-(U-14 
C) Ile. Note that treating the muscle fibre bundles with both BCH and 
MeAIB significantly (p<0.05) reduces the basal as well as the DHT-
induced increase in Ile uptake. Furthermore, DHT increases the 
expression of LAT2 but not that of SNAT2. FT and ST are the fast-
and slow-twitch samples treated with DHT, respectively.
In figure 5.7; (A) A typical Western blot and bar graphs showing the 
effects of DHT on the expression of LAT2 (A) in membrane proteins 
and SNAT2 (B) in cytosolic proteins extracted from fast- (F, filled 
bars) and slow- (S, clear bars) twitch muscle fibre bundles. Note that 
DHT increases the expression of LAT2 but not that of SNAT2. FT 
and ST are the fast- and slow-twitch samples treated with DHT, 
respectively.* p<0.05 compared to control. † p<0.05 compared to 
DHT treatment.
As the results displayed in Figure 5.6 show, treatment of the muscle 
fibre bundles with DHT significantly (p<0.01) increased the uptake of 
L-(U-14 C) Ile in the fast-twitch fibre bundles only. In contrast, pre-
incubating the fibre bundles with BCH and MeAIB significantly 
(p<0.05) decreased the basal uptake of L-(U-14 C) Ile in both fibre 
types. Pre-treatment with BCH and MeAIB also completely abolished 
the DHT-induced increase in Ile uptake (Fig. 5.6A and Fig. 5.6B).
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The effects of DHT on the expression of LAT2 and SNAT2 are 
shown in Fig.5.7. As the results show, under control conditions the 
slow twitch fibre bundles always expressed higher concentration of 
the two transporters than the fast twitch ones. Whether this 
difference is physiologically important is uncertain as the uptake of 
Ile and MeAIB under control conditions in the two fibre types only 
showed a small difference. For example the uptake of Ile was 
0.0420.0013Bqg-1 muscle protein in fast twitch fibres (n=4) and 
the uptake of Ile was 0.0390.007Bqg-1 muscle protein in slow 
twitch fibres (n=4). On the other hand, treatment of the muscle fibre 
bundles with DHT significantly increased the expression of LAT2 in 
the fast-twitch fibre bundles only (Figure 5.7A) without significantly 
(p=0.13) affecting the expression of SNAT2 in ether fibre type 
(Figure 5.7B).
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Bar graphs showing the effects of DHT on L-(U-14 C) Ile uptake in 
fast-(filled bars) and slow-(clear bars) twitch skeletal muscle fibre 
bundles treated with the standard Ringer’s solution, the standard 
Ringer’s solution plus DHT, the standard Ringer’s solution plus MEK 
inhibitor PD98059 or the standard Ringer’s solution plus DHT and 
PD98059. Note that treating the fibre bundles with DHT alone 
significantly increases the uptake of L-(U-14 C) Ile in the fast-twitch 
fibre bundles only. That treatment of the fibre bundles with PD98059 
alone significantly (p=0.001) reduces the basal amino acid uptake of 
L-(U-14 C) Ile in both fibre types. Additionally, it completely abolished 
the DHT-induced uptake of L-(U-14 C) Ile in the fast-twitch fibre 
bundles.* p<0.05 compared to control. † p<0.05 compared to DHT 
treatment.
As the result in Figure 5.8 show treatment of the muscle fibre 
bundles with the MEK inhibitor, PD98059 significantly decreased the 
basal uptake of isoleucine. Also PD98059 completely abolished the 
DHT-induced increase in amino acid uptake in the fast-twitch fibre 
bundles. 
AFigure 5.9: Rapamycin blunts the effect of DHT on amino acid uptake in mouse skeletal muscle fiber bundles 
B
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Bar graph showing the effects of DHT on L-(U-14 C) Ile uptake in 
fast-(filled bars) and slow-(clear bars) twitch skeletal muscle fibre 
bundles treated with the standard Ringer’s solution, the standard 
Ringer’s solution plus DHT, the standard Ringer’s solution plus the 
Akt specific inhibitor deguelin (A) or the mTOR inhibitor rapamycin 
(B) or the standard Ringer’s solution plus DHT and deguelin or 
rapamycin. Note that treating the fibre bundles with either deguelin 
alone (A) or rapamycin alone (B) significantly decreases the basal 
uptake of L-(U-14 C) Ile in both fibre types. Additionally, pre-treating 
the fibre bundles with rapamycin but not deguelin completely 
abolishes the DHT-induced increase in L-(U-14 C) Ile in the fast-
twitch fibre bundles. In contrast, deguelin blunts without abolishing 
the DHT-induced L-(U-14 C) Ile uptake.
The effects of treating the fibre bundles with either deguelin or 
rapamycin are shown in Fig 5.9. As the results show, treatment of 
the muscle fibre bundles with either deguelin alone or rapamycin 
alone decreased the basal uptake of isoleucine in both fibre types, 
suggesting that the Akt/mTOR pathway plays an essential role in the 
maintenance of basal amino acid transport in mammalian skeletal 
muscle fibres. Furthermore, pre-treating the fibre bundles with 
deguelin blunts without abolishing the effects of DHT on isoleucine 
uptake in the fast-twitch fibre bundles (Figure 5.9 A). In contrast, pre-
treatment of the fibre bundles with rapamycin completely abolished 
the effects of DHT isoleucine uptake in the fast-twitch fibre bundles 
(Figure 5.9 B). 
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Bar graph showing the effects of DHT on L-(U-14 C) Ile uptake in 
fast-(filled bars) and slow-(clear bars) twitch skeletal muscle fibre 
bundles treated with the standard Ringer’s solution, the standard 
Ringer’s solution plus DHT, the standard Ringer’s solution plus 
actinomycin D or the standard Ringer’s solution plus DHT and 
actinomycin D. Note that treating the fibre bundles actinomycin D 
alone does not significantly affect the basal uptake of L-(U-14 C) Ile in 
both fibre types. Additionally, pre-treating the fibre bundles with 
actinomycin D completely abolishes the DHT-induced increase in L-
(U-14 C) Ile in the fast-twitch fibre bundles.* p<0.05 compared to 
control. † p<0.05 compared to DHT treatment.
The results from this experiment are shown in Fig. 5.10. As the 
results show, treatment of the fibre bundles with actinomycin D alone 
did not significantly (p=0.47 in the fast-twitch and 0.13 in the slow-
twitch fibre bundles) affect the basal uptake of L-(U-14 C) Ile in either 
fibre type. However, pre-treatment of the fibre bundles with 
actinomycin D significantly (p=0.001) reduced the DHT-induced 
increase in L-(U-14 C) Ile uptake without completely abolishing it 
(Figure 5.10).
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As stated in 3.1, once activated RSK1/2 translocate into the nucleus 
where it activates a large numbers of transcription factors including 
CREB, cmyc and ATF2 (Krishna & Narang, 2008). Furthermore, as 
the results displayed in Fig. 5.10, suggested that the effects of DHT 
involved transcription, in another experiment, I examined the effects 
of DHT on the activation of some of these transcription factors.
The results from this experiment are displayed in Fig. 5.11 and as 
they show, treatment of the muscle fibre bundles with DHT had little 
or no effect on the expression and activation of cmyc (Fig. 5.11B) in 
both fibre types. On the other hand, it increased the phosphorylation 
of ATF2 (Fig. 5.11C) and completely abolished phosphorylation of 
CREB in fast fibre type only (Fig. 5.11A).
AFigure 5.11: The effects of DHT on the expression of c-myc
B
and the phosphorylation of CREB
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Representative Western blots and summary bar graphs showing the 
effects of DHT on the expression c-myc and the phosphorylation of 
CREB and ATF2 in fast-(F, filled bars) and slow- (S, clear bars) 
twitch muscle fibre bundles treated with the standard Ringer’s 
solution (FC, SC) or the standard Ringer’s solution plus DHT (FT, 
ST). Note that treating the muscle fibre bundles with DHT had no 
effect on the expression of c-myc in either fibre type. Instead, it 
increases the phosphorylation of ATF2 and completely abolishes 
that of CREB in the fast-twitch muscle fibre bundles only.* p<0.05 
when compared to control.
As the results displayed in Figure 5.11 show, treating the muscle 
fibre bundles with DHT had little or no effect on the expression and 
activation of cmyc (Fig. 5.11 B) in both fibre types. On the other 
hand, it increased the phosphorylation of ATF2 (Fig. 5.11 C) and 
completely abolished phosphorylation of CREB in fast fibre type only 
(Fig. 5.11 A).                                                    . .
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5.4.6 The effects of cyclohexamide on DHT-induced increase in 
isoleucine uptake in adult mammalian skeletal muscle fibre 
bundles
To investigate whether the effect of DHT-induced increase in 
isoleucine uptake involved the modulation of translation, another set 
of fibre bundles was treated with translational inhibitor 
cyclohexamide. The uptake of L-(U-14 C) Ile was then examined in 
the presence or absence of DHT.
Figure 5.1
DHT on isoleucine uptake in mammalian skeletal muscle fibre 
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bundles with cyclohexamide completely abolishes the DHT-induced 
increase in L-(U-14 C) Ile in the fast-twitch fibre bundles.* p<0.05 
compared to control. † p<0.05 compared to DHT treatment.
As the result displayed in Figure 5.12 show, treatment of the fibre 
bundles with cyclohexamide alone significantly (p<0.05) reduced the 
basal uptake of L-(U-14 C) Ile in both fibre types. Moreover,pre-
treating the fibre bundles with cyclohexamide completely abolished 
the DHT-induced increase in L-(U-14 C) Ile observed in the fast-twitch 
fibre bundles (Fig. 5.12).
5.4.7 The effects of DHT on translational eukaryotic elongation 
factor (eEF) 2 in adult mammalian skeletal muscle fibre bundles
Phosphorylation of eEF2 inhibits elongation and translation. To 
confirm the effects of cyclohexamide reported in the previous 
experiment, another set of fibre bundles was treated with DHT. The 
phosphorylation of eEF2 was then examined. As the results 
displayed in Fig. 5.13 show, the untreated fast-twitch fibre bundles 
expressed significantly (p<0.05) higher concentrations of 
phosphorylated eEF2 than the slow-twitch ones. However, treatment 
of the fibre bundles with DHT abolishes the phosphorylation of eEF2 
in both fibre types.
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5.5 Discussion
A key finding in the present study was the observation that treating 
small skeletal muscle fibre bundles isolated from the EDL (a fast-
twitch muscle) and soleus (a slow-twitch muscle) of adult female 
mice with physiological concentrations (630pgml-1) of DHT, for 
1hour, significantly (p=0.001) increased the uptake of both Ile and 
MeAIB in the fibre bundles isolated from the EDL but not in those 
isolated from the soleus (Figs. 5.4 and 5.5).
Although the acute administration of hormones such as insulin (Biolo 
et al. 1995), insulin-like growth factor 1 (IGF-1) (Fryburg et al. 1995) 
and growth hormone (Fryburg et al. 1995) has been shown to 
increase protein synthesis and to promote amino acid uptake in 
human skeletal muscle, this is the first time that an increase in amino 
acid uptake in response to the acute administration of an anabolic-
androgenic steroid in adult mammalian skeletal muscle has been 
demonstrated. Only two other studies have previously investigated 
the effects of T on amino acid uptake. Both studies used human 
subjects and were unable to demonstrate any changes in amino acid 
uptake in whole muscle groups (Bhasin et al. 1997; Ferrando et 
al.1998). Although small skeletal muscle fibre bundles were used in 
the present study and T was applied directly to the fibre bundles, it is 
important to note that T had no effect on amino acid uptake in either 
the fast- or slow twitch fibre bundles (Figures 5.4B and 5.5B). In 
contrast, treating the fibre bundles with DHT led to a marked 
increase in the uptake of both Ile and MeAIB in the fast-twitch fibre 
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bundles only (Fig.5.4A and 5.5A). Previous data from the laboratory 
has also shown that T has no acute effect on force production in 
isolated intact mouse skeletal muscle fibre bundles; whereas, DHT 
increased force production in the fast-twitch fibre bundles but 
decreased it in the slow-twitch ones (Hamdi & Mutungi, 2010). 
Taken together, these findings suggest that T may not have any 
acute/non-genomic effects in adult mammalian skeletal muscle 
fibres.
As mentioned in the section 1.6, in most tissues T is converted into 
DHT by the enzyme 5α-reductase. Therefore, it is likely that all the 
acute effects of T observed previously in cultured myocytes (Estrada 
et al. 2003) may have been exerted by DHT. Indeed, it has 
previously been suggested that the anabolic effects of T, in human 
skeletal muscles, may be indirect or secondary to the release of 
another hormone such as IGF-1 (Ferrando et al. 1998). Here I 
speculate that in addition to IGF-1, the effects of T in mammalian 
skeletal muscle may also be exerted by DHT. I also suggest that 
DHT is the main anabolic-androgenic steroid in adult mammalian 
skeletal muscles.
Amino acids enter and leave cells through highly specialized 
proteins known as amino acid carriers or transporters. Moreover, 
each cell expresses numerous varieties of these transporters 
(Christensen, 1990). As the data displayed in Fig. 5.7 shows, in 
addition to other transporters, adult mouse fast- and slow-twitch 
skeletal muscle fibres express both SNAT2 (a system A amino acid 
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transporter) (Fig. 5.7 B) and LAT2 (an amino acid transporter 
belonging to system L) (Fig. 5.7 A). Although mRNAs for these 
transporters have previously been identified in mammalian skeletal 
muscle (Utsunomiya-Tate et al. 1996; Segawa et al. 1999; Pineda et 
al. 1999; Yao et al. 2000; Hyde et al. 2001; Sugawara et al. 2000), 
this is the first time the protein for LAT2 has been shown to be 
present in adult mammalian skeletal muscle. It is also the first time 
the expression of both transporters in different muscle fibre types 
has been described. As the data displayed in Fig.5.7 show the 
untreated slow-twitch muscle fibre bundles express more (~1.8 
times) transporter proteins than the corresponding fast-twitch fibres. 
However, whether this difference is physiologically important is 
uncertain and further studies are necessary.
It is now generally accepted that certain nutrients such as amino 
acids are essential for the maintenance of tissue structure, growth 
and function. Therefore, it has been suggested that their uptake and 
release by cells is highly regulated. Although many factors including 
pH (Bevington et al. 2002; Yao et al. 2000; Sugawara et al. 2000), 
osmolarity (Horio et al. 1997), intracellular amino acid levels 
(Gazzola et al. 1972; Drummond et al. 2010), hormones (Barber et 
al. 1982), growth factors (Moule & McGivan, 1987) and mitogens 
(Franchi-Gazzola et al. 1999) have been shown to regulate the 
expression and activity of SNAT2 (so called adaptive response) in 
many cell types, far less is known about the factors that control the 
activity and function of L-type amino acid transporters. The results 
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reported in this study show that although DHT increases the activity 
of SNAT2, it does not affect its expression. Instead, it increases the 
activity and expression of LAT2 (see Fig. 5.7 A). Furthermore, 
preloading the muscle fibre bundles with the classical system A and 
L-type amino acid inhibitors led to a marked decrease in the basal 
uptake of L-(U-14 C) Ile in both fibre types and completely abolished 
the DHT-induced increase in Ile uptake (Figure 5.6 A and B). From 
these observations, I suggest that although the effects of DHT on 
amino acid uptake are mediated through LAT2, SNAT2 is somehow 
involved. Thus, by modulating the expression and activity of LAT2, 
DHT also seems to indirectly regulate the activity of SNAT2. This 
type of coupling, commonly referred to as tertiary active transport,
has been previously reported and is thought to exist in most cells 
(see Figure 5.14) (Hyde et al. 2007; Baird et al. 2009). Indeed, 
recent data published by Drummond and his co-workers suggest 
that it may also exist between SNAT2 and LAT1 in human skeletal 
muscle (Drummond et al. 2010); suggesting that this type of coupling 
may be widespread in skeletal muscle. However, further studies to 
confirm this are necessary.
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of DHT in adult mammalian skeletal muscles are exerted mainly 
through the ERK1/2 module of the MAPK pathway (Fig. 5.8).
In adult animals, an increase in skeletal muscle mass (hypertrophy) 
occurs mainly as a result of an increase in the size rather than the 
number of muscle fibres and is generally thought to be regulated by 
the Akt)/ mTOR pathway (Glass, 2003). The Akt/mTOR pathway is 
activated by many stimuli including many growth factors, hormones 
and nutrients and its activation culminates in the block of apoptosis, 
induction of protein synthesis, gene transcription and cell 
proliferation (Dann et al. 2007). Therefore, my expectation was that 
DHT and T would activate this pathway. However, as the results 
displayed in Fig.5.9A show, the Akt specific inhibitor deguelin 
blunted the DHT-induced amino acid uptake in fast-twitch fibres 
without completely abolishing it.  Thereby, suggesting that the non-
genomic actions of DHT are not mediated through Akt. Instead, the 
results present in this chapter suggest that DHT increases protein 
synthesis by regulating the translation of mRNA already present in 
the cells. Indeed, treatment of the muscle fibre bundles with DHT led 
to a marked decrease in the phosphorylation of eEF2 (see Fig. 
5.13). Furthermore, pre-treating the fibre bundles with the 
translational inhibitor cyclohexamide completely abolished the DHT-
induced increase in amino acid uptake (Fig.5.12).
Cyclohexamide is a glutarimide antibiotic that binds the E-site on the 
60S ribosomal subunit thereby inhibiting the binding of eEF2 on this 
site and tRNA translocation from the A-site to the P-site (Schneider-
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Poetsch et al. 2010).  Therefore, both of these observations provide 
further evidence in support of my hypothesis that DHT increases 
amino acid uptake by increasing protein translation. However, this 
cannot be the only mechanism involved because pre-treating the 
fibre bundles with the transcriptional inhibitor actinomycin D also 
abolished the DHT-induced increase in amino acid uptake (Fig. 
5.10). However, as DHT did not increase the activity of many of the 
transcription factors examined, I hypothesis that it increases the 
transcription of genes that are already active.
It is also noteworthy that pre-treating the fibre bundles with the 
mTOR specific inhibitor rapamycin not only reduced the basal 
uptake of Ile, it also completely abolished the DHT-induced increase 
in the uptake of Ile in the fast-twitch fibre bundles (Fig. 5.9B). These 
findings suggest that some of the non-genomic effects of DHT are 
probably mediated through mTOR. Indeed, a number of studies 
have suggested that mTOR is the link between amino acid 
availability and increased protein synthesis (Avruch et al. 2009; 
Beugnet et al. 2003). However, rapamycin can also induce 
autophagy (Ravikumar et al. 2004). Therefore, another possibility is 
that its effects are due to a build-up of amino acids in the muscle 
fibres. However, the exact mechanism underlying the effects of 
rapamycin is uncertain and further studies are necessary.
214
In summary, the results reported in this study show that another 
physiological function of the non-genomic actions of DHT in adult 
mammalian skeletal muscle fibres is to increase the uptake of 
essential amino acids mediated through the L-type amino acid 
transporter LAT2.
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CHAPTER 6
RECEPTOR MEDIATING THE RAPID/NON-GENOMIC EFFECTS 
OF DHT IN ISOLATED INTACT FAST- AND SLOW-TWITCH
FIBRE BUNDLES
6.1 Introduction
As the results reported in Chapters 3, 4 and 5 show, DHT like all 
other steroid hormones has acute/non-genomic effects in adult 
mammalian skeletal muscle fibres. Thus, treating small skeletal 
muscle fibre bundles isolated from the EDL (a fast-twitch) and soleus 
(slow-twitch) of adult female mice with physiological concentrations 
of DHT significantly increases amino acid uptake in the fast-twitch 
fibres (see the results reported in Chapter 5). This effect was 
mediated through the MAPK pathway (see the results reported in 
Chapter 3 and involved an increase in the expression of the L-type 
amino acid transporter LAT2 (see the results reported in Chapter 5). 
These effects occurred within 1hour; suggesting that they were 
mediated via a cell surface receptor rather than through the classical 
androgen receptors. However, very little is known about the receptor 
involved.
Only one other study has previously investigated the acute/non-
genomic effects of T in skeletal muscle cells (Estrada et al. 2003).
From their results, the authors suggested that the effects of the 
hormones used (testosterone (T) and nandrolone) were mediated 
via a G-protein coupled receptor (GPCR) on the cell membrane. 
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However, they never identified the GPCR involved. Therefore, it is 
uncertain whether the acute/non-genomic effects of anabolic 
androgen steroids are mediated through a GPCR as previously 
suggested (Estrada et al. 2003) or another cell surface receptor.
6.2 Aim of this chapter
Therefore, the primary aim of this study was to investigate the 
receptor(s) mediating the acute/non-genomic effects of DHT in 
isolated intact mouse fast- and slow- twitch skeletal muscle fibre
bundles. 
6.3 Materials and methods
The materials and methods used in this study are similar to those 
described in previous chapters and will only be briefly outlined here.
Like in all the experiments reported in previous Chapters, the 
experiments reported here were performed at room temperature 
(~20C) using small muscle fibre bundles (mean cross-sectional 
diameter 35017μm, n=60) isolated from the EDL and soleus of
adult female CD1 mice aged 52.1  2.2 days (n=30; range 48 - 56 
days) killed as described elsewhere in this thesis.
During an experiment, the muscle fibre bundles were mounted 
horizontally between two stainless steel hooks in specially designed 
muscle chambers. Two types of muscle chambers, one with a total 
volume of 25ml and the other 5ml, were used in this study. The 25ml 
chamber was used in the experiments investigating the receptor 
mediating the acute/non-genomic effects of DHT in the muscle fibre 
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bundles; whereas, the chambers with a total volume of 5mls were 
used in the amino acid uptake experiments. The fibre bundles were 
continuously perfused with the standard mammalian Ringer’s 
solution alone or the standard Ringer’s solution plus the various 
compounds/inhibitors listed in Table 6.1. The composition of the 
Ringer’s solution was as detailed in section 2.2 and its pH was 
maintained at 7.42 by constantly bubbling it with 95% O2 and 5% 
CO2.
6.3.1 Determination of the receptor mediating the non-genomic 
effects of DHT in isolated mouse skeletal muscle fibre bundles
To investigate the receptor(s) mediating the acute effects of DHT on 
amino acid uptake 32 muscle fibre bundles (16 fast-twitch and 16 
slow-twitch) were divided into four equal groups. Each group was 
then treated for at least 20 minutes as follows; Groups 1 (control), 2 
and 4 were treated with the standard Ringer’s solution; whereas,
Group 3 was treated with the Ringer’s solution plus one of the 
inhibitors listed in Table 6.1. At the end of this period, they were then 
treated for 1hour as follows; Group 1 was treated with the standard 
Ringer’s solution plus 107.9M ethanol (the vehicle used to dissolve 
DHT), Group 2 was treated with the standard Ringer’s solution plus 
630ρgml-1 (2.16M) DHT, Group 3 was treated with the Ringer’s 
solution plus the inhibitor whose effects were being investigated and 
Group 4 was treated with the Ringer’s solution containing DHT plus 
the inhibitors whose effects being investigated. At the end of the
experiments, the muscle fibre bundles were processed for Western 
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blotting as described in previous chapters. In another study, the 
above experiments were repeated in the presence of 2mM L-(U-14 C) 
Ile. At the end of this experiment the fibre bundles were processed 
for liquid scintillation counting.
6.3.2 Immunoblotting 
At the end of all the experiments described above, proteins were 
extracted and separated as described in section 2.24. They were 
then immunoblotted overnight with antibodies raised against the C-
terminus- and N-terminus- of the AR, pERK1/2-Thr202/Ser204, the 
20kDa pMLC, pEGFR-Tyr1173 and peEF2 (for details of the 
antibodies and concentrations used see table 6.2). The following 
day, the membranes were incubated with species-specific secondary 
antibodies conjugated to horse-radish peroxidise for 1 hour at room 
temperature. They were later developed using ECL substrate and 
exposure of the membranes to film. On the third day, the 
membranes were stripped and re-probed for with total ERK, total 
MLC, or actin for loading control and normalisation.
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6.3.3 Liquid scintillation counting
The proteins from the second study were processed for liquid 
scintillation counting as described in section 5.3.4. Briefly, 5l of 
each lysate was used to determine the protein concentration in the 
sample. The rest of the lysate was mixed with an equal amount of 
Optima Gold XR liquid scintillant (PerkinElmer, Buckinghamshire, 
UK) and the level of radioactivity in the mixture was determined 
using a liquid scintillation counter (Tri-Carb 2250 CA, Canberra-
Packard) 1hour and 24hours after the end of each experiment.
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Table 6.1:  The concentration and source of the inhibitors used in this chapter
PROTEIN INHIBITORS
Scientific name                                                           Common name      Concentration   Source
Androgen receptor (AR) 6-Chloro-1β,2β-dihydro-17-hydroxy-3′H-cyclopropa(1,2)-
pregna-1,4,6-triene-3,20-dione acetate
Cyproterone 
acetate
1M Sigma-Aldrich
2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-propanamide Flutamide 3M Sigma-Aldrich 
Src 4-amino-5-(4-chlorophenyl)-7-(t-
butyl)pyrazolo[3,4,d]pyrimidine
PP2 10μM Alexis 
Biochemicals, 
Nottingham, UK.
Insulin-like growth factor 
1 receptor (IGF-1R)
α-Cyano-(3-methoxy-4-hydroxy-5-iodocinnamoyl)-(3′,4′-
dihydroxyphenyl)ketone
Tyrphostin AG 538 100M Sigma-Aldrich
221
Platelet derived growth 
factor receptor (PDGFR)
4-(6,7-Dimethoxy-4-quinazolinyl)-N-(4-phenoxyphenyl)-1-
piperazinecarboxamide
PDGFR Tyrosine 
kinase Inhibitor III
200nM Calbiochem
Epidermal growth factor 
receptor (EGFR)
(N-[3-Chlorophenyl]-6,7,-dimethoxy-4-quinazolamine) Tyrphostin AG 
1478
100nM Sigma-Aldrich
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ANTIBODIES/PEPTIDES SOURCE
Antigens Description Dilution
Androgen receptor  (C-terminal domain) Rabbit polyclonal antibody 1:1000 SantaCruz Biotechnology Inc. 
(USA)
Androgen receptor (N-terminal domain)  Rabbit monoclonal antibody 1:1000 Abcam (Cambridge, England)
ERK 1/2 phosphorylated at Thr202 and Ser204  Rabbit polyclonal antibody 1:1000 SantaCruz Biotechnology Inc. 
(USA)
Myosin Light Chain phosphorylated at Serine 
20 
Rabbit polyclonal antibody 1:1000 Abcam (Cambridge, England)
eEF2 phosphorylated at Thr56 and Thr 58 Rabbit monoclonal antibody 1:500 Abcam (Cambridge, England)
Table 6.2: List of the antigens of interest probed and the antibodies used to probe them in this chapter
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EGFR phosphorylated at Tyrosine 1173 Rabbit polyclonal antibody 1:500 Cell signaling technology Inc. 
(Beverly, USA)
Total ERK 1 [C-16] Rabbit polyclonal antibody 1:1000 SantaCruz Biotechnology Inc. 
(USA)
Total myosin light chain Rabbit polyclonal antibody 1:1000 Abcam (Cambridge, England)
Actin Mouse monoclonal antibody 1:1000 Abcam (Cambridge, England)
Goat anti-rabbit IgG-HRP 1:1000 SantaCruz Biotechnology Inc. 
(USA)
Goat anti mouse IgG-HRP 1:1000 SantaCruz Biotechnology Inc. 
(USA)
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6.3.4 Analysis and data handling
The radioactivity of each lysate was counted and expressed as the 
disintegration per minute. It was then normalized to the protein 
content of the lysate and expressed as Becquerel per microgram of 
protein (Bq/g). The radioactivity was then normalized to that 
recorded under control conditions and all the data are presented as 
the mean percentage change in uptake S.D.
All the Western blots were run in triplicate and each experiment was 
repeated at least three times. To determine the statistical 
significance of the changes, the intensity of the bands, from each 
experiment, was analyzed using Scion Image from NIH and was 
normalized to that of the loading control (either actin or the total 
protein).
Statistical analysis of the data was performed using SigmaPlot 
11.2 (Systat Software Inc., London, UK). The data obtained from the 
two fibre types under control and from the various experimental 
conditions were then compared using a 3-way ANOVA and p<0.05 
was considered statistically significant. 
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6.4 Results
6.4.1 Receptor mediating the acute effects of DHT in 
isolated intact mammalian skeletal muscle fibre bundles
6.4.1.1 Androgen receptor involvement
A few studies have previously shown that that the acute/non-
genomic effects of DHT in the prostate cancer cell line, LnCaP 
(Peterziel et al. 1999) and sertoli cells (Cheng et al. 2007) are 
mediated through classical androgen receptor. Therefore, in this 
study I investigated whether the acute/non-genomic effects of DHT 
in adult mammalian skeletal muscle fibre bundles are mediated 
through the AR. To determine this, I pre-treated some muscle fibre 
bundles with 1M cyproterone (a steroidal AR inhibitor) and 3M 
flutamide (a non-steroidal inhibitor of the AR).
I then examined the effects of DHT on the phosphorylation of 
ERK1/2 and the 20kDa RMLCs as well as the uptake of isoleucine 
by the muscle fibres. The results from this study are displayed in 
Figs. 6.1, 6.2 and 6.3 and as they show, both inhibitors did not affect 
the effects of DHT on the phosphorylation of ERK1/2 and the 20kDa 
RMLCs. On the other hand, they both blunted the effects of DHT-
induced increase in Ile uptake by the fast-twitch fibre bundles. 
Moreover, the effects were greater when the fibre bundles were pre-
treated with flutamide than when they were pre-treated with 
cyproterone. Indeed, treating the muscle fibre bundles with 
cyproterone alone increased the uptake of Ile in both fibre bundles.
Figure 6.
A
1: Inhibiting the AR does not abolish the effects of DHT on the phosphorylation of ERK 1/2
* * *
B
in both fibre types 
* *
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Representative Western blots and summary bar graphs showing the 
effects of treating female fast-(filled bars) and slow-(clear bars) 
twitch skeletal muscle fibre bundles with the standard Ringer’s 
solution (A,B,FC,SC), DHT alone (A,B,FT,ST), and the standard 
Ringer’s solution containing both DHT and cyproterone (A,FCT,SCT) 
or flutamide (B,FLt,SLt) on the phosphorylation of ERK1/2. Note that 
treating the muscle fibre bundles with DHT significantly (p=0.015; 
*p<0.05) increases the phosphorylation of ERK1/2 in both fibre types 
and that pre-treating the fibre bundles with cyproterone (A) or 
flutamide (B) does not reverse these effects. 
Figure 6.2
A
: Inhibiting the AR does not abolish the effects of DHT on the phosphorylation of regulatory MLC in both fibre types 
*
B
*
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Representative Western blots and summary bar graphs showing the 
effects of treating female fast-(filled bars) and slow-(clear bars) 
twitch skeletal muscle fibre bundles with the standard Ringer’s 
solution (A,B,FC,SC), DHT alone (A,B,FT,ST), and the standard 
Ringer’s solution containing both DHT and cyproterone 
(A,B,FCT,SCT) or flutamide (B,FLt,SLt) the on the phosphorylation 
of the 20kDa regulatory myosin light chain (pMLC). Note that treating 
the muscle fibre bundles with DHT significantly (p=0.015; *p<0.05) 
increases the phosphorylation of RMLCs in both fibre types and that 
treating fibre bundles with cyproterone (A) or flutamide (B) does not 
reverse these effects.
AFigure 6.
androgen receptor 
3: The effects of DHT on amino acid uptake in mouse skeletal muscle fibre bundles are 
B
partly mediated through the 
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Bar graphs showing the effects of treating fast- (filled bars) and slow-
(clear bars) twitch skeletal muscle fibre bundles with the standard 
Ringer’s solution or the Ringer’s solution plus physiological levels of 
DHT alone or DHT plus the androgen receptor inhibitors cyproterone 
(A) and flutamide (B). Note that treatment of the fibre bundles with 
cyproterone alone significantly (p=0.001 and 0.007, respectively) 
increases the basal uptake of L-(U-14 C)Ile in both fibre types. In 
contrast, flutamide on its own significantly (p=0.028) increases 
amino acid uptake in the fast-twitch fibre bundles only. Additionally, 
pre-treating the fibre bundles with both compounds significantly 
(p<0.05) reduces the DHT-induced increase in Ile uptake. However, 
these effects were greater in the fibre bundles pre-treated with 
flutamide than in those pre-treated with cyproterone.* p<0.05 
compared to control. † p<0.05 compared to DHT treatment.
6.4.1.2 Androgen receptor density
Previously, it has been suggested that the diverse effects of chronic 
steroid hormones treatment observed in animal experiments arise 
from differences in their androgen receptor (AR) densities 
(Eisenberg & Gordon 1950; Metcalf & Gross, 1960; Egginton, 1987; 
Salmons, 1992; Heinlein & Chang 2002). Furthermore, the AR 
density in mammalian skeletal muscles has never been directly 
investigated. I also wanted to rule out the involvement of AR density 
in the fast-/slow fibre differences seen in uptake of Ile.
Therefore, 
fast-
compared fibre bundles isolated from female animals with those 
from male animals. As the results displayed in Fig. 6.4 show, the 
fibre bundle
receptor irrespective of their phenotype or gender of the animal they 
were from.
Figure 6.
concentrations of the androgen receptor
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polyclonal antibody against the C terminus of the human AR (A) or a 
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Western blots showing the androgen receptor 
experiment I examined the AR densities in the 
C), female slow (SC), male fast (MF) and 
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Note that the polyclonal antibody identified two proteins, one with a 
molecular weight of ~110kDa (AR-B) and the other with a molecular 
weight of ~67kDa (AR-A); whereas, the monoclonal antibody 
identified only a single band with a molecular weight of ~110kDa. 
Note that the fast- and slow-twitch muscles from the same sex 
animal express similar concentrations of the AR and no difference 
was observed when the concentration of the receptor in the male 
and female muscles were compared.
6.4.2 Src involvement in mediating the non-genomic effects of 
DHT in adult mammalian skeletal muscle fibre bundles
It has been suggested that in the non-genomic mechanism, DHT 
recruits signaling pathways that are often associated with cell 
membrane receptors such as GPCR (Heinlein & Chang, 2000; 
Falkenstein et al. 2000; Simoncini & Genazzani, 2003; Estrada et al.
2003). One of the pathways implicated in these studies is the 
src/MAPK pathway (Kousteni et al. 2001; Cheng et al. 2007). 
Therefore, to test the involvement of src in the acute effects of DHT 
in adult mammalian skeletal muscle fibre bundles, I pre-treated 
some muscle fibres with src inhibitor PP2. I then examined the 
effects of DHT on the phosphorylated ERK1/2 in the fibre bundles. 
Figure 6.
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As the results displayed in figure 6.5 shows pre-treatment of the fibre 
bundles with PP2 (a potent and specific inhibitor of src) had no effect 
on the DHT induced phosphorylation of ERK1/2 in both fibre types.
This suggests that the non-genomic effect of DHT is not mediated 
through the src.
6.4.3 Receptor tyrosine kinase involvement
6.4.3.1 IGF-1R, PDGFR and EGFR Involvement
As stated in section 1.7.4, the non-genomic actions of DHT and T 
can be mediated through surface membrane receptor such as 
Receptor tyrosine kinases (RTKs) which includes insulin-like growth 
factor-1 receptor (IGF-1R) (Rennie et al. 2004), platelet derived 
growth factor receptor (PDGFR) (Albrecht & Tidball, 1997) and 
epidermal growth factor receptor (EGFR) (Zwick et al. 1999).
Therefore, to determine whether the acute effects of DHT in adult 
mammalian skeletal muscle fibre bundles were exerted through 
these receptors, another set of fibre bundles was pre-treated for 
20minutes with the IGF-1R inhibitor tyrphostin AG538, the PDGFR
inhibitor PDGFR tyrosine kinase Inhibitor III or the EGFR specific 
inhibitor Tyrphostin AG1478. The effects of DHT on the
phosphorylation of ERK1/2 and the 20kDa RMLCs was then 
determined.
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As the results displayed in Fig.6.6 show, treating the fibre bundles 
with tyrphostin AG538 (Fig 6.6A) and PDGFR Tyrosine kinase 
Inhibitor III (Fig.6.6B) had no effect on effects of DHT on the 
phosphorylation of ERK1/2 in both fibre types. Similarly, they also 
did not affect the effects of DHT on the phosphorylation of the 20kDa 
RMLCs (Fig.6.7).
Figure 6.
fibre types 
A
6: Inhibiting the IGF-1R and PDGFR does not abolish the effects of DHT on the phosphorylation of ERK 1/2 in both 
* *
B
* *
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Representative Western blots and summary bar graphs showing the 
effects of treating female fast-(filled bars) and slow-(clear bars) 
twitch skeletal muscle fibre bundles with the standard Ringer’s 
solution (A,B,FC,SC), DHT alone (A,B,FT,ST), and the standard 
Ringer’s solution containing both DHT and tyrphostin AG538 
(A,B,FGT,SGT) (A) or  Tyrosine Kinase Inhibitor III (FPT,SPT) (B) on 
the phosphorylation of ERK1/2. Note that treating the muscle fibre 
bundles with DHT significantly (p=0.015; *p<0.05) increases the 
phosphorylation of ERK1/2 in the fast- and slow- twitch muscle fibre 
bundles. And that adding the inhibitors does not abolish these 
effects.
Figure 6.
A
7: Inhibiting the IGF-1R and PDGFR does not abolish the effects of DHT on the phosphorylation of MLC in both fibre types 
*
B
*
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Representative Western blots and summary bar graphs showing the 
effects of treating female fast-(filled bars) and slow-(clear bars) twitch 
skeletal muscle fibre bundles with the standard Ringer’s solution 
(A,B,FC,SC), DHT alone (A,B,FT,ST), and the standard Ringer’s 
solution containing both DHT and Tyrphostin AG538 (A,B,FGT,SGT) 
(A) or the Tyrosine Kinase Inhibitor III (FPT,SPT) (B) on the 
phosphorylation of the 20kDa regulatory myosin light chain (pMLC). 
Note that treating the muscle fibre bundles with DHT significantly 
(p=0.01; *p<0.05) increases the phosphorylation of MLC in both fibre 
types. And that adding the inhibitors does not abolish these effects.
A number of studies have suggested that the ERK dependent 
phosphorylation of myosin light chain and hence motility of non-muscle 
cell is mediated through EGFR (Klemke et al. 1997; Iwabu et al. 2004). 
Therefore, to test whether the acute effects of DHT in adult 
mammalian skeletal muscle fibre bundles were mediated through the 
EGFR, I pre-treated another set of fibre with the EGFR specific 
inhibitor, Tyrphostin AG1478. The effects of DHT on the 
phosphorylation of ERK1/2 and the 20kDa RMLC was then 
determined.
Figure 6.
A
8: Inhibiting the EGFR abolishes the effect of DHT on the phosphorylation of ERK 1/2 and MLC in both fibre types 
* *
B
*
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Representative Western blots and summary bar graphs showing the 
effects of treating female fast-(filled bars) and slow-(clear bars) 
twitch skeletal muscle fibre bundles treated with the standard 
Ringer’s solution (A,B,FC,SC), DHT alone (A,B,FT,ST), and the 
standard Ringer’s solution containing both DHT and Tyrphostin 
AG1478 (A,B,FiT,SiT) on the on the phosphorylation of ERK1/2 (A) 
and phosphorylation of the 20kDa regulatory myosin light chain 
(pMLC) (B). Note that treating the muscle fibre bundles with DHT 
significantly increased (p=0.01; *p<0.05) the phosphorylation of 
ERK1/2 in fast-and slow- twitch fibres and that this was abolished
when they were pre-treated with Tyrphostin AG1478. 
As the result in Figure 6.8 A,B show, pre-treatment of the muscle 
fibre bundles with Tyrphostin AG1478 completely abolished the 
effects of DHT on the phosphorylation of ERK1 (p44) and the 20kDa 
RMLCs in both fibre types; thereby suggesting that the non-genomic 
effect of DHT in adult mammalian skeletal muscle fibre bundles were
mediated through EGFR. 
In another experiment, I investigated whether this receptor (EGFR) 
also mediates the acute/non-genomic effects of DHT on amino acid 
uptake in these fibre bundles. To do this, I treated another set of
fibre bundles with the Ringer’s solution containing DHT only or the 
Ringer’s solution containing DHT plus EGFR inhibitor, Tyrphostin 
AG1478. The uptake of Ile and the concentration of phosphorylated 
eEF2 were then determined.
Figure 6.
A
9: The effects of DHT on amino acid uptake in skeletal muscle fibre bundles are mediated 
B
C
through the EGFR
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(A) Bar graphs showing the effects of treating fast- (filled bars) and 
slow- (clear bars) twitch skeletal muscle fibre bundles with the 
standard Ringer’s solution or the standard Ringer’s solution plus 
physiological levels of DHT alone or DHT plus tyrphostin AG1478 
(A). Note that treatment of the fibre bundles with tyrphostin AG1478 
significantly (p=0.004) reduces the basal uptake of L-(U-14 C)Ile in 
both fibre types. Also, it completely abolishes the DHT-induced
increase in amino acid uptake in the fast-twitch muscle fibre bundles. 
(B) Representative Western blot showing the effects of treating the 
muscle fibre bundles with DHT alone (B, FT,ST) or DHT plus 
AG1478 (B,FiT,SiT) on the phosphorylation of the EGFR in crude 
membrane proteins. Note that treating the bundles with DHT 
increases the phosphorylation of EGFR and this effect is completely 
reversed by AG1478. (C) Representative Western blot showing the 
effects of treating the muscle fibre bundles with DHT alone (C, 
FT,ST) or DHT plus AG1478 (C,FiT,SiT) on the phosphorylation of 
eEF2 in cytosolic proteins. Note that treating the bundles with DHT 
abolishes the phosphorylation of eEF2 and this effect is completely 
reversed by AG1478.* p<0.05 compared to control. † p<0.05 
compared to DHT treatment. F=fast-twitch; S=slow-twitch.
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As the results displayed in Fig. 6.9A show, treatment of the fibre 
bundles with the EGFR inhibitor AG1478 alone significantly (p<0.05) 
decreased the basal uptake of L-(U-14 C)Ile in both fibre types and 
adding DHT did not recover the basal amino acid uptake. Also, it 
completely abolished the DHT-induced increase in amino acid 
uptake in the fast-twitch muscle fibre bundles (Fig.6.9B).
Furthermore, treatment of the fibre bundles with DHT led to a 
marked increase in the phosphorylation of the EGFR in the fast-
twitch fibre bundles (Fig. 6.9 B). This marked increase in the 
phosphorylation was also completely abolished when the fibre 
bundles were pre-incubated in Ringer’s solution containing the 
EGFR inhibitor AG1478 (Fig. 6.9B). Treatment of the fibre bundles 
with DHT abolished the phosphorylation of eEF2 in both fibre types
and the pre-treatment of the fibre bundles with AG1478 completely 
reversed the reduction.
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6.5 Discussion
One of the key findings in this study was the observation that pre-
treating small muscle fibre bundles isolated from the EDL and soleus 
of adult female mice with inhibitors of androgen receptors had no 
effect on DHT induced phosphorylation of ERK 1 (Fig. 6.1) and 
RMLCs (Fig. 6.2). Although a number of studies have recently 
suggested that the AR mediates the non-genomic effects of DHT in 
the AR positive prostate cancer cell line LNCaP (Migliaccio et al.
2000) and osteocytic cell line MLO-Y4 (Kousteni et al. 2001), the 
results I report here suggest that the AR is not the receptor 
mediating the non-genomic effects of DHT in adult mammalian 
skeletal muscle fibre bundles. However, as the results displayed in 
Fig.6.3 show, this cannot be completely ruled out.
In the LNCaP and MLO-Y4 cell lines, it is thought that the DHT-AR 
complex interacts with Src forming a DHT-AR-Src complex which in 
turn recruits and activates the adaptor protein Shc (Kousteni et al.
2001). Once activated, Shc rapidly forms Shc/Grb2/SOS complexes 
which further activate Ras or Ras-like GTPase and subsequently 
stimulate Raf-MAPKKK and activation of the MAPK pathway 
(Migliaccio et al. 2000, Song et al. 2002). However, as the results 
displayed in Fig. 6.5 show, pre-treating the fibre bundles with the cell 
permeable src specific inhibitor PP2 has no effect of the DHT-
induced changes in the phosphorylation of ERK1/2; suggesting that 
src does not mediate the acute effects of DHT in mammalian 
skeletal muscle fibres either.
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The results I present here, also suggest that IGF-1R and PDGFR do 
not mediate the acute/non-genomic effects of DHT in adult 
mammalian skeletal muscle fibre bundles. Thus, pre-treating the 
muscle fibre bundles with inhibitors of both receptors did not abolish 
the DHT-induced increase in the phosphorylation of ERK (Fig. 
6.6A,B) and RMLCs (Fig. 6.7A,B).
In plasma the majority of steroid hormones are bound to either 
steroid hormone binding globulin (SHBG) or albumin. Therefore, a 
number of studies have suggested that steroid hormones exert their 
non-genomic effects through the binding of a cell surface SHBG 
receptor. Although a SHBGR has been identified in the prostate, 
testis, breast and liver (Hryb et al. 1985; Krupenko et al. 1994; 
Fortunati, 1999), it is uncertain whether this receptor is expressed in 
skeletal muscle. Although the SHGBR has not been cloned, it is 
thought to be either a G-PCR or coupled to one (Nakhla et al. 1999; 
Rosner et al. 1999). Previously, it has been suggested that the non-
genomic effects of T in cultured myocytes are mediated via an AR 
coupled to a GPCR (Estrada et al. 2003). However, as the GPCR 
binding T in that study was not identified, it is uncertain whether the 
SHBGR was involved and further studies to confirm this are needed
In the present study cyproterone increase the uptake of Ile in both 
the fast- and slow-twitch skeletal muscle fibre bundles. Cyproterone 
is a steroidal AR inhibitor that is structurally similar to DHT. 
Therefore, it might be competing and binds to any of the receptors 
linked to a G protein such as sex hormone binding globulin receptor 
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(SHBGR) (Nakhla et al. 1999) leading to the transactivation of EGFR
(Prenzel et al. 1999) and activation of the MAPK/ERK pathway (see 
Fig. 6.10). However, it is uncertain whether this is the mechanism 
underlying the effects of cyproterone on amino acid uptake in these 
fibre bundles and further studies to confirm this are needed.
Instead, the results I present here suggest that the acute/non-
genomic effects of DHT in adult mammalian skeletal muscle are 
mediated through the EGFR. Thus, pre-treating the muscle fibre 
bundles with the cell permeable and EGFR specific inhibitor AG1478 
completely abolished the effects of DHT on the phosphorylation of 
ERK1/2 and the 20kDa RMLCs. It also completely reversed the 
effects of DHT on amino acid uptake in the fibre bundles. Although in 
non-muscle cells the EGFR has been shown to regulate cell motility 
by modulating the phosphorylation of RMLCs by MLCK (Klemke et 
al. 1997), this is the first time that the EGFR has been implicated in 
the control of the non-genomic effects of anabolic-androgenic 
steroids. DHT can stimulate the EGFR in a number ways (see Fig. 
6.10). It can also activate a metalloproteinase leading to the release 
of EGF (Prenzel et al. 1999). However, the exact mechanism 
involved is uncertain and further studies to confirm this are needed.
Figure 6.10
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CHAPTER 7
GENERAL DISCUSSION
7.1 The acute effects of DHT on the MAPK pathway
In chapter 3, I showed that all the fibre bundles expressed similar 
levels of phosphorylated/active ERK2 (p42) irrespective of their fibre 
type and treatment. Moreover, the untreated fibre bundles expressed 
little or no phosphorylated ERK1 (p44) and only the DHT-treated 
muscle fibre bundles expressed this isoform in large quantities. In 
contrast, T treatment increased the phosphorylation of ERK1 in the 
slow-twitch fibre type only. To me these findings reflect the relative 
roles played by the different isoforms of ERK1/2. My hypothesis is 
that ERK2 is essential for the survival of both the fast- and slow-
twitch muscle fibres; whereas, ERK1 is involved in the regulation of 
the fast-fibre phenotype.
This hypothesis is supported by the findings of Saba-El-Leil and co-
workers who showed that mice lacking ERK2 died in utero; 
suggesting that ERK2 may be essential for the maintenance of 
normal cell function and survival (Saba-El-Leil et al. 2003). On the 
other hand, mice deficient in ERK1 were viable and of normal size. 
However, thymocyte maturation was severely reduced in these mice 
suggesting that ERK1 may be essential for cell differentiation (Pages 
et al. 1999). Taken together these findings suggest that ERK2 may
be essential for the development and maintenance of all cells in the 
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body; whereas, ERK1 is what is transduced and regulated by 
environmental factors including mitogens and growth factors.
Another key finding from the results reported in Chapter 3 is the 
observation that DHT but not T increases the 
phosphorylation/activation of RSK1/2 and the 20kDa myosin light 
chains. RSK 1/2 is one of the downstream effector molecules of 
ERK1/2, the other being MSK1/2 (Blenis, 1993). RSK has two kinase 
domains, a linker region, C- and N-terminal tails and the Arg-X-X-Ser
consensus N terminal tail sequence. It is activated by the sequential 
phosphorylation by ERK (Frodin & Gemmeltoft, 1999) and its 
activation is believed to promote cell growth and survival (Itoh et al. 
2005). On the other hand, the phosphorylation of the 20kDa 
regulatory myosin light chain by myosin light chain kinase has been 
implicated in the modulation of force production (Sweeny et al. 1993; 
Hamdi & Mutungi, 2010). From these observations, I propose that 
DHT acts though RSK1/2 and the phosphorylation of the 20kDa 
RMLCs to modulate force production in skeletal muscle fibres. 
Indeed, DHT has been shown to increase force production in fast-
twitch muscle fibres and to decrease it in slow-twitch fibres (Hamdi &
Mutungi, 2010). However, the molecular mechanism(s) underlying 
these effects is uncertain and further studies are necessary.
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7.2 The acute effects of DHT on the Akt/mTOR pathway
The results presented in chapter 4 showed that treating fast- and 
slow- twitch skeletal muscle fibre bundles with Ringer’s solution 
containing physiological concentrations of DHT or testosterone for 
1hour abolishes the phosphorylation of Akt at both Thr308/Ser473 in 
both fibre types (Figs. 4.4, 4.5, 4.7 and 4.8). However, when the fibre 
bundles were treated with DHT for a longer period (3hours) the 
reverse effect was observed i.e. DHT led to an increase in the 
phosphorylation of Akt at both sites. From these observations, I 
suggest that the acute effects of DHT are to inhibit the Akt/mTOR 
pathway. This pathway is important in the regulation of skeletal 
muscle hypertrophy (Glass, 2003); whereas, the MAPK pathway has 
been implicated in fibre type switching (Shi et al. 2008). From these 
results, it seems as if DHT is activating ERK1/2 and Akt sequentially. 
Indeed, these two pathways have been shown to have different roles 
and to be activated sequentially in differentiating C2C12 cells. To me 
this is important as it allows the ERK pathway to initiate fibre type 
switching and any other effects it has in skeletal muscle before Akt is 
switched on. However, whether this is a common phenomenon is 
uncertain and further studies are needed.
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7.3 The effects of DHT and T on amino acid uptake
In chapter 5 I investigated the physiological role of the acute/ non-
genomic effects of DHT and T. As the results reported in that 
chapter show, treatment of the muscle fibre bundles with DHT 
increases amino acid uptake in the fast-twitch bundles without 
significantly affecting that of the slow-twitch ones. In contrast, 
treatment of the fibre bundles with T had no effect on amino acid 
uptake in either fibre type (Figs. 5.4 and 5.5). Although the acute 
administration of other hormones such as insulin (Biolo et al. 1995), 
insulin-like growth factor 1 (IGF-1) (Fryburg et al. 1995) and growth 
hormone (Fryburg et al. 1995) has been shown to increase protein 
synthesis and to promote amino acid uptake in human skeletal 
muscle, this is the first time that an increase in amino acid uptake in 
response to the acute administration of an anabolic-androgenic 
steroid in adult mammalian skeletal muscle has been demonstrated.
Although in the present study T was applied directly to the fibre 
bundles it still had no effect on amino acid uptake in the muscle fibre 
bundles suggesting that T may not have any direct acute effects in 
adult mammalian skeletal muscle fibres. Indeed, it has been 
suggested that the effects of T in skeletal muscles may not be direct 
but due to the release of another hormone such as IGF-1. Here, I 
propose that this secondary hormone is DHT. However, further 
studies to confirm this are necessary.
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The results in Chapter 5 also showed that the acute effects of DHT 
on amino acid uptake are mediated through the MAPK pathway. 
Thus, pre-treating the muscle fibre bundles with the MEK inhibitor 
PD98059 completely abolished the DHT-induced increased in amino 
acid uptake. The increase in amino acid uptake was also abolished 
by cyclohexamide and actinomycin D suggesting that it involved both 
translation and transcription. The suggestion that the increase in 
amino acid uptake was coupled to an increase in protein synthesis 
was further supported by my observation that DHT treatment of the 
muscle fibre bundles completely abolished the phosphorylation of 
eEF2. Indeed, as stated in section 1.9.2, the unphosphorylated eEF2 
is essential for the elongation of the polypeptide chain.
Another important finding in chapter 5 was the observation that DHT 
treatment increased the activity of the sodium-dependent neutral 
amino acid transporter (SNAT) 2 and the expression of the L-type 
amino acid transporter (LAT) 2. Indeed, the DHT-induced amino acid 
uptake was completely abolished by the system A amino acid 
transporter inhibitor MeAB and the archetypal system L amino acid 
transporter inhibitor BCH. To me these results suggest that the DHT-
induced amino acid transport is mediated through these two amino 
acid transport systems. Thus by activating LAT2, DHT also indirectly 
activates SNAT2. This type of coupling, commonly referred to as 
tertiary active transport, which has been previously reported and is 
thought to exist in most cells (Hyde et al. 2007; Baird et al. 2009). 
Indeed, recent data published by Drummond and his co-workers 
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suggest that it may also exist between SNAT2 and LAT1 in human 
skeletal muscle (Drummond et al. 2010); suggesting that this type of 
coupling may be widespread in skeletal muscle. However, further 
studies to confirm this are necessary.
7.4 The receptor mediating the physiological effect of DHT 
on amino acid uptake
In chapter 6, I investigated the receptor mediating the acute/non-
genomic effect of DHT and T. As the results reported in that chapter
show pre-treating small muscle fibre bundles with inhibitors of 
androgen receptor had no effect on the DHT-induced increase in the 
phosphorylation of ERK1/2 (Fig. 6.1) and the 20kDa RMLCs (Fig. 
6.2). In the chronic/genomic mechanism, testosterone exerts its 
effects by activating the cytosolic androgen receptor. The hormone-
receptor complex then translocates to the nucleus where the 
hormone-receptor complex acts as a transcription factor (Simental et 
al. 1991). However, as this mechanism of steroid action involves 
gene transcription and mRNA translation, its effects usually take 
several hours to days to be manifested (Florini, 1970; Beato, 1989; 
Beato et al. 1996). In chapter 6 of this thesis, the effects of DHT 
were evident within 1hour and were insensitive to androgen receptor 
inhibitors cyproterone and flutamide. Therefore, from these I suggest 
that the non-genomic effects of DHT on phosphorylated ERK1/2 and 
RMLCs reported here are not exerted through the androgen 
receptor. Furthermore, they were also insensitive to inhibitors of src 
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(Fig. 6.5), IGF-1R (Fig. 6.6) and PDGFR (Fig. 6.7); suggesting that 
they were not mediated via these receptors either. 
Previously, I have shown that the acute/non-genomic actions of DHT 
on force production in adult mouse skeletal muscle fibre bundles are 
mediated through the epidermal growth factor receptor (EGFR) and 
activation of ERK1/2 module of the MAPK pathway (Hamdi & 
Mutungi, 2010). The results presented in Chapter 6 suggest that the 
acute/non-genomic actions of DHT on amino acid uptake in adult 
mammalian skeletal muscle fibres are also mediated through this 
receptor too (Fig.6.9). Thus pre-treating the muscle fibre bundles 
with the EGFR inhibitor tyrphostin AG1478 completely abolished the 
DHT-induced increase in amino acid uptake and the phosphorylation 
of the receptor (EGFR). It also abolished the activation of ERK1/2
and RSK 1/2. However, how DHT stimulates the EGFR is uncertain 
and further research to confirm is needed.
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7.5 Summary
In summary, the results I have presented in this thesis suggest that 
the acute/non-genomic actions of DHT in adult mammalian skeletal 
muscle fibres are to increase the uptake of essential amino acids. As 
Fig. 7.1, shows, DHT somehow seems to activate the EGFR leading
to increase in the phosphorylation of ERK 1/2. The activated ERK1/2
then phosphorylates RSK1/2 which in turn increases the expression 
of the L-type amino acid transporter LAT2. LAT2 then increases the 
uptake of isoleucine. DHT also increases protein synthesis and 
eventually to skeletal muscle hypertrophy.
Figure 7.
fibres
1: Proposed cellular signalling pathway mediating the non-genomic actions of DHT in adult mammalian skeletal muscle 
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A schematic diagram illustrating the cellular signalling mechanism 
that I think mediates the acute effects of DHT in adult mammalian 
skeletal muscle fibre bundles. My hypothesis is that DHT somehow 
activates the EGFR leading to an increase in the phosphorylation of 
ERK 1/2. The activated ERK1/2 then phosphorylates RSK1/2 which 
in turn increases the expression of the L-type amino acid transporter 
LAT2 on the cell surface. LAT2 then increases the uptake of 
branched chain amino acids such as isoleucine. The end product of 
all this I think is an increase in skeletal muscle hypertrophy.
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Dihydrotestosterone activates the MAPK pathway and
modulates maximum isometric force through the EGF
receptor in isolated intact mouse skeletal muscle fibres
M. M. Hamdi and G. Mutungi
Biomedical and Clinical Sciences Research Institute, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich NR4 7TJ, UK
It is generally believed that steroid hormones have both genomic and non-genomic (rapid)
actions. Although the latter form an important component of the physiological response of
these hormones, little is known about the cellular signalling pathway(s) mediating these effects
and their physiological functions in adult mammalian skeletal muscle fibres. Therefore, the
primary aim of this study was to investigate the non-genomic actions of dihydrotestosterone
(DHT) and their physiological role in isolated intact mammalian skeletal muscle fibre bundles.
Our results show that treating the fibre bundles with physiological concentrations of DHT
increases both twitch and tetanic contractions in fast twitch fibres. However, it decreases
them in slow twitch fibres. These changes in force are accompanied by an increase in the
phosphorylation ofMAPK/ERK1/2 in bothfibre types and that of regulatorymyosin light chains
in fast twitch fibres. Both effects were insensitive to inhibitors of Src kinase, androgen receptor,
insulin-like growth factor 1 receptor and platelet-derived growth factor receptor. However, they
were abolished by the MAPK/ERK1/2 kinase inhibitor PD98059 and the epidermal growth
factor (EGF) receptor inhibitor tyrphostin AG 1478. In contrast, testosterone had no effect
on force and increased the phosphorylation of ERK1/2 in slow twitch fibres only. From these
results we conclude that sex steroids have non-genomic actions in isolated intact mammalian
skeletal muscle fibres. These are mediated through the EGF receptor and one of their main
physiological functions is the enhancement of force production in fast twitch skeletal muscle
fibres.
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digitorum longus; EGFR, epidermal growth factor receptor; ERK1/2, extracellular signal-regulated kinase1/2; IGF-1R,
insulin-like growth factor 1 receptor; MAPK, mitogen-activated protein kinase; MEK1/2, MAPK/ERK kinase1/2;
MLCK, myosin light chain kinase; PDGFR, platelet-derived growth factor receptor; RMLCs, regulatory myosin light
chains; src, Src kinase.
Introduction
Testosterone, the principle sex hormone in males, is a
C19 steroid synthesised from cholesterol in Leydig cells of
the male testes. In healthy young adult men, its plasma
concentration ranges from 300 to 1000 ng dl−1 (Basaria
et al. 2001). In plasma, most of the testosterone is bound
to either albumin (∼54%) or the sex hormone-binding
globulin (∼44%) and only 2% (∼1.5–20 ng dl−1) is free
(Pardridge, 1986; Evans, 2004). In certain target tissues
suchas the liver, brain, prostate andpubic skin testosterone
is irreversibly converted to dihydrotestosterone (DHT) by
the enzyme 5α-reductase (Bruchovsky & Wilson, 1968).
Although, in healthy young men, the concentration of
DHT (normal range 4–57.5 ng dl−1) in the plasma is
similar to that of free testosterone,DHT is considered to be
the more potent hormone because it has a higher receptor
binding affinity and a lower dissociation constant than
testosterone (Saartok et al. 1984). However, as skeletal
muscle is thought to lack 5α-reductase (Thigpen et al.
1993), it is uncertain whether DHT has any physiological
functions in this tissue.
Testosterone and DHT are lipid-soluble hormones
and can cross the cell membrane freely. Once inside
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society DOI: 10.1113/jphysiol.2009.182162
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the cell, they bind the androgen receptor (AR)
leading to a conformational change in its tertiary
structure, the release of the chaperones bound to
it and exposure of nuclear localisation sequences
(Gelmann, 2002; Heinlein & Chang, 2002a). The
hormone–receptor complex then translocates into the
nucleus where it binds to the hormone-responsive
elements on the promoter regions of its target genes.
Depending on the co-activators/co-repressors recruited,
the hormone–receptor complex leads to either the
activation or repression of these genes (Rahman &
Christian, 2007). This mechanism of steroid action is
known as the classical or genomic pathway and because
it involves gene transcription and mRNA translation, its
effects usually take several hours to days to be manifested
(Florini, 1970; Beato, 1989, 1996).
In addition to their genomic actions, it is now generally
accepted that steroid hormones can also exert actions that
are too rapid to be explained by the classical/genomic
pathway (Falkenstein et al. 2000;Heinlein&Chang, 2002b;
Simoncini&Genazzani, 2003). These actions occurwithin
seconds to minutes after administration of the hormone
and are generally insensitive to inhibitors of the androgen
receptor (Estrada et al. 2003), suggesting that they are
regulated by cellular signalling pathways involving surface
membrane receptors and second messengers (Heinlein
& Chang, 2002b). This mechanism of steroid action is
referred to as non-genomic or non-classical (Lo¨sel et al.
2003).
Although the non-classical actions of other steroid
hormones such as oestrogen, progesterone and
aldosterone have received a lot of attention and their
actions in many tissues are well characterised (for
details see review by Lo¨sel et al. 2003), little is known
about the non-genomic actions of steroid hormones in
adult mammalian skeletal muscles. Furthermore the two
studies published so far were performed on cultured
muscle cells and used supra-physiological levels of
testosterone (Estrada et al. 2000, 2003). Therefore, it
is uncertain whether physiological levels of testosterone
or its metabolite DHT have any rapid actions in iso-
lated intact mammalian skeletal muscle fibres. It is also
uncertain whether these actions have a physiological
role.
Therefore, the primary aims of this study were to
investigate: (1) the rapid actions of DHT in adult
mammalian skeletal muscle fibres, (2) the cellular
signalling pathway(s) mediating these actions, and (3)
their physiological role. Our results show that the rapid
actions of DHT in adult mammalian skeletal muscles
include the modulation of force production. These effects
are mediated through the EGF receptor (EGFR) and
involve the phosphorylation of the 20 kDa regulatory
myosin light chains (RMLCs) by the extracellular
signal-regulated kinases (ERK) 1/2.
Methods
Preparation of intact skeletal muscle fibre bundles
All the experiments reported here were performed at
20± 0.1◦C on small muscle fibre bundles isolated from
either the extensor digitorum longus (EDL, a mainly
fast twitch muscle in adult mice) or the soleus (a
predominantly slow twitch muscle in adult mice) of
adult female (n = 20) and male (n = 4) CD1 mice
aged 49± 5 days (range 40–84 days). The mice were
killed by cervical disarticulation as recommended in the
Animals (Scientific Procedures) Act 1986 (for details
of the regulations see Drummond, 2009) and all the
experiments conformed to the local animal welfare
committee guidelines. The EDL and soleus muscle from
both hind limbs were isolated. Small muscle fibre
bundles (∼10–15 fibres, mean cross-sectional diameter
230.6± 17.7μm, n = 24) were dissected under dark-field
illumination and care was taken to ensure that the fibres
in a bundle were electrically excitable.
Determination of the effects of dihydrotestosterone
(DHT) and testosterone on force
The procedure used was basically similar to that described
previously by Mutungi & Ranatunga (2000). Briefly, the
fibre bundles were mounted horizontally between two
stainless steel hooks, one attached to a force transducer
(Model 400A, Aurora Scientific Inc., Ontario, Canada)
and the other to a servo-motor (Model 322C, Aurora
Scientific Inc.), in a muscle chamber with a glass bottom.
The bundles were then perfused, at the rate of 1 ml min−1,
with the standard Ringer solution or the standard Ringer
solution plus the various compounds whose effects were
being tested. The standard Ringer solution contained (in
mM): 109 NaCl, 5 KCl, 1 MgCl2, 4 CaCl2, 24 NaHCO3, 1
NaHPO4, 10 sodium pyruvate plus 200mg l−1 bovine calf
serum; the pH was maintained at ∼7.24 by continuously
bubbling with 95% O2 and 5% CO2. The temperature
of the muscle chamber was maintained using a thermo-
electric controller (Model 825A, Aurora Scientific Inc.)
and a Peltier device placed next to the muscle chamber.
At the beginning of each experiment, the sarcomere
length of each preparationwas set at 2.4μmusing aHe-Ne
laser (Laser Lines Ltd, Oxon, UK). The preparations were
then electrically stimulated once every 90 s using a single
supra-maximal stimulus to elicit twitch contractions and
once every 5min with trains of stimuli (30–60 Hz in slow
twitch fibres and 90–120 Hz in the fast twitch fibres)
to elicit fully fused tetani. The fibre bundles were then
perfused with either the standard Ringer solution or the
standardRinger solutionplus 630 ρgml−1 androstanolone
(17β-hydroxy-5α-androstan-3-one,DHT) or testosterone
propionate (Sigma, Gillingham, Dorset, UK) dissolved in
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
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Table 1. The receptors/proteins tested and the inhibitors used
Inhibitors
Receptor/protein Scientific name Common name Concentration Source
Androgen receptor
(AR)
6-Chloro-1β,2β-dihydro-17-hydroxy-3′H-
cyclopropa(1,2)-pregna-1,4,6-
triene-3,20-dione acetate
Cyproterone acetate 1 μM Sigma-Aldrich
2-Methyl-N-[4-nitro-3-(trifluoromethyl)
phenyl]-propanamide
Flutamide 3 μM Sigma-Aldrich
Epidermal growth
factor receptor
(EGFR)
(N-[3-Chlorophenyl]-6,7,-dimethoxy-4-
quinazolamine)
Tyrphostin AG 1478 100 nM Sigma-Aldrich
Myosin light chain
kinase (MLCK)
1-(5-Iodonaphthalene-1-sulfonyl)
homopiperazine, HCl
ML-7 hydrochloride 500 nM Sigma-Aldrich
MAP kinase kinase
(MEK)
2′-Amino-3′-methoxyflavone PD98059 20 μM Alexis biochemicals
Platelet-derived
growth factor
receptor (PDGFR)
4-(6,7-Dimethoxy-4-quinazolinyl)-N-
(4-phenoxyphenyl)-1-
piperazinecarboxamide
PDGFR tyrosine kinase
inhibitor III
200 nM Calbiochem
Insulin-like growth
factor 1 receptor
(IGF-1R)
α-Cyano-(3-methoxy-4-hydroxy-5-
iodocinnamoyl)-(3′,4′-dihydroxyphenyl)
ketone
Tyrphostin AG 538 100 μM Sigma-Aldrich
Src kinase (src) 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)
pyrazolo[3,4,d]pyrimidine
PP2 10 μM Alexis biochemicals
absolute ethanol for at least 30min. Twitch and tetanic
contractionswere then recorded in the presence or absence
of DHT and testosterone.
In another experiment, the fibre bundles were perfused
for 15min with Ringer solution containing the inhibitors
listed in Table 1. The Ringer solution was then switched
to one containing the inhibitor plus either DHT or
testosterone for at least 30min. Twitch and tetanic con-
tractions were then recorded. Finally, the fibre bundles
were switched back to the standard Ringer solution.
Most of the compounds were dissolved in either DMSO
or absolute ethanol. Therefore, to ensure that the vehicle
(absolute ethanol or DMSO) had no affect on maximum
isometric force (Po), someof the fibre bundleswere treated
for 30min with Ringer solution containing the vehicle
only. Twitch and tetanic contractions were then recorded.
Analysis of these data showed that, at the concentration
used, the vehicle had no effect on either twitch or tetanus.
At the end of the experiments, some of the muscle fibre
bundles were processed forWestern blot analysis and their
myosin heavy chain isoforms were analysed using mono-
clonal antibodies from Sigma-Aldrich (Fig. 2D).
Determination of the cellular signalling pathways
mediating the rapid actions of DHT and testosterone
To investigate the cellular signalling pathway(s) mediating
the effects of DHT and testosterone on force, small muscle
fibre bundles (∼200μm in diameter) were used. The fibre
bundles were divided into two equal groups. One half
was treated with the standard Ringer solution plus the
vehicle (absolute ethanol/DMSO) for 1 h. Proteins from
these fibres acted as controls. The other half was treated for
the same period of time with Ringer solution containing
630 ρgml−1 DHT or testosterone. In some experiments,
the fibre bundles were pre-incubated for 15min in Ringer
solution containing the inhibitors listed in Table 1. They
were then treated with DHT or testosterone plus the
inhibitor for a further 1 h. During these experiments, the
fibre bundles were subjected to twitch contractions once
every 90 s.
Immunoblotting
At the end of the experiments described above, the
muscle fibre bundles were snap frozen in liquid nitrogen,
pulverised and proteins extracted using NP40 lysis
buffer. The proteins were then immunoblotted as pre-
viously described by Mutungi (2008). Briefly, equal
amounts of the proteins (10μg per lane) were resolved
in 10% SDS-polyacrylamide gels and transferred onto
PVDF membranes. The membranes were blocked for
non-specific antibody binding with 5% milk for at least
30min. They were then incubated overnight with anti-
bodies against ERK1/2 phosphorylated at threonine 202
and serine 204 (Santa Cruz Biotechnology, CA, USA), the
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
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20 kDa regulatory myosin light chains phosphorylated at
serine 20 (Abcam, Cambridge, UK), the C-terminus of
the AR (Santa Cruz Biotechnology) and the N-terminus
of the AR (Abcam). The following day the membranes
were incubated with species-specific secondary antibodies
conjugated to horseradish peroxidase. Finally, they were
visualised using SuperSignalWestPico (Perbio Science UK
Ltd, Cramlington, UK) chemiluminescence substrate and
exposure of the membranes to film.
On the third day, the membranes were stripped and
re-probed for total ERK1/2 (Santa Cruz Biotechnology)
and total regulatorymyosin light chains (Abcam). In some
experiments, the membranes were probed for actin using
a pan-actin antibody from Abcam.
Data handling and analysis
The force (produced by the muscle fibres) and the
temperature (from the thermocouple) signals were
collected via a CED 1401Micro laboratory interface using
Signal 2.11 software (Cambridge Electronic Design Ltd,
Cambridge, UK) and stored in a computer. The amplitude
of the twitch and tetanus was determined using the Signal
2.11 software. The amplitude of the tension (= force)
records was normalised to the cross-sectional area of the
bundles. The tension recorded fromeachbundle under the
various experimental conditionswas averaged anddivided
by the mean tension recorded from the same fibre bundle
in the standard Ringer solution. The data are presented as
a percentage± S.E.M. of the control tension.
Figure 1. The effects of DHT on maximum isometric force (Po) in isolated intact mammalian skeletal
muscle fibre bundles are fibre type dependent
Representative force records obtained from a female fast twitch (A), a female slow twitch (B) and a male fast
twitch (C) muscle fibre bundle before (continuous line traces), during (dotted line traces) and after (dashed line
traces) exposure to DHT. Note that DHT leads to a reversible increase in Po in the fast twitch fibre bundles and to
an irreversible decrease in Po in the slow twitch muscle fibre bundles irrespective of whether they are from a male
or female mouse. D, data summarising the effects of DHT on Po in fast (i) and slow (ii) twitch muscle fibre bundles
isolated from 10 female (hatched bars) and 4 male (filled bars) mice. The data are presented as a percentage of
the Po recorded from the same fibre bundles perfused with Ringer solution containing no added DHT (open bars).
Note that DHT induces a statistically significant (∗P = 0.02) increase in Po in the fast twitch fibre bundles but to a
statistically significant (∗P = 0.03) decrease in Po in the slow twitch fibre bundles.
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All the Western blots were run in triplicate and
each experiment was repeated at least three times. The
intensity of the protein bands from an experiment
were analysed using Scion Image from NIH and are
presented asmean± S.D. Statistical analysis of the datawas
performed using Statistica 5.0 (StatSoft. Inc., Tulsa, USA).
Comparison of the various data sets was performed using
two-wayANOVAandP < 0.05was considered statistically
significant.
Results
The effects of treating small muscle fibre bundles
with DHT and testosterone on maximum isometric
tension (Po)
Figures 1 and 2 show the basic observations from this
study. As the results show, treating small skeletal muscle
fibre bundles with physiological levels of DHT for at
least 30 min increased Po in the fast twitch fibre bundles
(Fig. 1A) but decreased it in the slow twitch fibre bundles
(Fig. 1B) irrespective of whether they were from a female
(Fig. 1A and B) or male (Fig. 1C) mouse. The increase in
Po observed in the fast twitch fibres was transitory and
Po reverted back to its control values within 1–2 h after
the fibres were transferred back into the standard Ringer
solution. In contrast, the decline in Po recorded in the slow
twitch fibres was considered to be permanent as none of
the fibres fully recovered after they were transferred back
into the standard Ringer solution.
The summary data from 10 female and 4 male mice is
shown in Fig. 1D. As the data shows, DHT treatment led
to a 29.6± 3% (n = 8 fibre bundles) and to a 24.1± 3%
(n = 4 fibre bundles) increase in Po in the female andmale
fast twitchmusclefibrebundles, respectively.Conversely, it
Figure 2. Testosterone has no effect on Po in isolated intact mouse skeletal muscle fibre bundles
Force records obtained from a female fast (A) and a female slow (C) twitch muscle fibre bundle before (continuous
line traces), during (dotted line traces) and after (dashed line traces) treatment with 630 ρg ml−1 testosterone.
Note that testosterone has no effect on Po in either fibre type. B, summary data showing the effects of DHT
(hatched bars) and testosterone (filled bars) on Po in 5 fast (i) and 4 slow (ii) twitch muscle fibre bundles isolated
from 6 female mice. The open bars show data recorded from the same fibre bundles in Ringer solution containing
no testosterone. Note that while DHT significantly (∗P = 0.02) increases Po in the fast twitch fibres and significantly
(∗P = 0.025) decreases it in the slow twitch fibre bundles, testosterone had no effect on Po in either fibre type. D,
representative Western blots showing the myosin heavy chain (MHC) isoform composition of female fast (F) and
female slow (S) twitch muscle fibre bundles probed using monoclonal antibodies against fast (i) and slow (ii) MHC.
Note that each bundle consists mainly of a single MHC isoform.
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led to a 21.1± 3%(n = 7fibrebundles) and to a 19.8± 3%
(n = 4 fibre bundles) decrease inPo in the female andmale
slow twitch fibre bundles, respectively. Statistical analysis
of thedata showed that the increaseordecrease in forcewas
statistically significant. However, no statistical difference
was observed between the effects of DHT in the fibres
isolated from male and female mice.
On the other hand, when the muscle fibre bundles were
treated with testosterone propionate, no changes in Po
were observed in either fibre type (Fig. 2).
The effects of treating small muscle fibre bundles
with DHT and testosterone on twitch tension
The effects of treating small muscle fibre bundles with
DHT and testosterone on twitch tension are displayed in
Fig. 3. As the results show, the effects of these hormones
on twitch tension were similar to those on Po. Thus,
treating the fibre bundles with DHT led to a 23.6± 1.3%
(n = 6 fibre bundles) increase in peak twitch tension in
fast twitch muscle fibre bundles and to a 15.3± 2.1%
(n = 6 fibre bundles) decrease in twitch tension in slow
twitch fibre bundles isolated from adult female mice
(Fig. 3B). However, DHT did not alter the characteristics
of the isometric twitch (Fig. 3A and C). For example,
the half rise time of twitch tension in the fast fibres was
9.3± 0.8 ms and 9.6± 0.4 ms in the absence and presence
of DHT, respectively. The corresponding values in the
slow twitch fibres were 20.5± 3ms and 21.2± 6ms in
the presence and absence of DHT, respectively. Treating
the fibre bundles with testosterone had no effects on the
amplitude of the isometric twitch tension in both fibre
types (Fig. 3D). Similar effects were seen in muscle fibre
bundles isolated from male mice (results not shown).
The effects of treating small muscle fibre bundles
with DHT and testosterone on the activation of the
mitogen-activated protein kinase (MAPK) pathway
It has been previously shown that treating cultured
muscle cells with supra-physiological doses of testosterone
increases the phosphorylation of ERK1/2 (Estrada et al.
2003). However, from these results it is uncertain whether
similar changes occur in adult mammalian skeletal muscle
fibres treated with physiological levels of either DHT
or testosterone. Therefore, in another experiment we
investigated the effects of treating small skeletal muscle
fibre bundles isolated from adult female mice with either
Figure 3. The effects of DHT on
isometric twitch tension in isolated
intact mammalian skeletal muscle fibre
bundles are fibre type dependent
Representative twitch myographs recorded
from a female fast (A) and a female slow (C)
twitch muscle fibre bundle before
(continuous line traces), during (dotted line
traces) and after (dashed line traces)
treatment with DHT. Note that DHT
reversibly increases twitch tension in the fast
twitch fibre bundle and irreversibly
decreases it in the slow twitch muscle fibre
bundle. Summary data illustrating the
effects of DHT (B, hatched bars) and
testosterone (D, hatched bars) on isometric
twitch tension in 6 fast (i) and 6 slow (ii)
twitch muscle fibre bundles isolated from 6
adult female mice. The open and filled bars
show the twitch tension recorded from the
same fibre bundles before and after
treatment with DHT, respectively. Note that
DHT induces a statistically significant
(∗P = 0.021) increase in Po in the fast twitch
fibre bundles and a statistically significant
(∗P = 0.034) decrease in Po in the slow
twitch fibre bundles.
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DHT or testosterone on the phosphorylation of ERK1/2.
As the results in Fig. 4 show, treating small muscle fibre
bundles with physiological concentrations of DHT for
1 h led to a 2- to 3-fold increase in the phosphorylation
of ERK1/2 in both fibre types (Fig. 4A). In contrast,
testosterone led to an increase in the phosphorylation of
ERK1/2 in slow twitch fibres only (Fig. 4B).
To determine whether there was a link between
the phosphorylation of ERK1/2 and the changes in
tension reported above, some of the fibre bundles were
pre-treated with Ringer solution containing 20μM of
the mitogen-activated protein kinase kinase (MEK)1/2
inhibitor PD98059. They were then treated with Ringer
solution containing DHT and the inhibitor for 1 h. As the
results in Fig. 4C show, pre-treating the fibre bundles with
PD98059 completely abolished the effects of DHT on the
phosphorylation of ERK1/2.
Androgen receptor density in fast and slow twitch
skeletal muscles
Previously, it has been suggested that the diverse
effects of steroid hormones on specific muscle tension
observed in animal experiments arise from differences in
their androgen receptor (AR) densities (Egginton, 1987;
Salmons, 1992). Therefore, to test this hypothesis and to
determine whether the different effects of DHT on Po in
fast and slow twitch muscle fibre bundles reported above
arose from differences in their AR densities, we examined
Figure 4. DHT increases the phosphorylation of ERK1/2
Representative Western blots showing the concentration of phosphorylated ERK1/2 (pERK1/2; A, B and C) in
female fast twitch (F) and female slow twitch (S) skeletal muscle fibre bundles treated with either the standard
Ringer solution (FC and SC) or the standard Ringer solution plus 630 ρg ml−1 DHT (A, FT, ST) or testosterone (B,
FT, ST). In C, the fibre bundles were pre-treated with the MEK1/2 inhibitor PD89059, followed by DHT plus the
inhibitor (FMT, SMT). Note that treating the muscle fibre bundles with DHT significantly (∗P = 0.02) increased the
phosphorylation of ERK1/2 in both fibre types, whereas testosterone increased the phosphorylation of ERK1/2
in slow twitch fibres only. Moreover, the effects of DHT on the phosphorylation of ERK1/2 were abolished by
PD89059 and fast twitch muscle fibre bundles expressed higher concentrations of total ERK1/2 (tERK1/2) than
slow twitch fibres.
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the concentration of the AR in EDL (fast twitch) and
soleus (slow twitch) muscles of adult male and female
mice. As the results displayed in Fig. 5 show, one of the
antibodies (from Santa Cruz) identified two proteins: one
with a molecular mass of 110 kDa and the other ∼67 kDa
in all the samples probed (Fig. 5A). On the other hand, a
secondantibody (fromAbcam) identifiedonly oneprotein
with a molecular mass of ∼110 kDa (Fig. 5B). Moreover,
the concentration of both proteins was similar in the
fast and slow twitch muscles isolated from each animal
irrespective of sex. From these results, we think that the
proteinwith amolecularmass of∼110 kDacorresponds to
the full-lengthAR(alsoknownasAR-B),whereas thatwith
a molecular mass of ∼67 kDa represents the truncated or
AR-A isoform (Wilson & McPhaul, 1996).
The effects of DHT and testosterone on the
phosphorylation of the 20 kDa regulatory
myosin light chains
Previously, a number of studies have shown that
the motility of non-muscle cells results from an
ERK1/2-dependent increase in the phosphorylation of
the 20 kDa RMLCs (Klemke et al. 1997; Iwabu et al.
2004). However, it is uncertain whether the changes
in the phosphorylation of ERK1/2 induced by DHT in
intact mammalian skeletal muscles have similar effects
on the phosphorylation of RMLCs. Therefore, in another
experiment, we investigated the effects of DHT and
testosteroneon thephosphorylationof the20 kDaRMLCs.
As the results displayed in Fig. 6 show, treating the muscle
Figure 5. Fast twitch and slow twitch muscles express similar concentrations of the androgen receptor
Western blots showing the androgen receptor expression in female fast (FF), female slow (FS), male fast (MF) and
male slow (MS) twitch skeletal muscles immunoblotted with a polyclonal antibody against the C-terminus of the
human AR (A) or a monoclonal antibody against the N-terminus of the human AR (B). Note that the polyclonal
antibody identified two proteins, one with a molecular mass of ∼110 kDa (AR-B) and the other with a molecular
mass of ∼67 kDa (AR-A), whereas the monoclonal antibody identified only a single band with a molecular mass
of ∼110 kDa. C and D, summary data showing the relative concentrations of AR-B (C) and AR-A (D) in fast (F)
and slow (S) twitch muscles isolated from male (M) and female (F) mice. Note that fast and slow twitch muscles
from the same sex animal express similar concentrations of the AR and that no significant difference (P = 0.12)
was observed when the concentration of the receptor in the male and female muscles were compared.
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fibre bundles with DHT led to a 20–40% increase in the
phosphorylation of RMLCs in fast twitch fibre bundles
only (Fig. 5A). In contrast, testosterone, which had no
effect on Po led to a decrease in the phosphorylation
of RMLCs in both fibre types (Fig. 6C). Furthermore,
treating the fibre bundles with the myosin light chain
kinase inhibitor ML-7 did not significantly affect Po
(Fig. 6D) but completely reversed the effects of DHT on
force (Fig. 6B).
Identity of the surface membrane receptor mediating
the rapid actions of DHT in mammalian skeletal
muscle fibres
As stated in the Introduction, the genomic/classical actions
of anabolic androgenic steroids (AAS) are mediated
through the androgen receptor. Therefore, to determine
whether the effects of DHT described above were exerted
through this mechanism, small muscle fibre bundles were
treated with Ringer solution containing the AR inhibitors
cyproterone (a steroidal inhibitor) and flutamide (a
non-steroidal inhibitor). As the results in Fig. 7 show,
treating the fibre bundles with cyproterone had no effect
on the DHT-induced changes in force (Fig. 7A), ERK1/2
phosphorylation (Fig. 7B) and the phosphorylation of the
RMLCs (Fig. 7C). Similar results were obtained when the
muscle fibre bundles were treated with flutamide (results
not shown), the insulin-like growth factor 1 receptor
(IGF-1R) inhibitor tyrphostin AG 538 (Fig. 8A and B), the
Src kinase (src)-specific inhibitor PP2 (results not shown)
and the platelet-derived growth factor receptor (PDGFR)
inhibitor (Fig. 8C and D).
A number of studies have recently suggested that the
ERK1/2-dependent phosphorylation of MLCs and hence
the motility of non-muscle cells is mediated through the
EGFR (Klemke et al. 1997; Iwabu et al. 2004). Therefore,
in another experiment we used pharmacological inter-
ventions to investigate whether the rapid actions of DHT
in adult mammalian skeletal muscle fibres were mediated
through the EGFR. As the results displayed in Fig. 9
show, treating the fibres with the EGFR-specific inhibitor
tyrphostin AG 1473 completely abolished the effects of
DHT on Po in both fibre types (Fig. 9A). It also blocked
the DHT-induced increase in the phosphorylation of
ERK1/2 (Fig. 9B) as well as that of RMLCs (Fig. 9C
and D).
Figure 6. DHT increases the phosphorylation of regulatory myosin light chains in fast and slow twitch
muscle fibre bundles
Representative Western blots showing the effects of treating female fast twitch (F), female slow twitch (S), male
fast twitch (MF) and male slow twitch (MS) skeletal muscle fibre bundles treated with Ringer solution containing
either DHT (A) or testosterone (C) on phosphorylation of the 20 kDa regulatory myosin light chains (pMLC; A and
C). Note that treating the muscle fibre bundles with DHT significantly (∗P = 0.018) increases the phosphorylation
of the RMLCs in fast twitch fibre bundles (A). In contrast, treating the bundles with testosterone led to a small
decrease in the phosphorylation of the RMLCs which was not statistically different from that in control fibres
(P = 0.08). Furthermore, fast twitch fibres contained 15–20% more unphosphorylated myosin light chains (tMLC)
than slow twitch fibres. B and D show the effects of treating small muscle fibre bundles with the standard Ringer
solution (Con), the standard Ringer solution plus DHT (DHT), or the standard Ringer solution containing the myosin
light chain kinase inhibitor ML-7 alone (D, ML-7) or with DHT (B, DML-7) on Po. Note that treating the fibre bundles
with ML-7 alone has no effect on Po (D) but reversibly abolishes the effects of DHT on Po.
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Discussion
One of the key findings in the present study is the
observation that treating small skeletal muscle fibre
bundles with Ringer solution containing physiological
levels of male sex steroids can modulate Po in a fibre type-
and hormone-dependent manner. Thus, DHT increased
Po in fast twitch fibres but decreased it in slow twitch
fibres. In contrast, testosterone had no effect on Po in
both fibre types. Although the effects of treating animals
with AAS for several weeks have been the subject of a
number of previous studies and some of their effects
are generally accepted (Exner et al. 1973a,b; Egginton,
1987; Salmons, 1992), their effects on specificmuscle force
are still controversial. For example, treating female rats
(Egginton, 1987),male rats (Exner et al. 1973a) and female
rabbits (Salmons, 1992) with nandrolone for 4–6 weeks
has been shown to have no effect on specific muscle
force in the EDL and soleus muscles. On the other hand,
it increased specific muscle force in the flexor hallucius
muscle of female rats (Exner et al. 1973b) and the tibialis
anterior of female rabbits (Salmons, 1992). Interestingly, a
similar increase in specific muscle force could be induced
by exercise alone or exercise plus nandrolone (Exner et al.
1973b) suggesting that the effects of theAASmayhavebeen
Figure 7. Inhibiting the AR does not abolish the effects of DHT in isolated intact mammalian skeletal
muscle fibres
A, summary data showing the effects of treating small skeletal muscle fibre bundles with the standard Ringer
solution (open bars), the standard Ringer solution plus DHT (hatched bars) and the standard Ringer solution
containing DHT plus the AR inhibitor cyproterone (filled bars) on Po. Note that treating the muscle fibres bundles
with cyproterone does not reverse the effects of DHT on Po in either fibre type. B and C, representative Western
blots and summary data showing the effects of treating fast (F) and slow (S) twitch skeletal muscle fibre bundles
isolated from female mice with the standard Ringer solution (FC, SC), DHT alone (FT, ST) or DHT plus cyproterone
(FCT, SCT) on the phosphorylation of ERK1/2 (B) and regulatory myosin light chains (C). Note that treating
the muscle fibre bundles with DHT significantly (∗P = 0.015) increases the phosphorylation of ERK1/2 in both
fibre types (B) and the regulatory myosin light chains in fast twitch fibre bundles only (A) and that treating the
fibre bundles with cyproterone does not reverse these effects.
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non-specific. It is not just in animal experiments where the
effects of AAS on specific muscle force are controversial,
the results from human studies are as variable (Bhasin
et al. 2001).
Previously, this variability has been attributed to factors
such as the generalised increase in muscle mass that
accompanies chronic AAS treatment (Egginton, 1987),
the sensitivity of different muscles/species to the AAS
(Salmons, 1992), the androgen receptor density in the
muscles (Salmons, 1992), route of administration and
variability in the resorption of the drugs from muscles
and fat depots (van der Vies, 1970), study design (Bhasin
et al. 2001) and the effects of the AAS on the nervous
system (Blanco et al. 1997; Nguyen et al. 2005). In the
present study, most of these variables were eliminated by
the use of small muscle fibre bundles isolated from age-
and weight-matchedmice kept under the same laboratory
conditions. Furthermore, each fibre bundle acted as its
own control and the AAS was delivered directly to the
fibres.Additionally, fast and slow twitchmuscles contained
Figure 8. Inhibiting the IGF-1 and the PDGF receptors does not abolish the effects of DHT in isolated
intact mammalian skeletal muscle fibres
Summary data showing the effects of treating small skeletal muscle fibre bundles with the standard Ringer solution
(open bars), the standard Ringer solution plus DHT (hatched bars) and the standard Ringer solution containing
both DHT and the IGF-1R inhibitor tyrphostin AG 538 (A) or the PDGFR inhibitor tyrosine kinase inhibitor III (C)
on Po in fast (i) and slow (ii) twitch muscle fibre bundles. Note that treating the muscle fibres bundles with both
inhibitors does not reverse the effects of DHT on Po in either fibre type. B and D, representative Western blots and
summary data showing the effects of treating fast (F) and slow (S) twitch skeletal muscle fibre bundles isolated
from female mice with the standard Ringer solution (FC, SC), DHT alone (FT, ST) or DHT plus AG 538 (FGT, SGT)
or tyrosine kinase inhibitor III (FPT, SPT) on the phosphorylation of ERK1/2. Note that treating the muscle fibre
bundles with DHT significantly (∗P = 0.015) increases the phosphorylation of ERK1/2 in the slow twitch muscle
fibre bundles and that adding the inhibitors does not abolish these effects.
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similar levels of AR (Fig. 5). Thus, the results we report
here provide the first unequivocal evidence suggesting
that AAS may have direct effects on force in isolated
intact mammalian skeletal muscle fibre bundles, and
that these effects may depend on both the fibre type as
well as the AAS used. Therefore, it is possible that the
variable effects of AAS on specific muscle force reported
previously in both animal and human experiments may
have arisen from the fibre type composition of the various
muscles examined, the AAS used, or a combination of
both factors.
In addition to the changes in force reported above,
treating small muscle fibre bundles with DHT led to an
increase in the phosphorylation of ERK1/2 in both fibre
types and the 20 kDa RMLCs in fast twitch fibres. It is
important to note that testosterone, which had no effect
on maximum isometric tension in either fibre type, did
not affect the phosphorylation of RMLCs in both fibre
types and increased the phosphorylation of ERK1/2 in the
slow twitch fibres only. In both muscle and non-muscle
cells, force generation results from the interaction of
myosin and actin leading to the formation of the
Figure 9. Inhibiting the EGF receptor abolishes the effects of DHT in isolated intact mammalian skeletal
muscle fibres
A, summary data showing the effects of treating small skeletal muscle fibre bundles with the standard Ringer
solution (open bars), the standard Ringer solution plus DHT (hatched bars) and the standard Ringer solution
containing DHT plus the EGFR inhibitor tyrphostin AG 1478 (filled bars) on Po. Note that treating the muscle fibre
bundles with tyrphostin AG 1478 reverses the effects of DHT on Po in both fibre types. B, C and D, representative
Western blots and summary data showing the effects of treating fast (F) and slow (S) twitch skeletal muscle
fibre bundles isolated from female mice with the standard Ringer solution (FC, SC), DHT alone (FT, ST), DHT
plus tyrphostin AG 1478 (FiT, SiT) or DHT plus PD89059 (FMT, SMT) on the phosphorylation of ERK1/2 (B) and
regulatory myosin light chains (C and D). Note that treating the muscle fibre bundles with DHT significantly
(∗P = 0.01) increases the phosphorylation of ERK1/2 (B) and the regulatory myosin light chains (C and D) in fast
fibres and that treating the fibre bundles with tyrphostin AG 1478 and PD89059 abolishes these effects.
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independent force-generatingunits knownas crossbridges
(Gordon et al. 2000). Although thismechanism is basically
similar in all cells, its regulation in striated muscles
and other cells is different. Thus, in striated muscle,
the interaction between myosin and actin is regulated
mainly through the thin (actin) filament, whereas, in
smooth muscles and non-muscle cells it is controlled via
the thick (myosin) filament (Adelstein, 1983). The thick
filament regulation of actino-myosin interaction involves
the phosphorylation anddephosphorylation of the 20 kDa
regulatory light chains locatedwithin themyosinmolecule
by myosin light chain kinase and myosin phosphatase,
respectively (Adelstein, 1983; Bresnick, 1999). Thus, in
smoothmuscle and non-muscle cells the phosphorylation
of the RMLCs is essential for actino-myosin interaction
to occur, whereas in striated muscles it is not. In striated
muscle, the phosphorylation of these light chains seems
to have a modulatory rather than a regulatory function
on force production (Manning & Stull, 1979). Therefore,
from our observations we suggest that the changes in
force induced by DHT in mouse skeletal fibres and
the phosphorylation of the RMLCs are interlinked. This
suggestion is further supported by the observations that
treating fast twitch muscle fibre bundles with the myosin
light chain kinase inhibitor ML-7 led to a 10% decrease
in Po and completely abolished the effects of DHT on Po
(Fig. 6).
Why DHT increases maximum isometric force in fast
twitch fibres and decreases it in slow twitch fibres is
uncertain. Previously, it has been suggested that these
differences may arise from the androgen receptor (AR)
density in the muscles (Egginton, 1987; Salmons, 1992).
However, as our results show, fast and slow twitchmuscles
from the same animal contain similar concentrations
of the androgen receptor (Fig. 5). Furthermore, treating
musclefibrebundleswith the androgen receptor inhibitors
cyproterone and flutamide does not abolish the effects of
DHT on force, the phosphorylation of ERK1/2 as well as
that of the 20 kDa RMLCs (Fig. 7). Therefore, it is unlikely
that the opposing effects of DHT on force in fast and slow
twitch muscle fibres arise from their androgen receptor
densities.
In mammalian skeletal muscles, a brief period of
repetitive stimulation leads to a transitory increase of
the isometric twitch in fast twitch muscles and its
depression in slow twitch muscles (Close & Hoh, 1968,
1969). Furthermore, this post-tetanic twitch potentiation
is accompanied by an increase in the phosphorylation of
the 20 kDa RMLCs (Klug et al. 1982; Moore & Stull, 1984;
Houston et al. 1985). Although the phosphorylation of the
RMLC does not seem to affect maximum Ca2+-activated
force in chemically skinned skeletal muscle fibre bundles
(Metzger et al. 1989), our results suggest that under
certain circumstances it may. It is generally believed
that the phosphorylation of RLMCs potentiates the iso-
metric twitch by increasing the sensitivity of the contra-
ctile apparatus to Ca2+ and freeing crossbridges from the
surface of the thick filament (Sweeny et al. 1993). Here
we speculate that in addition to the phosphorylation of
RMLCs, DHT treatment increases the phosphorylation of
other proteins of the contractile system such as troponin I
and myosin binding protein C that are involved in the
regulation of actino-myosin interaction; and that this
accentuates its effects on force production. However, the
Figure 10. Proposed cellular signalling
pathway mediating the non-genomic
actions of DHT in adult mammalian
skeletal muscle fibres
Schematic diagram illustrating the molecular
mechanism that we suggest underlies the
effects of DHT in adult mammalian skeletal
muscle fibre bundles. Our hypothesis is that
DHT activates the epidermal growth factor
receptor (EGFR), either directly or indirectly,
and this leads to an increase in the
phosphorylation of ERK1/2. The activated
ERK1/2 then phosphorylates MLCK which in
turn phosphorylates the 20 kDa RMLCs and
this increases force production in fast twitch
fibres but decreases it in slow twitch fibres.
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exactmechanismunderlying the effects ofDHT in isolated
mammalian skeletal fibres is still uncertain and further
studies to elucidate this are necessary.
In the classical or genomic pathway, testosterone exerts
its effects by activating the cytosolic androgen receptor.
The hormone–receptor complex then translocates to the
nucleus where the hormone–receptor complex acts as a
transcription factor (Simental et al. 1991).However, as this
mechanism of steroid action involves gene transcription
and mRNA translation, its effects usually take several
hours to days to bemanifested (Florini, 1970; Beato, 1989,
1996). In thepresent study, the effects ofDHTwere evident
within 30min after its application and were insensitive
to both cyproterone and flutamide, both inhibitors of
the intracellular androgen receptor. Therefore, from these
results we suggest that the effects of DHT reported here
are not exerted through the androgen receptor. They were
also insensitive to inhibitors of src, IGF-1R and PDGFR;
suggesting that they were not mediated via these receptors
either. Instead, our results suggest that these effects
are mediated through EGFR. Our hypothesis, shown in
Fig. 10, is that DHT binds to the EGFR on the sarcolemma
leading to the activation of the MAPK pathway. The
activatedMAPK pathway then drives the phosphorylation
of the regulatorymyosin light chains bymyosin light chain
kinase, culminating in the changes in force reported in
this study. This mechanism of action is similar to that
previously reported in Sertoli cells (Cheng et al. 2007).
However, unlike that study, no evidence was observed
to suggest that Src kinase is involved. In the only other
study of muscles cells, it was suggested that testosterone
and nandrolone exert their rapid actions through an
unidentified G-protein-coupled receptor located on the
cell membrane (Estrada et al. 2003). From the results
presented here, we suggest that this receptor is probably
the EGFR. However, whether the effects of DHT are
direct or indirect remain uncertain and further studies
are necessary.
Besides the phosphorylation of myosin light chain
kinase (MLCK) the activation of the MAPK pathway
in most non-muscle cells leads to the transcriptional
regulation of genes important for cell proliferation and
differentiation (Marshall, 1995). Therefore, it is likely
that in addition to its effects on force, the activation of
ERK1/2 by DHT may have other functions such as the
transformation of slow to fast twitch muscle fibres. Our
speculation is that the irreversible decline of force induced
by DHT in slow twitch fibre bundles marks the onset of
this process. The atrophying slow twitch fibres are then
slowly replaced by fast fibres generated from satellite cells.
Indeed, in animal models, the prolonged administration
of AAS is accompanied by satellite cell activation (see
review by Chen et al. 2005). Thus, the rapid actions of
AAS in mammalian skeletal muscles may be multifaceted
and their main physiological function may be to
prepare the muscles for their genomic actions. However,
whether this is the case is uncertain and further studies are
needed.
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Lay Summary 
In a recent study we showed that DHT, but not testosterone, increases force production in 
fast contracting muscles and decreases it in slow contracting ones. These findings led us 
to suggest that DHT may be a better muscle building hormone than testosterone. In the 
present study, we have examined the effects of these hormones on amino acid transport in 
mouse fast and slow contracting skeletal muscle fibre bundles. Our results show that DHT 
increases protein synthesis and the transport of essential amino acids into fast contracting 
muscle fibre bundles; whereas, testosterone does not. These findings confirm our previous 
proposition and reinforce our suggestion that DHT may be a better hormone for the 
treatment of muscle wasting conditions than testosterone.  
Abstract 
Dihydrotestosterone (DHT) has acute/non-genomic actions in adult mammalian skeletal 
muscles whose physiological functions are still poorly understood. Therefore, the primary 
aim of this study was to investigate the acute/non-genomic effects of DHT on amino acid 
uptake as well as the cellular-signal transduction events underlying these actions in mouse 
fast- and slow-twitch skeletal muscle fibre bundles. 14C-labelled amino acids were used to 
investigate the effects of DHT and T on amino acid uptake; whereas, pharmacological 
interventions were used to determine the cellular-signal transduction events mediating 
these actions. While T had no effect on the uptake of isoleucine (Ile) and MeAIB in both 
fibre types, DHT increased their uptake in the fast-twitch fibre bundles. This effect was 
reversed by inhibitors of protein translation, the EGFR, system A, system L, mTOR and 
MEK. However, it was relatively insensitive to those of transcription, androgen receptors 
and PI3K/Akt. Additionally, DHT treatment increased the expression of LAT2 and the 
phosphorylation of the EGFR in the fast-twitch fibre bundles and that of ERK1/2, RSK1/2 
and ATF2 in both fibre types. Also, it decreased the phosphorylation of eEF2 and 
increased the incorporation of Ile into proteins in both fibre types. Most of these effects 
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were reversed by EGFR and MEK inhibitors. From these findings we suggest that another 
physiological function of the acute/non-genomic actions of DHT in isolated mammalian 
skeletal muscle fibres is to stimulate amino acid uptake. This effect is mediated through 
the EGFR and involves the activation of the MAPK pathway and an increase in LAT2 
expression. 
Abbreviations list: AAS, anabolic-androgenic steroid; ATF2, activating transcription 2; 
Akt, protein kinase B; BCH, 2-aminobicyclo-(2,2,1)heptane-2-carboxylic acid; DHT, 
dihydrotestosterone; eEF2, eukaryotic elongation factor 2; EGFR, epidermal growth factor 
receptor; ERK1/2, extracellular-signal regulated kinases 1/2; Ile, isoleucine; JNK, c-Jun N-
terminal kinase; LAT2, L-type amino acid transporter 2; MAPK pathway, mitogen-activated 
protein kinase pathway; MeAIB, α-methylaminoisobutyric acid; MEK, mitogen-activated 
protein kinase/ERK kinase; MSK1/2, mitogen- and stress-activated protein kinases 1/2; 
mTOR, mammalian target of rapamycin; RSK1/2, 90kDa ribosomal s6 kinase; SNAT2, 
sodium-coupled neutral amino acid transporter 2. 
Introduction 
Dihydrotestosterone (DHT) is a metabolite of the male sex hormone testosterone (T) that 
is produced in many tissues following the rapid and irreversible reduction of T by 5α-
reductase (Bruchovsky & Wilson, 1968). Although the free plasma concentration of DHT 
and T (normal range 1.5-20ng dL-1 and 4-57.5ng dL-1 for testosterone and DHT, 
respectively) in healthy young adult men is similar, it is generally accepted that DHT is the 
more potent hormone because of its receptor binding kinetics (Saartok et al. 1984). 
However, as the expression of 5α-reductase in adult mammalian skeletal muscles is still 
controversial, it has been suggested that DHT may not have any physiological functions in 
skeletal muscle (Thigpen et al. 1993). Nevertheless, in a recent study we showed that 
DHT, but not T, modulates force production in isolated intact mouse skeletal muscle fibres. 
These effects were mediated through the EGFR and involved the activation of ERK1/2. 
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From these findings we suggested that DHT may be the more potent anabolic-androgenic 
steroid (AAS) in adult mammalian skeletal muscle fibres (Hamdi & Mutungi, 2010). 
However, whether DHT has any other acute/non-genomic physiological functions in 
mammalian skeletal muscles is uncertain. 
In adult males, AASs are important determinants of body composition (Wilson et al., 1988; 
Bhasin et al. 2001). For example, treating adult female laboratory animals (Exner et al. 
1973a; Salmons, 1992), hypogonadal men (Bhasin et al. 1997), elderly men with low T 
concentrations (Ferrando et al. 2002), and men suffering from AIDS (Bhasin et al. 2000) 
with T or any of its many derivatives (commonly referred to as anabolic-androgenic 
steroids; AAS) for several weeks has been shown to increase lean body mass. Although 
the mechanisms underlying the changes in lean body mass are still poorly understood, it is 
generally believed that AAS administration increases protein synthesis (Kochakian, 1950; 
Ferrando et al. 2002) while at the same time decreasing its breakdown (Ferrando et al. 
2002). 
Skeletal muscle is the largest pool of amino acids in the body with the branched chain 
amino acids leucine, isoluecine and valine forming 35% of total skeletal muscle proteins 
(Harper et al. 1984). Therefore, for skeletal muscle mass to increase, as occurs following 
the chronic administration of AASs, it must have an adequate supply of essential amino 
acids. However, the few studies that have investigated amino acid uptake in human 
skeletal muscles, following AAS administration, were unable to demonstrate any changes 
in their uptake (Ferrando et al. 2002); thereby leaving the source of the new/extra amino 
acids unresolved. Therefore, it is still uncertain whether DHT and T have any effects on 
amino acid uptake in adult mammalian skeletal muscle fibres. 
Amino acids enter and leave cells through specialized transport systems known as amino 
acid transporters (Christensen, 1990). Although all cells express a variety of these 
transporters, the combinations found in each cell type seem to depend on the 
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physiological functions of the cell and the location of the transporters; suggesting that their 
(the transporters) expression and activity is carefully regulated (McGivan et al. 1994; 
Wagner et al., 2003). While some of the physiological factors regulating the activity and 
expression of amino acid transporters belonging to system A in mammalian cells have 
been the subject of a number of previous studies (Sugawara et al. 2000; Hyde et al. 2002; 
Franchi-Gazzola et al. 2004; Palii et al. 2004; Kashiwagi et al. 2009), little is known about 
the physiological factors regulating the expression and activity of L-type amino acid 
transporters, especially in adult mammalian skeletal muscle fibres. 
Therefore, the primary aims of this study were to investigate the acute effects of DHT and 
T on; (1) amino acid uptake, (2) the expression of the amino acid transporters SNAT2 and 
LAT2 and (3) the cellular signalling pathway(s) mediating these actions in fast- and slow-
twitch muscle fibre bundles isolated from adult female mice. Our results show that DHT, 
but not T, increases the uptake of essential amino acids and their incorporation into 
proteins in the fast-twitch skeletal muscle fibre bundles. These effects are mediated 
through the EGFR and involved activation of the MAPK pathway and an increase in the 
expression of LAT2. From these results we suggest that another physiological function of 
the non-genomic actions of DHT in adult mammalian skeletal muscle fibres is to regulate 
the transport of essential amino acids and their incorporation into proteins. 
Materials & Methods 
Preparation of the small intact skeletal muscle fibre bundles 
All the experiments reported in this study were performed at room temperature (~20°C) on 
small skeletal muscle fibre bundles isolated from either the extensor digitorum longus (edl, 
a mainly fast-twitch muscle in adult mice) or the soleus (a predominantly slow-twitch 
muscle in adult mice) of adult female CD1 mice aged 57.4 ± 2.3 days (n=34; range 45 - 79 
days). The mice were killed by cervical disarticulation as recommended by the Animals 
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(Scientific Procedures) Act 1986, UK (for a summary of the regulations see Drummond, 
2009) and all the experiments conformed to the local animal welfare committee guidelines. 
The edl and soleus muscles from both hind limbs were then isolated and small muscle 
fibre bundles, containing approximately 10-15 fibres (mean cross-sectional diameter 
350±17μm, n=68), were dissected and care was taken to ensure that all the fibres in a 
bundle were intact and electrically excitable. 
During an experiment, the muscle fibre bundles were mounted horizontally between two 
stainless steel hooks in specially designed muscle chambers. Two types of muscle 
chambers, one with a total volume of 5ml and the other 25mls were used for the 
determination of amino acid uptake and cellular-signal transduction events, respectively. 
The fibre bundles were continuously perfused with the standard mammalian Ringer’s 
solution alone or the standard Ringer’s solution plus the various compounds/inhibitors 
listed in Table 1. The composition of the Ringer’s solution was (in mM); 109 NaCl, 5 KCl, 1 
MgCl2, 4 CaCl2, 24 NaHCO3, 1 NaHPO4, 10 sodium pyruvate plus  200mg l-1 bovine calf 
serum; and its pH was maintained at 7.42 by constantly bubbling it with 95% O2 and 5% 
CO2. 
Determination of the effects of Dihydrotestosterone (DHT) and testosterone (T) on 
the uptake of isoleucine and α-(Methylamino)isobutyric acid 
To determine the uptake of the amino acids, 8 fast-twitch and 8 slow-twitch muscle fibre 
bundles were divided into two groups. Half were treated with the standard Ringer’s 
solution containing 6.3µl/100ml (107.9µM) ethanol (the vehicle used to dissolve both DHT 
and T) plus either 2mM C14 isoleucine (L-[U-14 C] Ile; radioactivity level 3.46µCi ml -1) or 
68.3µM C14 α-methylaminoisobutyric acid (α-[1-14C]-MeAIB; 2-(Methylamino)-2-
methylpropionic acid; radioactivity level 0.8µCi ml -1) (both purchased from PerkinElmer, 
Buckinghamshire, UK) for 1hr. These preparations acted as controls. The other half were 
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treated with the Ringer’s solution containing 630ρgml-1 4,5α-Dihydrotestosterone (2.17ηM; 
DHT; 5α-Androstan-17β-ol-3-one) or testosterone propionate (1.83ηM; T; 17β-Hydroxy-4-
androsten-3-one 17-propionate) (both from Sigma, Gillingham, Dorset, UK) plus the radio-
labelled amino acids for the same duration (1hr). These fibre bundles acted as the 
experimental/treatment group. Radio-labelled Ile was used in these studies because, 
unlike leucine, it does not stimulate protein synthesis in adult mammalian skeletal muscle 
(Anthony et al. 2000). 
At the end of the experiments described above, the Ringer’s solution was aspirated and 
the fibre bundles were washed twice in ice cold phosphate buffer saline (PBS). The excess 
buffer was blotted out and the bundles were then snap frozen in liquid nitrogen, pulverised 
and cytosolic proteins were extracted using the non-ionic cell lysis buffer NP40 as 
described in Mutungi (2008). The amount of proteins in each lysate was then determined 
using the quick Bradford assay (Bradford, 1976). The rest of the lysate was mixed with an 
equal amount of Optima Gold XR liquid scintillant (PerkinElmer, Buckinghamshire, UK) 
and the level of radioactivity in the mixture was determined using a liquid scintillation 
counter (Tri-Carb 2250 CA, Canberra-Packard) 1hr and 24hrs after the end of each 
experiment. Also, each experiment was repeated at least twice. As T had no effect on 
amino acid uptake in either fibre type, the rest of the experiments were performed using 
DHT. 
To investigate the cellular-signal transduction events underlying the effects of DHT on 
amino acid uptake, the experiments described above were repeated using 8 fast- and 8 
slow- twitch muscle fibres bundles. Briefly, half of the fibre bundles were treated with the 
standard Ringer’s solution containing 107.9µM ethanol plus the radio-labelled amino acids 
for 1 hr. The other half was pre-incubated for 20 minutes in the standard Ringer’s solution 
containing one of the inhibitors listed in Table 1. They were then treated, for 1hr, with the 
Ringer’s solution containing DHT plus either 2mM L-[U-14 C] Ile or 68.3µM α-[1-14C]-MeAIB 
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plus the inhibitor whose effects were being investigated. Most of the inhibitors used and 
their concentrations are similar to those used previously in Hamdi & Mutungi (2010). The 
uptake of the amino acids in the presence and absence of the inhibitors as well as DHT 
were then determined as described above. 
Table 1 near here 
In adult mammals, muscle hypertrophy and hence protein synthesis is regulated by the 
Akt/mTOR pathway (Glass, 2003). Therefore, in another experiment we determined 
whether the Akt/mTOR pathway affected the basal uptake of amino acids or the DHT-
induced increase in amino acid transport into the muscle fibre bundles. Briefly, 16 muscle 
fibre bundles (8 fast- and 8 slow-twitch) were divided into four groups each consisting of 2 
fast- and 2 slow-twitch muscle fibre bundles. Each group was then treated for at least 20 
minutes as follows; Group 1 (control) was treated with the standard Ringer’s solution plus 
107.9µM ethanol, Group 2 was treated with the Ringer’s solution plus DHT alone, Group 3 
was treated with Ringer’s solution containing 10ηM deguelin (a specific (PI3K)/protein 
kinase B (Akt) inhibitor) (Chun et al. 2003) or 100ηml-1 rapamycin (an mTOR specific 
inhibitor) (Shepherd et al. 1995) plus 1 mM ethanol; whereas, Group 4 was treated with 
the Ringer’s solution containing DHT plus the above concentrations of deguelin and 
rapamycin. At the end of this period, the solutions were replaced with the same solutions 
but this time containing 2mM L-[U-14 C] Ile. The fibre bundles were then incubated in these 
solutions for 1hr after which the uptake of L-[U-14 C] Ile was determined as described 
above. 
Determination of amino acid incorporation into proteins 
In another experiment, a modification of the trichloroacetic acid (TCA) precipitation method 
was used (Jiang et al. 2003). Briefly, 6 fast-twitch and 6 slow-twitch fibre bundles were 
divided into two equal groups.  Half (controls) were treated with the standard Ringer’s 
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solution containing 107.9µM ethanol plus 2mM L-[U-14 C] Ile for 1hr. These preparations 
acted as controls. The other half (experimental) were treated with the Ringer’s solution 
containing 630ρgml-1 DHT plus the radio-labelled amino acid for the same duration (1hr). 
At the end of the experiment, proteins were extracted as described above. The lysates 
were then mixed with equal amounts of 10% ice-cold TCA and left standing on ice for 2-
3hrs. The lysate/TCA mixture was then centrifuged at 15000g for 20 minutes and the 
supernatant was discarded. The pellet was washed twice in ice-cold acetone, centrifuged 
at 15000g for 10 minutes and the supernatant was discarded. Finally, the pellet was dried, 
pulverised and re-dissolved in 50-100µl urea buffer depending on the size of the pellet. 
The buffer contained 7M urea, 2M thiourea and 20mM trisbase, pH 8.5. The radioactivity 
of the mixture was then determined as described above. 
Determination of the amino acid transporter mediating the effects of DHT on amino 
acid transport in mammalian skeletal muscle fibre bundles 
Both MeAIB and Ile are neutral amino acids and are transported across the cell membrane 
through system A and system L amino acid transporters, respectively (Christensen, 1990; 
Palacin et al. 1998). Although each of these systems has several isoforms (Palacin et al. 
1998; Mackenzie and Erickson 2004), only the sodium-coupled neutral amino acid 
transporter (SNAT) 2 (Utsunomiya-Tate et al. 1996; Yao et al. 2000; Hyde et al. 2001; 
Mackenzie and Erickson 2004) and the sodium-independent L-type amino acid transporter 
(LAT) 2 (Segawa et al., 1999; Pineda et al., 1999; Sugawara, et al., 2000), have 
consistently been identified in skeletal muscle. Furthermore, both these transporters can 
be inhibited by the synthetic amino acid analogues α-(methylamino)isobutyric acid (MeAiB; 
2-(Methylamino)-2-methylpropionic acid) and 2-aminobicyclo-(2,2,1)heptane-2-carboxylic acid 
(BCH), respectively (Christensen, 1985). Therefore, in another experiment we used these 
analogues to investigate the amino acid transporters mediating the effects of DHT on 
amino acid uptake observed in the preceding experiments. Briefly, the muscle fibre 
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bundles were divided into four groups each containing 4 fast- and 4 slow-twitch fibre 
bundles. Each group was then treated for at least 20 minutes as follows; Group 1 (control) 
was treated with the standard Ringer’s solution plus 107.9µM ethanol, Group 2 was 
treated with the Ringer’s solution plus DHT alone, Group 3 was treated with the Ringer’s 
solution containing either BCH or MeAIB alone plus 107.9µM ethanol; whereas, Group 4 
was treated with the Ringer’s solution containing DHT plus either 10mM BCH or 100µM 
MeAIB. At the end of this period, the solutions were then replaced with the same solutions 
but this time 2mM L-[U-14 C] Ile was added. The bundles were then incubated in these 
solutions for 1hr after which the uptake of Ile by the fibre bundles was determined as 
described above. 
BCH inhibits both LAT1 and LAT2. Therefore, in another experiment we determined 
whether the DHT-induced uptake of Ile was through LAT2. Briefly, another set of fibre 
bundles (6 fast- and 6 slow-twitch) was treated for 20 minutes with Ringer’s solution 
containing 1:500 dilution of a rabbit polyclonal antibody against LAT2 (Santa Cruz 
Biotechonology, Inc, CA, USA). They were then incubated for 1hr in the Ringer’s solution 
containing 2mM L-[U-14 C] Ile plus either the antibody alone or the antibody plus DHT. The 
uptake of Ile by the fibres was then determined as described above.   
In another experiment, we examined whether DHT treatment affects the expression of 
LAT2 and SNAT2 in the fibre bundles. To do this, we treated another set of fibre bundles 
with the standard Ringer’s solution plus the vehicle (107.9µM ethanol) or the standard 
Ringer’s solution plus DHT. Cytosolic and crude membrane proteins were then extracted 
and immunoblotted for the expression of SNAT2 and LAT2 (Santa Cruz Biotechonology, 
Inc, CA, USA) as described below. 
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Determination of the cellular-signal transduction pathway(s) mediating the effects of 
DHT on amino acid uptake 
To investigate the cellular-signal transduction events mediating the effects of DHT on 
amino acid uptake, another set of fibre bundles was treated with the standard Ringer’s 
solution plus the vehicle or the standard Ringer’s solution plus DHT for 1hr. In some of the 
experiments, the fibre bundles were pre-incubated with the standard Ringer’s solution plus 
the EGFR inhibitor tyrphostin AG1478 or the MEK inhibitor PD98059 for 20 minutes. They 
were then treated with the Ringer’s solution containing the inhibitor whose effects were 
being investigated plus DHT for 1hr. At the end of the experiments, proteins were 
extracted from the muscle fibre bundles and immunoblotted as described below. 
Immunoblotting 
At the end of the experiments described above, the fibre bundles were snap frozen in 
liquid nitrogen and pulverized. Cytosolic and crude membrane proteins were extracted 
using NP40 lysis buffer. To extract cytosolic/total cell proteins, the lysates were centrifuged 
for 10min at 15000rpm. The supernatant was then collected and stored at -80°C until 
required. To extract crude membrane proteins, the pellets from the cytosolic extractions 
were washed twice in ice cold PBS and blotted with filter paper to remove excess PBS. 
They were then snap frozen in liquid nitrogen, pulverized and proteins were extracted as 
described above. Equal amounts (10µg) of the proteins were then immunoblotted as 
described in (Mutungi, 2008). Briefly, the proteins were resolved in either 10% or 5% SDS-
polyacrylamide gels, depending on the molecular weight of the proteins being probed. 
They were then transferred onto PVDF membranes. The membranes were blocked for 
non-specific antibody labelling with 5% milk for 30 minutes. They were then incubated 
overnight at 4°C with primary antibodies against pEGFR, pJNK, pp38 and pATF2 (from 
Cell Signalling Technology, Inc, MA, USA); pEK1/2, cmyc, pcJUN, MyoD , SNAT2 and 
LAT2 (from Santa Cruz Biotechnology); pRSK1/2, pMSK1/2 and peEF2 (Abcam, 
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Cambridge, UK). The following day they were washed and incubated for 2hr with species 
specific secondary antibodies conjugated with horse-radish peroxidase. Finally, they were 
visualised using SuperSignal WestPico (Perbio Science UK Ltd, Cramlington, 
Northumberland) chemiluminescence substrate and exposure to film. 
The following day, the membranes were stripped as described in Hamdi & Mutungi (2010). 
They were then re-probed with either a pan-actin antibody (ab3280) from Abcam or an 
antibody against the total (unphosphorylated) protein whose phosphorylation was being 
investigated. These blots were used as loading controls. In some experiments, the fibre 
bundles were also fibre typed using monoclonal antibodies against fast and slow MyHCs 
(Sigma-Aldrich, Gillingham, Dorset, UK). 
Analysis and Data handling 
The radioactivity of each lysate was counted and expressed as the disintegration per 
minute. It was then normalized to the protein content of the lysate and expressed as 
Becquerel per microgram of protein (Bq/µg). The radioactivity was then normalized to that 
recorded under control conditions and all the data are presented as the mean percentage 
change in uptake ±S.D. 
All the Western blots were run in triplicate and each experiment was repeated at least 
three times. To determine the statistical significance of the changes, the intensity of the 
bands, from each experiment, was analyzed using Scion Image® from NIH and was 
normalized to that of the loading control (either actin or the total protein). 
Statistical analysis of the data was performed using SigmaPlot® 11.2 (Systat Software 
Inc., London, UK). The data obtained from the two fibre types under control and from the 
various experimental conditions were then compared using a 3-way ANOVA and a p<0.05 
was considered statistically significant. 
Fig. 1 near here 
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Results 
Acute effects of DHT and T on amino acid uptake in fast- and slow-twitch skeletal 
muscle fibre bundles 
Treatment of the fibre bundles with physiological concentrations (630ρgml-1) of DHT 
significantly (p=0.001) increased the uptake of L-[U-14 C]Ile and α-[1-14C]-MeAIB in the 
fast-twitch fibre bundles without significantly (p=0.72) affecting that of the slow-twitch ones. 
For example, DHT led to an 88.7±14% (n=4 fibre bundles) increase in the uptake of L-[U-14 
C]Ile in the fast-twitch fibre bundles but only to a 5.9 ± 4.5% (n=4 fibre bundle) increase in 
the slow-twitch ones (Fig. 1A). The corresponding values for α-[1-14C]-MeAIB were 
53.9±12.8% (n=4 fibres) and 7.0 ± 4.0% in the fast- and slow-twitch fibre bundles, 
respectively (Fig.1B). In contrast, T did not significantly (p=0.47 and 0.59 for Ile and 
MeAIB, respectively) affect the uptake of L-[U-14 C]Ile and α-[1-14C]-MeAIB in either fibre 
type (Fig. 1C and 1D). For example, it led to 3.2 ± 4.9% (n=4 fibres) increase and to an 
4.4±5% (n=4 fibres) decrease in the uptake of L-[U-14 C]Ile in the fast- and slow-twitch 
muscle fibres, respectively (Fig. 1C). The corresponding values for α-[1-14C]-MeAIB) were 
6.0±5% (n=4 fibres) increase and 6.5±5% (n=4 fibres) decrease in the fast- and slow-
twitch fibres, respectively (Fig.1D). 
Amino acid transporter(s) mediating the effects of DHT on amino acid transport in 
isolated intact mammalian skeletal muscle fibre bundles 
Fig. 2 shows the effects of pre-incubating another set of fast- and slow-twitch muscle fibre 
bundles with 100µM MeAiB (a system A inhibitor) on the basal and DHT-induced uptake of 
L-[U-14 C]Ile. As the results show, treatment of the muscle fibre bundles with DHT 
significantly (p<0.001) increased the uptake of L-[U-14 C]Ile in the fast-twitch fibre bundles 
only. In contrast, pre-incubating the fibre bundles with MeAIB significantly (p<0.05) 
decreased the basal uptake of L-[U-14 C]Ile in both fibre types (Fig. 2A). Also, it completely 
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abolished the DHT-induced increase in Ile uptake in both fibre types (Fig. 2A); suggesting 
that a system A amino acid transporter was probably involved. However, as the results 
displayed in Fig. 2B show, treatment of the muscle fibres with DHT did not significantly 
(p>0.05) affect the expression of SNAT2 (the commonest system A amino acid transporter 
identified in skeletal muscle) in both fibre types. 
Fig. 3 near here 
In another experiment, we investigated the effects of pre-treating the muscle fibre bundles 
with the L-type amino acid transporter inhibitor, BCH. Treatment of the muscle bundles 
with BCH alone significantly (p<0.05) decreased the basal transport of L-[U-14 C]Ile in both 
fibre types. Also, it completely abolished the DHT-induced increase in L-[U-14 C]Ile uptake 
(Fig.3A); suggesting that the increase was via an L-type amino acid transporter. However, 
from these experiments it was uncertain whether the transporter was LAT1 or LAT2. 
Therefore, in another experiment we examined the effects of DHT on the expression of 
LAT2. In the untreated fibre bundles, the slow-twitch muscle fibre bundles always 
expressed higher concentrations of the transporter than the fast-twitch ones. Moreover, 
treating the fibre bundles with DHT significantly (p=0.01) increased the expression of LAT2 
in the fast-twitch fibre bundles without significantly (p=0.13) affecting its expression in the 
slow-twitch ones. LAT2 was extracted mainly in the membrane fraction of the fibres; 
whereas, SNAT2 was extracted mainly in the cytosolic fraction. Again these results 
suggest that the effects of DHT were probably mediated through LAT2. However, they 
were not conclusive. Therefore, in another experiment, we used an antibody against LAT2 
as an inhibitor of the transporter. As the results displayed in Fig.3C show, treatment of the 
fibre bundles with the antibody alone significantly (p<0.05) reduced the basal transport of 
L-[U-14 C]Ile in both fibre types. Also, it completely abolished the DHT induced uptake of L-
[U-14 C]Ile (Fig.3C) in the fast-twitch fibre bundles.. 
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Receptor(s) mediating the effects of DHT in isolated intact mammalian skeletal 
muscle fibre bundles 
DHT and T have both genomic and non-genomic actions (Heinlein & Chang 2002; Hamdi 
& Mutungi, 2010). The genomic actions are mediated through the classical androgen 
receptors (Fuller, 1991); whereas, the non-genomic ones are mediated through surface 
membrane receptors such as the epidermal growth factor receptor (EGFR; Hamdi & 
Mutungi, 2010) and an unidentified G-protein coupled androgen receptor (GPCR; Estrada 
et al. 2003). Therefore, in another experiment we determined whether the effects of DHT 
on amino acid transport reported above were mediated through the androgen receptor. As 
the results displayed in Fig.4 show, treatment of the fibre bundles with cyproterone (Fig. 
4A; a steroidal inhibitor of the AR) alone significantly (p<0.05) increased the basal uptake 
of L-[U-14 C]Ile in both fibre types. On the other hand, it significantly (p<0.05) reversed the 
effects of DHT on amino acid uptake in both fibre types. Thus, pre-treating the fibre 
bundles with cyproterone significantly (p=0.001) reduced the DHT-induced increase in 
amino acid uptake in the fast-twitch fibre bundles; whereas, in the slow-twitch ones it led to 
a further (12.4±4%) increase in the uptake of L-[U-14 C]Ile. In contrast, treatment of the 
fibre bundles with flutamide (Fig. 3B; a non-steroidal AR inhibitor) alone significantly 
(p=0.007) increased the basal uptake of L-[U-14 C]Ile in the fast-twitch fibre bundles only; 
whereas, pre-treating the fibre bundles with it completely reversed the DHT-induced amino 
acid uptake seen in the fast-twitch  fibre bundles. 
Fig. 4 near here 
Previously, we have shown that the acute/non-genomic effects of DHT on force production 
in isolated intact mammalian skeletal muscle fibre bundles are mediated through the 
epidermal growth factor receptor (EGFR) (Hamdi & Mutungi, 2010). Therefore, in another 
experiment we investigated whether this receptor (EGFR) mediated the acute/non-
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genomic effects of DHT on amino acid uptake in these fibre bundles. As the results 
displayed in Fig. 5A show, treatment of the fibre bundles with the EGFR inhibitor AG1478 
alone significantly (p<0.05) decreased the basal uptake of L-[U-14 C]Ile in both fibre types. 
Also, it completely abolished the DHT-induced increase in amino acid uptake in the fast-
twitch muscle fibre bundles (Fig.5A). 
Fig. 5 near here 
Upon stimulation, the EGFR dimerises and then undergoes autophosphorylation 
(Mendelsohn & Baselga, 2000). Therefore, in another experiment we examined the effects 
of DHT on the phosphorylation of the EGFR. As the results displayed in Fig. 4 B show, 
treatment of the fibre bundles with DHT led to a marked increase in the phosphorylation of 
the EGFR in the fast-twitch fibre bundles. Furthermore, this DHT-induced increase in the 
phosphorylation of the EGFR was completely abolished by pre-treating the fibre bundles 
with Ringer’s solution containing EGFR inhibitor tyrphostin AG1478. 
The cellular signal transduction events mediating the effects of DHT on amino acid 
transport in isolated intact mammalian skeletal muscle fibre bundles. 
To determine the cellular-signal transduction events mediating the acute/non-genomic 
actions of DHT on amino acid uptake in these muscles, another set of fibre bundles was 
treated with DHT alone or DHT plus the mitogen-activated protein kinase kinase (MEK) 
inhibitor, PD98059. The uptake of L-[U-14 C]Ile as well as the phosphorylation of the 
extracellular-signal regulated kinases (ERK)1/2, the 90kDa ribosomal S6kinases (RSK)1/2 
and the mitogen and stress-activated protein kinases (MSK)1/2 were then determined. 
Treatment of the muscle fibre bundles with DHT increased the uptake of L-[U-14 C]Ile in the 
fast-twitch fibre bundles (Fig 6A). On the other hand, treating them with PD98059 alone 
significantly decreased the basal uptake of L-[U-14 C]Ile in both fibre types. Also, PD98059 
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completely abolished the DHT-induced increase in amino acid uptake in the fast-twitch 
fibre bundles (Fig. 6A). 
Fig. 6 near here 
When the phosphorylation of ERK1/2 was examined, we found that the untreated fibre 
bundles expressed mostly phosphorylated ERK 2 (p42). Furthermore, its expression was 
always greater in the fast than in the slow-twitch fibre bundles. Moreover, phosphorylated 
ERK 1 (p44) was observed mainly in the fibre bundles treated with DHT. In contrast, the 
untreated fast- and slow-twitch fibres expressed similar concentrations of pRSK1/2 and 
treatment of the fibre bundles with DHT significantly (p=0.03) increased its phosphorylation 
in both fibre types (Fig. 6B). In Fig. 6C, the effects of pre-treating the fibre bundles with 
PD98059 on the phosphorylation of ERK1/2 and RSK1/2 are shown. As the results show, 
pre-treating the fibre bundles with PD98059 completely abolished the DHT-induced 
increase in the phosphorylation of both ERK1/2 and RSK1/2 in the two fibre types (Fig. 
6C). Unlike, ERK and RSK, the untreated fibre bundles expressed mainly phosphorylated 
MSK and its phosphorylation was not significantly (p>0.05) affected by treatment with DHT 
except in the slow-twitch fibre bundles where it was slightly reduced (Fig. 6B).  
Although the results reported in the previous section clearly showed that DHT was exerting 
its effects on amino acid uptake through activation of the ERK1/2 module of the MAPK 
pathway. Its effects on the activation of the other modules have never been investigated. 
Therefore, in another experiment we determined the effects of DHT on the activation of c-
Jun N-terminal kinase (JNK) and p38 (stress-activated protein kinase, SAPK). As the 
results displayed in Fig. 6D show, under control conditions the slow-twitch fibre bundles 
always expressed higher levels of the phosphorylated proteins than the fast-twitch ones. 
Additionally, treating the fibre bundles with DHT did not significantly (p=0.08) affect the 
phosphorylation of both kinases in either fibre type (Fig. 6D). 
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Fig. 7 near here 
Another cell signalling pathway that has been implicated in the regulation of skeletal 
muscle mass (Glass, 2003) and hence amino acid uptake (Beugnet et al. 2003; Avruch et 
al. 2009) is the Akt (protein kinase B)/mammalian target of rapamycin (mTOR) pathway. 
Therefore, in another experiment we investigated the role of this pathway on the DHT-
induced increase in amino-acid uptake. As the results in Fig. 7 show, treatment of the 
muscle fibre bundles with deguelin  and rapamycin  decreased the basal uptake of L-[U-14 
C]Ile in both muscle fibre types; suggesting that this pathway plays an essential role in the 
maintenance of basal amino acid transport in mammalian skeletal muscle fibres. 
Additionally, pre-treating the fibre bundles with rapamycin completely abolished the DHT-
induced changes in amino acid uptake seen in the fast-twitch muscle fibres (Fig. 7B). In 
contrast, pre-treating the fibre bundles with deguelin blunted, without completely 
abolishing, the DHT-induced increase in L-[U-14 C] Ile uptake in the fast-twitch muscle fibre 
bundles (Fig. 7A). 
DHT increases protein synthesis in isolated intact mammalian skeletal muscle fibre 
bundles 
To determine whether the effects of DHT on amino acid uptake involved an increase in 
transcription or translation, another set of fibre bundles was treated with either the 
transcriptional inhibitor actinomycin D or translational inhibitor cyclohexamide. The uptake 
of L-[U-14 C] Ile was then examined in the presence or absence of DHT. As the results in 
Fig.8 show, treatment of the fibre bundles with actinomycin D alone did not significantly 
(p=0.47 in the fast-twitch and 0.13 in the slow-twitch fibre bundles) affect the basal uptake 
of L-[U-14 C]Ile in either fibre type. However, pre-treatment of the fibre bundles with it 
significantly (p=0.001) reduced the DHT-induced increase in L-[U-14 C]Ile uptake without 
completely abolishing it (Fig. 8A). In contrast, treatment of the fibre bundles with 
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cyclohexamide significantly (p<0.05) reduced the basal uptake of L-[U-14 C]Ile in both fibre 
types and pre-treating another set of fibre bundles with it completely abolished the DHT-
induced increase in L-[U-14 C]Ile observed in the fast-twitch fibre bundles (Fig. 9A). 
Fig. 8 near here 
Upon activation, MAPKs can translocate into the nucleus where they regulate gene 
expression by phosphorylating many transcription factors including C-jun, c-myc and ATF 
(Krishna & Narag, 2008). Therefore, in another experiment, we examined the effects of 
DHT on some of these transcription factors as well as the translational regulator, 
eukaryotic elongation factor (eEF) 2. As the results displayed in Fig. 8B show, treating the 
muscle fibre bundles with DHT had little or no effect on the expression and activation of 
cmyc, MyoD, and c- Jun. On the other hand, it increased the phosphorylation of ATF2 (Fig. 
8B) and completely abolished that of eEF2 in both fibre types (Fig. 9B). Furthermore, 
treatment of the muscle fibre bundles with DHT significantly (p<0.05) increased the 
incorporation of Ile into proteins in the fast-twitch fibre bundles. In contrast, it led to a slight 
(9.8±5.6%, n=3 fibres) decrease in Ile incorporation in the slow-twitch fibre bundles (Fig. 
9C); suggesting that DHT treatment was also regulating protein synthesis in the fibre 
bundles. 
Fig. 9 near here 
Discussion 
A key finding in the present study was the observation that treating small skeletal muscle 
fibre bundles isolated from the edl and soleus of adult female mice with physiological 
concentrations (630pgml-1) of DHT, for 1hr, significantly (p=0.001) increased the uptake of 
both Ile and MeAiB in the fibre bundles isolated from the edl but not in those isolated from 
the soleus. Although the acute administration of hormones such as insulin (Biolo et al. 
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1995), insulin-like growth factor 1 (IGF-1) (Fryburg et al. 1995) and growth hormone 
(Fryburg et al. 1995) has been shown to increase protein synthesis and to promote amino 
acid uptake in human skeletal muscle, this is the first time that an increase in amino acid 
uptake in response to the acute administration of an anabolic-androgenic steroid in adult 
mammalian skeletal muscle has been demonstrated. Only two other studies have 
previously investigated the effects of T on amino acid uptake. Both studies used human 
subjects and were unable to demonstrate any changes in amino acid uptake in whole 
muscle groups (Bashin et al. 1997; Ferrado et al.1998). Although small skeletal muscle 
fibre bundles were used in the present study and T was applied directly to the fibre 
bundles, it is important to note that T had no effect on amino acid uptake in either fibre 
type. In contrast, treating the fibre bundles with DHT led to a marked increase in the 
uptake of both Ile and MeAIB in the fast-twitch fibre bundles only (Fig.1). Previously, we 
have also shown that T has no acute effects on force production in isolated intact mouse 
skeletal muscle fibre bundles; whereas, DHT increased force production in the fast-twitch 
fibre bundles but decreased it in the slow-twitch ones (Hamdi & Mutungi, 2010). Taken 
together, these findings suggest that T may not have any acute/non-genomic effects in 
adult mammalian skeletal muscle fibres. 
As mentioned in the introduction, in most tissues T is converted into DHT by the enzyme 
5α-reductase. Therefore, it is likely that all the acute effects of T observed previously in 
cultured myocytes (Estrada et al. 2003) may have been exerted by DHT. Indeed, it has 
previously been suggested that the anabolic effects of T, in human skeletal muscles, may 
be indirect or secondary to the release of another hormone such as IGF-1 (Ferrado et al. 
1998). Here we speculate that in addition to IGF-1, the effects of T in mammalian skeletal 
muscle may also be exerted through the release of DHT. We also suggest that DHT is the 
main anabolic-androgenic steroid in adult mammalian skeletal muscles. 
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Although all the experiments reported here were performed using muscle fibre bundles 
isolated from female mice, we suggest that these hormones have similar effects in muscle 
bundles isolated from male mice. Indeed, we have previously shown that DHT has similar 
effects on force production in male and female mouse skeletal muscle fibre bundles 
(Hamdi & Mutungi, 2010). The main reason we used female muscles in this study was to 
avoid previous exposure to these hormones as these may compromise their effects (see 
Exner et al. 1973a & b). As mentioned in the introduction, anabolic-androgenic steroids are 
major determinants of body composition and their presence or absence in plasma has 
huge effects on body structure and composition (Wilson et al., 1988; Bhasin et al. 2001; 
Herrera & Regnier, 1993). Therefore, we speculate that the presence of these hormones in 
males may be the main reason male muscles are larger and stronger muscle than those of 
females. Indeed, in frogs the flexor carpi radialis muscle has been shown to be dimorphic 
and sensitive to testosterone (Regnier & Herrera, 1993). However, whether the differences 
between the muscles of males and females are due to these hormones only is uncertain 
and further investigation is needed. 
Amino acids enter and leave cells through highly specialized proteins known as amino acid 
carriers or transporters. Moreover, each cell expresses numerous varieties of these 
transporters (Christensen, 1990). As the data displayed in Fig. 2 and Fig.3 shows, in 
addition to other transporters, adult mouse fast- and slow-twitch skeletal muscle fibres 
express both SNAT2 (a system A amino acid transporter) and LAT2 (an amino acid 
transporter belonging to system L). Although mRNAs for these transporters have 
previously been identified in mammalian skeletal muscle (Utsunomiya-Tate et al. 1996; 
Segawa et al. 1999; Pineda et al. 1999; Yao et al. 2000; Hyde et al. 2001; Sugawara et al. 
2000), this is the first time the protein for LAT2 has been shown to be present in adult 
mammalian skeletal muscle. It is also the first time the expression of both transporters in 
different muscle fibre types has been described. As the data we display in Fig.2 show, the 
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untreated slow-twitch muscle fibre bundles express more (~1.8 times) transporter proteins 
than the corresponding fast-twitch fibres. However, whether this difference is 
physiologically important is uncertain and further studies are necessary. 
It is now generally accepted that certain nutrients such as amino acids are essential for the 
maintenance of tissue structure, growth and function. Therefore, it has been suggested 
that their uptake and release by cells is highly regulated. Although many factors including 
pH (Yao et al. 2000; Sugawara et al. 2000), osmolarity (Horio et al. 1997), intracellular 
amino acid levels (Gazzola et al. 1972; Drummond et al. 2010), hormones (Edmonson and 
Lumeng, 1980; Barber et al. 1982), growth factors (Moule and McGivan, 1987) and 
mitogens (Franchi-Gazzola et al. 1999) have been shown to regulate the expression and 
activity of SNAT2 (so called adaptive response) in many cell types, far less is known about 
the factors that control the activity and function of L-type amino acid transporters. The 
results we report in this study (see Fig. 2 and Fig. 3) show that although DHT increases 
the activity of SNAT2, it does not affect its expression. Instead, it increases the activity and 
expression of LAT2 (see Fig. 3). Furthermore, preloading the muscle fibre bundles with the 
classical system A and L-type amino acid inhibitors led to a marked decrease in the basal 
uptake of L-[U-14 C]Ile in both fibre types and completely abolished the DHT-induced 
increase in Ile uptake. Similar effects were also observed when the fibre bundles were 
treated with Ringers solution containing an antibody against LAT2 (see Fig. 3C); 
suggesting that the effects of DHT on Ile are mediated through this transporter. From 
these observations we suggest that the two transporters (LAT2, SNAT2) are somehow 
linked. Thus, by modulating the expression and activity of LAT2, DHT also seems to 
indirectly regulate the activity of SNAT2. This type of coupling, commonly referred to as 
tertiary active transport, has been previously reported and is thought to exist in most cells 
(Hyde et al. 2007; Baird et al. 2009). Indeed, recent data published by Drummond and his 
co-workers suggest that it may also exist between SNAT2 and LAT1 in human skeletal 
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muscle (Drummond et al. 2010); suggesting that this type of coupling may be widespread 
in skeletal muscle. However, further studies to confirm this are necessary. 
Previously, we have shown that the acute/non-genomic actions of DHT on force 
production in adult mouse skeletal muscle fibre bundles are mediated through the 
epidermal growth factor receptor (EGFR) and involve activation of ERK1/2 (Hamdi & 
Mutungi, 2010). It is interesting to note that the results we report here suggest that the 
acute/non-genomic actions of DHT on amino acid uptake in adult mammalian skeletal 
muscle fibres are also mediated through the same receptor and pathway. However, as the 
data presented in Fig. 4 show, involvement of the classical androgen receptors in the 
DHT-mediated increase in amino acid uptake cannot be ruled out. Thus, pre-treating the 
fibre bundles with either cyproterone (Fig. 4A) or flutamide (Fig. 4B) significantly (p<0.05) 
blunted the effects of DHT on Ile uptake without completely abolishing them. Previously, it 
has been suggested that testosterone can activate the MAPK pathway via a G-protein 
coupled androgen receptor (Estrada et al. 2003). However, whether this mechanism(s), 
commonly referred to as transactivation, is the one that mediates the acute/non-genomic 
effects of DHT in adult mammalian skeletal muscle fibres is uncertain and further research 
to clarify this is necessary.. 
Upon activation, ERK1/2 can either remain in the cytosol or translocate into the nucleus 
where it plays a critical role in the regulation of both gene expression and DNA replication 
(Brunet et al. 1999). In the nucleus, ERK1/2 phosphorylates an array of targets, including 
many transcription factors and a family of RSK-related kinases, the mitogen- and stress-
activated protein kinases (MSKs) (Deak et al. 1998). Although a large number of the 
downstream targets of ERK1/2 were examined in the present study, DHT treatment 
increased the phosphorylation of RSK1/2 and ATF2 only. Additionally, DHT had no effect 
on the phosphorylation of the other MAPK modules. To us, these findings suggest that the 
acute/non-genomic actions of DHT in adult mammalian skeletal muscles are exerted 
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mainly through the EGFR and involve activation of the ERK1/2 module of the MAPK 
pathway (for details see Fig.10). Our hypothesis is that DHT, either directly or indirectly, 
activates the EGFR which in turn activates the MAPK pathway leading to an increase in 
amino acid transport into the fibres and protein synthesis by the fibres. Furthermore, DHT 
seems to target mainly fast-twitch fibres.  
In adult animals, an increase in skeletal muscle mass (hypertrophy) occurs mainly as a 
result of an increase in the size rather than the number of muscle fibres and is generally 
thought to be regulated by the Akt)/ mTOR pathway (Glass, 2003). The Akt/mTOR 
pathway is activated by many stimuli including growth factors, hormones and nutrients. 
Moreover, its activation culminates in the block of apoptosis, induction of protein synthesis, 
gene transcription and cell proliferation (Dann et al. 2007). Therefore, we expected that 
DHT and T would activate this pathway. However, as the results displayed in Fig.7 show, 
the AKT specific inhibitor degulin blunted the DHT-induced amino acid uptake in fast-twitch 
fibres without completely abolishing it; thereby suggesting that the acute/non-genomic 
actions of DHT are not mediated through Akt. Instead, the results we present suggest that 
DHT increases protein synthesis by regulating the translation of mRNA already present in 
the cells. Indeed, treatment of the muscle fibre bundles with DHT led to a marked 
decrease in the phosphorylation of eEF2 and a moderate (~50%) increase in protein 
synthesis in the fast skeletal muscle fibre bundles (see Fig. 9C). Furthermore, pre-treating 
the fibre bundles with the translational inhibitor cyclohexamide completely abolished the 
DHT-induced increase in amino acid uptake. Cyclohexamide is a glutarimide antibiotic that 
binds the E-site on the 60S ribosomal subunit thereby inhibiting the binding of eEF2 on this 
site and tRNA translocation from the A-site to the P-site (Schneider-Petsch et al. 2010).  
Therefore, both of these observations provide further evidence in support of our 
hypothesis that DHT increases amino acid uptake by increasing mRNA translation. 
However, this cannot be the only mechanism involved because pre-treating the fibre 
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bundles with the transcriptional inhibitor actinomycin D also abolished the DHT-induced 
increase in amino acid uptake. However, as DHT did not increase the activity of many of 
the transcription factors examined in this study, we hypothesis that it increases the 
transcription of genes that are already active. 
It is also noteworthy that pre-treating the fibre bundles with the mTOR specific inhibitor 
rapamycin not only reduced the basal uptake of Ile, it also completely abolished the DHT-
induced increase in the uptake of Ile in the fast-twitch fibre bundles. To us these findings 
suggest that some of the acute/non-genomic effects of DHT are probably mediated 
through mTOR. Indeed, a number of studies have suggested that mTOR is the link 
between amino acid availability and increased protein synthesis (Avruch et al. 2009; 
Beugnet et al. 2003). However, rapamycin can also induce autophagy (Ravikumar et al. 
2004). Therefore, another possibility is that its effects are due to a build up of amino acids 
in the muscle fibres. However, the exact mechanism underlying the effects of rapamycin is 
uncertain and further studies are necessary. 
In summary, the results we report in this study show that another physiological function of 
the acute/non-genomic actions of DHT in adult mammalian skeletal muscle fibres is to 
increase the uptake of essential amino acids. Although we cannot completely rule out 
androgen receptor involvement, the main findings suggest that the increase in amino acid 
uptake and protein synthesis are mediated through the EGFR and involve the activation of 
the ERK1/2 module of the MAPK pathway which in turn activates RSK1/2 leading to an 
increase in the expression of the L-type amino acid transporter LAT2. 
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Table 1.  The proteins/receptors whose effect was being investigated and the inhibitors used 
PROTEIN/PROCESS                                                                           INHIBITORS 
Scientific name                                                  Common name              Concentration               Source 
Transcription Actinomycin IV Actinomycin D 1µgml-1 Sigma-Aldrich  
Translation 3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-
hydroxyethyl]glutarimide 
Cyclohexamide 10µgml-1 Sigma-Aldrich  
LAT2 
 
2-Aminobicyclo[2,2,1]heptane-2-carboxylic 
acid 
BCH 100µM Sigma-Aldrich  
Androgen receptor 6-Chloro-1β,2β-dihydro-17-hydroxy-3′H-
cyclopropa(1,2)-pregna-1,4,6-triene-3,20-
dione acetate 
Cyproterone 1µM Sigma-Aldrich 
 2-Methyl-N-(4-nitro-3 
[trifluoromethyl]phenyl)propanamide 
Flutamide 3µM Sigma-Aldrich 
SNAT2 2,N-Dimethylalanine,2 (Methylamino)-2-
methylpropionic acid 
MeAIB 10μM Sigma-Aldrich 
EGFR (N-[3-chlorophenyl]-6,7,-dimethoxy-4-
quinazolamine) 
 AG 1478 100nM Sigma-Aldrich  
MEK 2´-amino-3´-methoxyflavone PD98059 20μM Alexis 
Biochemicals 
Akt (7aS,13aS)-13,13a-Dihydro-9,10-dimethoxy-
3,3-dimethyl-3H-bis[1]benzopyrano[3,4-
b:6′,5′-e]pyran-7(7aH)-one 
Deguelin 10nM Sigma-Aldrich  
mTOR 23,27-Epoxy-3H-pyrido[2,1-
c][1,4]oxaazacyclohentriacontine 
Rapamycin 100ngml -1 Sigma-Aldrich 
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Figure legends 
Figure 1. DHT but not T increases amino acid uptake in fast-twitch skeletal muscle 
fibre bundles  
Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) twitch 
fibre bundles with physiological levels of DHT (A, B) and T (C,D) on the uptake of L-[U-14 
C]Ile (A,C) and α-[1-14C]-MeAIB (B,D). Note that treating the fibre bundles with DHT, but 
not T, significantly (p=0.001) increases the uptake of both L-[U-14 C]Ile and α-[1-14C]-
MeAIB) in the fast-twitch fibre bundles. In contrast, DHT had little effect on the uptake of 
both amino acids in the slow-twitch bundles. * p<0.05 when the data indicated by the 
asterisk was compared to that recorded under control conditions. 
Figure 2. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre 
bundles are partly mediated through a system A amino acid transporter 
 (A) Bar graphs showing the effects of treating fast-twitch (filled bars) and slow-twitch 
(clear bars) muscle fibre bundles with DHT and MeAIB, as shown, on the uptake of L-[U-14 
C]Ile. (B) A representative Western blot and summary data showing the effects of DHT on 
the expression of SNAT2 in cytosolic proteins extracted from fast- (F, filled bars) and slow- 
(S, clear bars) twitch muscle fibre bundles. Note that treating the muscle fibre bundles with 
MeAIB significantly (p<0.05) reduces the basal as well as the DHT-induced increase in Ile 
uptake in both fibre types. Furthermore the antibody labels a single band with a molecular 
weight (MW) of ~60kDa and that DHT treatment has no effect on the expression of 
SNAT2. FT and ST are the fast- and slow-twitch preparations treated with DHT, 
respectively. *$ indicate p<0.05 when the data shown was compared to that recorded 
under control conditions (*) or after DHT treatment ($). 
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Figure 3. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre 
bundles are mediated through LAT2 
 (A) Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) 
twitch muscle fibre bundles with DHT and BCH, as shown, on the uptake of L-[U-14 C]Ile. 
(B) A typical Western blot and summary data showing the effects of DHT on the 
expression of LAT2 in membrane proteins extracted from fast- (F, filled bars) and slow- (S, 
clear bars) twitch fibre bundles. Note that treating the muscle fibre bundles with BCH 
significantly (p<0.05) reduces the basal as well as the DHT-induced increase in Ile uptake 
in both fibre types. Additionally, the antibody labels a single band with a MW of ~60kDa 
and that DHT treatment increases the expression of LAT2 in the fast-twitch fibres only. FT 
and ST are the fast- and slow-twitch preparations treated with DHT, respectively. *$ 
indicate p<0.05 when the data shown was compared to that recorded under control 
conditions (*) or after DHT treatment ($). 
Figure 4. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre 
bundles are partly mediated through the androgen receptor  
Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) twitch 
skeletal muscle fibre bundles with the standard Ringer’s solution or the Ringer’s solution 
plus physiological levels of DHT alone or DHT plus the androgen receptor inhibitors 
cyproterone (A) and flutamide (B). Note that treatment of the fibre bundles with 
cyproterone alone significantly (p=0.001 and 0.005 in the fast- and slow-twitch fibres, 
respectively) increases the basal uptake of L-[U-14 C]Ile in both fibre types. In contrast, 
flutamide on its own significantly (p=0.028) increases amino acid uptake in the fast-twitch 
fibre bundles only. Additionally, pre-treating the fibre bundles with both compounds 
significantly (p<0.05) reduces the DHT-induced increase in Ile uptake. However, these 
effects were greater in the fibre bundles pre-treated with flutamide than in those pre-
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treated with cyproterone. *$ indicate p<0.05 when the data shown was compared to that 
recorded under control conditions (*) or following DHT treatment ($). 
Figure 5. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre 
bundles are mediated through the epidermal growth factor receptor (EGFR)  
(A) Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) 
twitch muscle fibre bundles with either DHT or tyrphostin AG1478 as shown in the figure. 
Note that treating the fibre bundles with AG1478 significantly (p<0.05) reduces the basal 
uptake of (L-[U-14 C] Ile) in both fibre types. Also, it completely abolishes the DHT-induced 
increase in amino acid uptake in the fast-twitch muscle fibre bundles.  (B) A Western blot 
showing the effects of treating the muscle fibre bundles with DHT alone or DHT plus 
AG1478 on the phosporylation of the EGFR in membrane proteins. Note that the antibody 
labels a single band with a MW of ~170kDa and that treating the bundles with DHT 
increases the phosphorylation of EGFR and this effect is completely reversed by AG1478. 
*$ indicate p<0.05 when the data shown was compared to that recorded under control 
conditions (*) or after DHT treatment ($). 
Figure 6. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre 
bundles are mediated through the ERK-pathway 
(A) Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) 
twitch muscle fibre bundles with either DHT or the MEK inhibitor PD98059, as shown in 
the figure, on the uptake of L-[U-14 C]Ile. Note that treating the fibre bundles with PD98059 
significantly reduces the basal uptake of Ile in both fibre types. Also, it completely 
abolishes the DHT-induced increase in Ile. (B) Western blots showing the effects of 
treating muscle fibre bundles with DHT on the phosphorylation of ERK1/2, RSK1/2 and 
MSK1/2. Note that treating the muscle fibre bundles with DHT increases the 
phosphorylation of ERK1/2 and RSK1/2 but not that of MSK1/2. (C) Western blots showing 
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the effects of treating small muscle fibre bundles with DHT and PD98059 (as shown) on 
the cytosolic concentrations of phosphorylated ERK1/2 and RSK1/2. Note that the pERK 
antibody labels two bands with MWs of ~42 and 44kDa; whereas, that of pRSK labels two 
bands with MWs of ~78 and 80kDa. Furthermore, treating the bundles with DHT increases 
the phosphorylation of ERK1/2 and RSK1/2 and that pre-treatment of the fibre bundles 
with PD98059 completely abolishes the effects of DHT. (D) Typical western blots showing 
the effects of DHT on the cytosolic concentrations of phosphorylated JNK and p38. Note 
that the pJNK antibody labels a single band with a MW ~60kDa; whereas, that of pp38 
labels a band with a MW of ~42kDa. Furthermore, DHT treatment has no effect on the 
phosphorylation of either kinase. *$ indicate p<0.05 when the data shown was compared 
to that recorded under control conditions (*) or after DHT treatment ($). 
Figure 7. The effects of DHT on amino acid uptake in mouse skeletal muscle fibre 
bundles are not mediated through the Akt 
(A) and (B) Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear 
bars) twitch muscle fibre bundles, with the compounds shown below each panel, on the 
uptake of L-[U-14 C]Ile. Note that treating the fibre bundles with either deguelin or 
rapamycin alone significantly (p=0.033 for deguelin and 0.025 for rapamycin) reduces the 
basal uptake of L-[U-14 C] Ile in both fibre types. Furthermore, rapamycin but not deguelin 
abolished the DHT-induced increase in Ile uptake. *$ indicate p<0.05 when the data 
shown was compared to that recorded under control conditions (*) or after DHT treatment 
($). 
Figure 8. Actinomycin D blunts the effects of DHT on amino acid uptake in mouse 
skeletal muscle fibre bundles 
(A) Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) 
twitch muscle fibre bundles with Ringer’s solution containing either DHT or actinomycin D 
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on the uptake of L-[U-14 C]Ile. Note that treating the muscle fibre bundles with actinomycin 
D alone had no effect on the basal uptake of Ile in both fibre types. Moreover, it blunts 
without completely abolishing the DHT-induced increase in Ile uptake. (B) Representative 
Western blots showing the effects of DHT on the expression of pc-Jun, myoD, cmyc and 
pATF2. Note that DHT does not significantly (p>0.05) affect the 
phosphorylation/expression of any of the transcriptional factors except ATF2. *$ indicate 
p<0.05 when the data shown was compared to that recorded under control conditions (*) 
or after DHT treatment ($). 
Figure 9. Actinomycin D blunts the effects of DHT on amino acid uptake in mouse 
skeletal muscle fibre bundles 
(A) Bar graphs showing the effects of treating fast- (filled bars) and slow- (clear bars) 
twitch muscle fibre bundles with Ringer’s solution containing either DHT or cyclohexamine 
on the uptake of L-[U-14 C]Ile. Note that treating the muscle fibre bundles with 
cyclohexamide significantly (p<0.05) reduces the basal uptake of Ile in both fibre types. 
Moreover, pre-treatment of the fibre bundles with it completely abolishes the DHT-induced 
increase in Ile uptake. (B) Representative Western blots showing the effects of DHT on the 
phosphorylationof eEF2. Note that the antibody labels a single band with a MW of 
~100kDa. Moreover, treatment of the muscle fibre bundles with DHT completely abolishes 
the phosphorylation of the protein in both fibre types. (C) Summary data showing the 
effects of treating muscle fibre bundles with DHT on Ile incorporation into the muscle fibre 
bundles. Note that treating the muscle fibre bundles with DHT significantly (p=0.004) 
increases the uptake of Ile in the fast-twitch fibre bundles. In contrast it leads to a slight 
decrease (9.8 ± 5.6%, n=3 fibres) in the incorporation of Ile in the slow-twitch fibre 
bundles.*$ indicate p<0.05 when the data shown was compared to that recorded under 
control conditions (*) or after DHT treatment ($). 
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Figure 10. Cell signalling pathway mediating the effects of DHT on amino acid 
transport in mammalian skeletal muscle fibres 
A schematic diagram showing the cellular signalling pathway we suggest mediates the 
acute effects of DHT on amino acid in mammalian skeletal muscle fibre bundles. Our 
hypothesis is that DHT, through an unknown mechanism, activates the EGFR and this 
leads to the activation of RSK1/2 by ERK1/2. The activated RSK1/2 then increases the 
activity and expression of LAT2 (blue circle with a cross) which in turn increases the 
transport of Ile into the muscle fibre bundles. Additionally, RSK1/2 enhances the mRNA 
translation into proteins. Note that the transport of Ile is coupled to that of small neutral 
amino acids such as Glutamine (Gln) that are transported into the cell by system A amino 
acid transporters such as SNAT2 (red circle with a cross). Thus, an increase in the activity 
of LAT2 indirectly increases the activity of SNAT2. The eventual effects of all these 
processes are to increase protein synthesis and hence skeletal muscle mass especially in 
fast-twitch muscle fibres. 
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